<!DOCTYPE html>
<html>
<head>

      <meta http-equiv="Content-Type" content="text/html; charset=utf-8">

        <script> var url = encodeURIComponent('https://www.mdpi.com/journal/biomolecules');</script>

        <script> var body_html = '<body> <div > <div > <div > <a > <h2>25th Anniversary</h2> </a> <a > <h2>Journals</h2> </a> <div > <div > <h2>Information</h2> </div> <div > <div > <div > <a >For Authors</a> <a >For Reviewers</a> <a >For Editors</a> <a >For Librarians</a> <a >For Publishers</a> <a >For Societies</a> </div> <div > <a >Article Processing Charges</a> <a >Open Access Policy</a> <a >Institutional Open Access Program</a> <a >Editorial Process</a> <a >Awards</a> <a >Research and Publication Ethics</a> </div> </div> </div> </div> <a > <h2>Author Services</h2> </a> <div > <div > <h2>Initiatives</h2> </div> <div > <div > <div > <a >Sciforum</a> <a >MDPI Books</a> <a >Preprints</a> <a >Scilit</a> <a >SciProfiles</a> <a >Encyclopedia</a> <a >JAMS</a> <a >Proceedings Series</a> </div> </div> </div> </div> <a > <h2>About</h2> </a> </div> <div > <a >Sign In / Sign Up</a> </div> </div> </div> <div > <h2 >Notice</h2> <a > <i >clear</i> </a> </div> <div > <div > <div > <h2 >Notice</h2> <p> You are accessing a machine-readable page. In order to be human-readable, please install an RSS reader. </p> </div> </div> <div > <div > <a >Continue</a> <a >Cancel</a> </div> </div> <a > <i >clear</i> </a> </div> <div > <p> All articles published by MDPI are made immediately available worldwide under an open access license. No special permission is required to reuse all or part of the article published by MDPI, including figures and tables. For articles published under an open access Creative Common CC BY license, any part of the article may be reused without permission provided that the original article is clearly cited. </p> </div> <div > <p> Feature Papers represent the most advanced research with significant potential for high impact in the field. Feature Papers are submitted upon individual invitation or recommendation by the scientific editors and undergo peer review prior to publication. </p> <p> The Feature Paper can be either an original research article, a substantial novel research study that often involves several techniques or approaches, or a comprehensive review paper with concise and precise updates on the latest progress in the field that systematically reviews the most exciting advances in scientific literature. This type of paper provides an outlook on future directions of research or possible applications. </p> </div> <div > <p> Editor’s Choice articles are based on recommendations by the scientific editors of MDPI journals from around the world. Editors select a small number of articles recently published in the journal that they believe will be particularly interesting to authors, or important in this field. The aim is to provide a snapshot of some of the most exciting work published in the various research areas of the journal. </p> </div> <div > <div >  </div> <section > <header> <div > <div > <div > <ul> <li > <a >25th Anniversary</a> </li> <li > <a >Journals</a> </li> <li > <a >Information</a> <ul > <li> <div > <div > <ul> <li> <a >For Authors</a> </li> <li> <a >For Reviewers</a> </li> <li> <a >For Editors</a> </li> <li> <a >For Librarians</a> </li> <li> <a >For Publishers</a> </li> <li> <a >For Societies</a> </li> </ul> </div> <div > <ul> <li> <a >Article Processing Charges</a> </li> <li> <a >Open Access Policy</a> </li> <li> <a >Institutional Open Access Program</a> </li> <li> <a >Editorial Process</a> </li> <li> <a >Awards</a> </li> <li> <a >Research and Publication Ethics</a> </li> </ul> </div> </div> </li> </ul> </li> <li > <a >Author Services</a> </li> <li > <a >Initiatives</a> <ul > <li> <div > <div > <ul> <li> <a > Sciforum </a> </li> <li> <a > MDPI Books </a> </li> <li> <a > Preprints </a> </li> <li> <a > Scilit </a> </li> <li> <a > SciProfiles </a> </li> <li> <a > Encyclopedia </a> </li> <li> <a > JAMS </a> </li> <li> <a > Proceedings Series </a> </li> </ul> </div> </div> </li> </ul> </li> <li > <a >About</a> </li> </ul> </div> <div > <div> <a >Sign In / Sign Up</a> <a >Submit</a> </div> </div> </div> </div> <div > <div > <div > <div > <a > Covered in: PubMed </a> </div></div> <div > <div > <a > IMPACTFACTOR 4.879 </a> </div> </div> </div> <div > Journals </div> <div > Biomolecules </div> </div> </header> <div > <div > <div > <div > <div > <ul > <li> <a > <div > Clinical Perspectives of Single-Cell RNA Sequencing </div> </a> </li> <li > <a > <div > The Bigger Picture: Why Oral Mucosa Heals Better Than Skin </div> </a> </li> <li > <a > <div > Pathophysiological Roles of Histamine Receptors in Cancer Progression: Implications and Perspectives as Potential Molecular Targets </div> </a> </li> <li > <a > <div > TGFβ-Neurotrophin Interactions in Heart, Retina, and Brain </div> </a> </li> <li > <a > <div > Insight into Calcium-Binding Motifs of Intrinsically Disordered Proteins </div> </a> </li> </ul> </div> </div> <div > <div > <h2 >Journal Description</h2> </div> <div > <div > <h1> Biomolecules </h1> <div > Biomolecules is a <a >peer-reviewed</a>, open access journal on structures and functions of bioactive and biogenic substances, molecular mechanisms with biological and medical implications as well as biomaterials and their applications. Biomolecules is published monthly online by MDPI. The <a >Spanish Society for Biochemistry and Molecular Biology (SEBBM)</a> is affiliated with Biomolecules and their members receive discounts on the article processing charges. <ul> <li>Open Access— free for readers, with <a >article processing charges (APC)</a> paid by authors or their institutions.</li> <li>High Visibility: indexed within <a >Scopus</a>, <a >SCIE (Web of Science)</a>, <a >PubMed</a>, <a >MEDLINE</a>, <a >PMC</a>, <a >Embase</a>, <a >CAPlus / SciFinder</a>, and many <a >other databases</a>.</li> <li>Journal Rank: <a >JCR</a> - Q2 (Biochemistry Molecular Biology)</li> <li>Rapid Publication: manuscripts are peer-reviewed and a first decision provided to authors approximately 16.3 days after submission; acceptance to publication is undertaken in 2.9 days (median values for papers published in this journal in the first half of 2021).</li> <li>Recognition of Reviewers: reviewers who provide timely, thorough peer-review reports receive vouchers entitling them to a discount on the APC of their next publication in any MDPI journal, in appreciation of the work done.</li> <li>Testimonials: See what our authors say about Biomolecules.</li> <li>Sections: published in twenty <a >topical sections</a>.</li> <li>Companion journal: <a >Receptors</a></li> </ul> </div> <div > Impact Factor: 4.879 (2020) ; 5-Year Impact Factor: 5.362 (2020) </div> <div> <a > <i >subject</i> Imprint Information </a> <a > <i >get_app</i> Journal Flyer </a> <a > Open Access </a> ISSN: 2218-273X </div> </div> </div> </div> <div > <div > <h2 >Latest Articles</h2> </div> <div > <div > <div > <div > <div > <a > <i >get_app</i> </a> </div> <div > <a > <i >subject</i> </a> <div > View online as: <a >Abstract Page</a> <a >Full-Text HTML</a> </div> </div> <div >Open AccessReview</div> Erectile Function and Sexual Behavior: A Review of the Role of Nitric Oxide in the Central Nervous System <div > by <span ><div >Maria Rosaria Melis</div> and </span><span ><div >Antonio Argiolas</div></span> </div> <div > Biomolecules <b>2021</b>, 11(12), 1866; https://doi.org/10.3390/biom11121866 (registering DOI) - 11 Dec 2021 </div> <div > Abstract <div > Nitric oxide (NO), the neuromodulator/neurotransmitter formed from l-arginine by neuronal, endothelial and inducible NO synthases, is involved in numerous functions across the body, from the control of arterial blood pressure to penile erection, and at central level from energy homeostasis regulation to [...] Read more. </div> <div > Nitric oxide (NO), the neuromodulator/neurotransmitter formed from l-arginine by neuronal, endothelial and inducible NO synthases, is involved in numerous functions across the body, from the control of arterial blood pressure to penile erection, and at central level from energy homeostasis regulation to memory, learning and sexual behavior. The aim of this work is to review earlier studies showing that NO plays a role in erectile function and sexual behavior in the hypothalamus and its paraventricular nucleus and the medial preoptic area, and integrate these findings with those of recent studies on this matter. This revisitation shows that NO influences erectile function and sexual behavior in males and females by acting not only in the paraventricular nucleus and medial preoptic area but also in extrahypothalamic brain areas, often with different mechanisms. Most importantly, since these areas are strictly interconnected with the paraventricular nucleus and medial preoptic area, send to and receive neural projections from the spinal cord, in which sexual communication between brain and genital apparatus takes place, this review reveals that central NO participates in concert with neurotransmitters/neuropeptides to a neural circuit controlling both the consummatory (penile erection, copulation, lordosis) and appetitive components (sexual motivation, arousal, reward) of sexual behavior. Full article </div> </div> <div > (This article belongs to the Section Biological Factors) </div> ►▼ Show Figures <div ><div ><div ><p>Figure 1</p></div></div></div> </div> </div> </div> <div > <div > <div > <div > <div > <a > <i >get_app</i> </a> </div> <div > <a > <i >subject</i> </a> <div > View online as: Abstract Page Full-Text HTML </div> </div> <div >Open AccessArticle</div> The Effect of Three-Month Vitamin D Supplementation on the Levels of Homocysteine Metabolism Markers and Inflammatory Cytokines in Sera of Psoriatic Patients <div > by <span ><div >Alma Prtina</div>, </span><span ><div >Nela Rašeta Simović</div>, </span><span ><div >Tatjana Milivojac</div>, </span><span ><div >Milorad Vujnić</div>, </span><span ><div >Milkica Grabež</div>, </span><span ><div >Dragan Djuric</div>, </span><span ><div >Miloš P. Stojiljković</div>, </span><span ><div >Valentina Soldat Stanković</div>, </span><span ><div >Miodrag J. Čolić</div> and </span><span ><div >Ranko Škrbić</div></span> </div> <div > Biomolecules <b>2021</b>, 11(12), 1865; https://doi.org/10.3390/biom11121865 (registering DOI) - 11 Dec 2021 </div> <div > Abstract <div > Psoriasis is an autoimmune and inflammatory skin disease. Psoriatic patients express higher levels of plasma homocysteine (Hcy) concentration and pro-inflammatory mediators than healthy people; this is frequently associated with vitamin D deficiency. The aim of this clinical study was to investigate the effects [...] Read more. </div> <div > Psoriasis is an autoimmune and inflammatory skin disease. Psoriatic patients express higher levels of plasma homocysteine (Hcy) concentration and pro-inflammatory mediators than healthy people; this is frequently associated with vitamin D deficiency. The aim of this clinical study was to investigate the effects of high doses of vitamin D supplementation on the parameters of Hcy metabolism and cytokines in sera of psoriatic patients. This prospective study was conducted on 40 psoriatic patients who had the vitamin D deficiency. All patients received vitamin D 5000 IU/day for three months. Clinical and biochemical measurements were taken at baseline and at follow up (3 months). The results showed that the severity of clinical features, measured by the psoriasis area severity index (PASI) score, were considerably improved in patients after vitamin D supplementation. After vitamin D supplementation, most of the patients (<i>n</i> = 25 or 62.5%) had mild clinical form (<i>p</i> &lt; 0.001). After twelve weeks of intervention period, there were significant increases in vitamin D and B<sub>12</sub> serum levels in comparison to the levels that had been measured at the beginning of the study (56.77 ± 14.66 nmol/L and 301.08 ± 95.02 pg/mL vs. 103.85 ± 32.20 nmol/L and 362.81 ± 118.56 pg/mL, respectively; <i>p</i> &lt; 0.001). Moreover, serum levels of Hcy and folate were significantly lower at the end of the study in comparison with the initial levels (12.45 ± 1.92 µmol/L and 8.01 ± 3.88 mg/mL vs. 10.38 ± 1.66 µmol/L and 6.27 ± 2.60 mg/mL, respectively). High doses of vitamin D supplementation led to a significant decrease in pro-inflammatory cytokines (IFN-ɤ, TNF-α, IL-1β, IL-6, IL-8, and IL-17) and high-sensitivity C-reactive protein (hsCRP), whereas the production of anti-inflammatory cytokines (IL-10, IL-5) was up-regulated. In conclusion, supplementation with high doses of vitamin D could be one of the possible preventive and therapeutic measures to reduce systemic inflammation in psoriatic patients. Full article </div> </div> <div > (This article belongs to the Special Issue Homocysteine: Biochemistry, Molecular Biology, and Role in Disease 2021) </div> ►▼ Show Figures <div ><div ><div ><p>Figure 1</p></div></div></div> </div> </div> </div> <div > <div > <div > <div > <a > <i >get_app</i> </a> </div> <div > <a > <i >subject</i> </a> <div > View online as: Abstract Page Full-Text HTML </div> </div> <div >Open AccessCommunication</div> <a >Activation of the α1β2γ2L GABA<sub>A</sub> Receptor by Physiological Agonists</a> <div > by <span ><div >Spencer R. Pierce</div>, </span><span ><div >Allison L. Germann</div> and </span><span ><div >Gustav Akk</div></span> </div> <div > Biomolecules <b>2021</b>, 11(12), 1864; https://doi.org/10.3390/biom11121864 (registering DOI) - 11 Dec 2021 </div> <div > Abstract <div > The Cl<sup>−</sup> permeable GABA<sub>A</sub> receptor is a major contributor to cellular inhibition in the brain. The receptor is normally activated by synaptically-released or ambient GABA but is sensitive to a number of physiological compounds such as β-alanine, taurine, and neurosteroids that, [...] Read more. </div> <div > The Cl<sup>−</sup> permeable GABA<sub>A</sub> receptor is a major contributor to cellular inhibition in the brain. The receptor is normally activated by synaptically-released or ambient GABA but is sensitive to a number of physiological compounds such as β-alanine, taurine, and neurosteroids that, to various degrees, activate the receptor and modulate responses either to the transmitter or to each other. Here, we describe α1β2γ2L GABA<sub>A</sub> receptor activation and modulation by combinations of orthosteric and allosteric activators. The overall goal was to gain insight into how changes in the levels of endogenous agonists modulate receptor activity and influence cellular inhibition. Experimental observations and simulations are described in the framework of a cyclic concerted transition model. We also provide general analytical solutions for the analysis of electrophysiological data collected in the presence of combinations of active compounds. Full article </div> </div> <div > (This article belongs to the Collection Feature Papers in Chemical Biology) </div> ►▼ Show Figures <div ><div ><div ><p>Figure 1</p></div></div></div> </div> </div> </div> <div > <div > <div > <div > <a > <i >get_app</i> </a> </div> <div > <a > <i >subject</i> </a> <div > View online as: Abstract Page Full-Text HTML </div> </div> <div >Open AccessArticle</div> The Association of Serum Circulating Neuropeptide Q and Chemerin Levels with Cardiometabolic Risk Factors among Patients with Metabolic Syndrome <div > by <span ><div >Marta Pelczyńska</div>, </span><span ><div >Aniceta Ada Mikulska</div>, </span><span ><div >Krystyna Czyżewska</div>, </span><span ><div >Paweł Bogdański</div> and </span><span ><div >Teresa Grzelak</div></span> </div> <div > Biomolecules <b>2021</b>, 11(12), 1863; https://doi.org/10.3390/biom11121863 (registering DOI) - 10 Dec 2021 </div> <div > Abstract <div > The potential involvement of neuropeptide Q (NPQ) and chemerin (CHEM) in metabolic disorders is yet to be fully elucidated. The aim of this study was to evaluate serum concentrations of NPQ and CHEM and to establish their relationship with cardiometabolic risk factors among [...] Read more. </div> <div > The potential involvement of neuropeptide Q (NPQ) and chemerin (CHEM) in metabolic disorders is yet to be fully elucidated. The aim of this study was to evaluate serum concentrations of NPQ and CHEM and to establish their relationship with cardiometabolic risk factors among individuals with metabolic syndrome. A total of 66 patients with metabolic syndrome (MetS) and 83 healthy volunteers (non-MetS) underwent biochemical, blood pressure, and anthropometric measurements. The concentration of NPQ in the MetS group was significantly lower (0.47 (0.34 ; 0.54) vs. 0.52 (0.43 ; 0.60) ng/mL, <i>p</i> = 0.015) than in non-MetS, while there were no differences in CHEM level. In the entire study population, we observed several negative correlations between NPQ concentration and waist-hip ratio (WHR), visceral adipose tissue, diastolic blood pressure (DBP), triglycerides (TG) along with a positive correlation with high-density lipoprotein (HDL), total muscle mass, and CHEM. Moreover, a negative correlation was observed in the MetS group between NPQ and glycemia. CHEM showed no significant correlations with cardiometabolic risk factors in the study population. In a multiple regression model, the total muscle mass proved to be an independent factor determining NPQ concentration in the population (<i>p</i> &lt; 0.00000001, <i>R</i><sup>2</sup><i><sub>adj</sub></i> = 28.6%). NPQ seems to protect against metabolic disorders correlated with obesity. Thus, it is worth considering NPQ level as a candidate protective biomarker of metabolic syndrome complications. Full article </div> </div> <div > (This article belongs to the Special Issue Obesity, Adipose Tissue and Cardiovascular Diseases) </div> </div> </div> </div> <div > <div > <div > <div > <a > <i >attachment</i> </a> <div > Supplementary material: Supplementary File 1 (ZIP, 1023 KiB) </div> </div> <div > <a > <i >get_app</i> </a> </div> <div > <a > <i >subject</i> </a> <div > View online as: Abstract Page </div> </div> <div >Open AccessArticle</div> AlphaFold-Predicted Structures of KCTD Proteins Unravel Previously Undetected Relationships among the Members of the Family <div > by <span ><div >Luciana Esposito</div>, </span><span ><div >Nicole Balasco</div>, </span><span ><div >Giovanni Smaldone</div>, </span><span ><div >Rita Berisio</div>, </span><span ><div >Alessia Ruggiero</div> and </span><span ><div >Luigi Vitagliano</div></span> </div> <div > Biomolecules <b>2021</b>, 11(12), 1862; https://doi.org/10.3390/biom11121862 - 10 Dec 2021 </div> <div > Abstract <div > One of the most striking features of KCTD proteins is their involvement in apparently unrelated yet fundamental physio-pathological processes. Unfortunately, comprehensive structure–function relationships for this protein family have been hampered by the scarcity of the structural data available. This scenario is rapidly changing [...] Read more. </div> <div > One of the most striking features of KCTD proteins is their involvement in apparently unrelated yet fundamental physio-pathological processes. Unfortunately, comprehensive structure–function relationships for this protein family have been hampered by the scarcity of the structural data available. This scenario is rapidly changing due to the release of the protein three-dimensional models predicted by AlphaFold (AF). Here, we exploited the structural information contained in the AF database to gain insights into the relationships among the members of the KCTD family with the aim of facilitating the definition of the structural and molecular basis of key roles that these proteins play in many biological processes. The most important finding that emerged from this investigation is the discovery that, in addition to the BTB domain, the vast majority of these proteins also share a structurally similar domain in the C-terminal region despite the absence of general sequence similarities detectable in this region. Using this domain as reference, we generated a novel and comprehensive structure-based pseudo-phylogenetic tree that unraveled previously undetected similarities among the protein family. In particular, we generated a new clustering of the KCTD proteins that will represent a solid ground for interpreting their many functions. Full article </div> </div> <div > (This article belongs to the Section Biomacromolecules: Proteins) </div> </div> </div> </div> <div > <div > <div > <div > <a > <i >get_app</i> </a> </div> <div > <a > <i >subject</i> </a> <div > View online as: Abstract Page </div> </div> <div >Open AccessArticle</div> The Effects of Angiotensin II or Angiotensin 1-7 on Rat Pial Microcirculation during Hypoperfusion and Reperfusion Injury: Role of Redox Stress <div > by <span ><div >Dominga Lapi</div>, </span><span ><div >Maurizio Cammalleri</div>, </span><span ><div >Massimo Dal Monte</div>, </span><span ><div >Martina Di Maro</div>, </span><span ><div >Maria Rosaria Santillo</div>, </span><span ><div >Anna Belfiore</div>, </span><span ><div >Gilda Nasti</div>, </span><span ><div >Simona Damiano</div>, </span><span ><div >Rossella Trio</div>, </span><span ><div >Martina Chiurazzi</div>, </span><span ><div >Barbara De Conno</div>, </span><span ><div >Nicola Serao</div>, </span><span ><div >Paolo Mondola</div>, </span><span ><div >Antonio Colantuoni</div> and </span><span ><div >Bruna Guida</div></span> </div> <div > Biomolecules <b>2021</b>, 11(12), 1861; https://doi.org/10.3390/biom11121861 (registering DOI) - 10 Dec 2021 </div> <div > Abstract <div > Renin–angiotensin systems produce angiotensin II (Ang II) and angiotensin 1-7 (Ang 1-7), which are able to induce opposite effects on circulation. This study in vivo assessed the effects induced by Ang II or Ang 1-7 on rat pial microcirculation during hypoperfusion–reperfusion, clarifying the [...] Read more. </div> <div > Renin–angiotensin systems produce angiotensin II (Ang II) and angiotensin 1-7 (Ang 1-7), which are able to induce opposite effects on circulation. This study in vivo assessed the effects induced by Ang II or Ang 1-7 on rat pial microcirculation during hypoperfusion–reperfusion, clarifying the mechanisms causing the imbalance between Ang II and Ang 1-7. The fluorescence microscopy was used to quantify the microvascular parameters. Hypoperfusion and reperfusion caused vasoconstriction, disruption of blood–brain barrier, reduction of capillary perfusion and an increase in reactive oxygen species production. Rats treated with Ang II showed exacerbated microvascular damage with stronger vasoconstriction compared to hypoperfused rats, a further increase in leakage, higher decrease in capillary perfusion and marker oxidative stress. Candesartan cilexetil (specific Ang II type 1 receptor (AT<sub>1</sub>R) antagonist) administration prior to Ang II prevented the effects induced by Ang II, blunting the hypoperfusion–reperfusion injury. Ang 1-7 or ACE2 activator administration, preserved the pial microcirculation from hypoperfusion–reperfusion damage. These effects of Ang 1-7 were blunted by a Mas (Mas oncogene-encoded protein) receptor antagonist, while Ang II type 2 receptor antagonists did not affect Ang 1-7-induced changes. In conclusion, Ang II and Ang 1-7 triggered different mechanisms through AT<sub>1</sub>R or MAS receptors able to affect cerebral microvascular injury. Full article </div> </div> <div > (This article belongs to the Special Issue Feature Papers in Section Molecular Medicine) </div> </div> </div> </div> <div > <div > <div > <div > <a > <i >get_app</i> </a> </div> <div > <a > <i >subject</i> </a> <div > View online as: Abstract Page </div> </div> <div >Open AccessReview</div> A Review on Microbial Products and Their Perspective Application as Antimicrobial Agents <div > by <span ><div >Alka Rani</div>, </span><span ><div >Khem Chand Saini</div>, </span><span ><div >Felix Bast</div>, </span><span ><div >Sunita Varjani</div>, </span><span ><div >Sanjeet Mehariya</div>, </span><span ><div >Shashi Kant Bhatia</div>, </span><span ><div >Neeta Sharma</div> and </span><span ><div >Christiane Funk</div></span> </div> <div > Biomolecules <b>2021</b>, 11(12), 1860; https://doi.org/10.3390/biom11121860 (registering DOI) - 10 Dec 2021 </div> <div > Abstract <div > <b> </b>Microorganisms including actinomycetes, archaea, bacteria, fungi, yeast, and microalgae are an auspicious source of vital bioactive compounds. In this review, the existing research regarding antimicrobial molecules from microorganisms is summarized. The potential antimicrobial compounds from actinomycetes, particularly <i>Streptomyces</i> spp.; archaea; fungi including endophytic, [...] Read more. </div> <div > <b> </b>Microorganisms including actinomycetes, archaea, bacteria, fungi, yeast, and microalgae are an auspicious source of vital bioactive compounds. In this review, the existing research regarding antimicrobial molecules from microorganisms is summarized. The potential antimicrobial compounds from actinomycetes, particularly <i>Streptomyces</i> spp.; archaea; fungi including endophytic, filamentous, and marine-derived fungi, mushroom; and microalgae are briefly described. Furthermore, this review briefly summarizes bacteriocins, halocins, sulfolobicin, etc., that target multiple-drug resistant pathogens and considers next-generation antibiotics. This review highlights the possibility of using microorganisms as an antimicrobial resource for biotechnological, nutraceutical, and pharmaceutical applications. However, more investigations are required to isolate, separate, purify, and characterize these bioactive compounds and transfer these primary drugs into clinically approved antibiotics. Full article </div> </div> <div > (This article belongs to the Topic Compounds with Medicinal Value) </div> </div> </div> </div> <div > <div > <div > <div > <a > <i >get_app</i> </a> </div> <div > <a > <i >subject</i> </a> <div > View online as: Abstract Page Full-Text HTML </div> </div> <div >Open AccessArticle</div> The Expression and Activity of Rhodanese, 3-Mercaptopyruvate Sulfurtransferase, Cystathionine γ-Lyase in the Most Frequently Chosen Cellular Research Models <div > by <span ><div >Marta Kaczor-Kamińska</div>, </span><span ><div >Kamil Kaminski</div> and </span><span ><div >Maria Wróbel</div></span> </div> <div > Biomolecules <b>2021</b>, 11(12), 1859; https://doi.org/10.3390/biom11121859 - 10 Dec 2021 </div> <div > Abstract <div > This paper provides information concerning the activity and expression levels of three sulfurtransferases (STRs): rhodanese (TST, EC: 2.8.1.1), 3-mercaptopyruvate sulfurtransferase (MPST, EC: 2.8.1.2) and cystathionine γ-lyase (CTH, EC: 4.4.1.1) in various cell lines. Since very limited data are available in the scientific literature [...] Read more. </div> <div > This paper provides information concerning the activity and expression levels of three sulfurtransferases (STRs): rhodanese (TST, EC: 2.8.1.1), 3-mercaptopyruvate sulfurtransferase (MPST, EC: 2.8.1.2) and cystathionine γ-lyase (CTH, EC: 4.4.1.1) in various cell lines. Since very limited data are available in the scientific literature on this subject, the available data are included in this paper. These shortages often force the researchers to carry out their own screening tests that allow them to choose an appropriate model for their further studies. This work supplements the existing deficiencies in this area and presents the activity and expression of STRs in the eight most frequently chosen cell lines: the mouse mammary gland cell line (NMuNG, ATCC: CRL-1636), mouse mammary gland tumor (4T1, ATCC: CRL-2539), mouse fibroblast (MEF, ATCC: SCRC-1008), mouse melanoma (B16-F1, ATCC: CRL-6323), human colorectal adenocarcinoma (Caco-2, ATCC: HTB-37), human embryonic kidney (HEK-293, ATCC: CRL-1573), human osteosarcoma (MG-63, ATCC: CRL-1427) and rat myocardium (H9c2, ATCC: CRL-1446). Changes in STRs activity are directly related to the bioavailability of cysteine and the sulfane sulfur level, and thus the present authors also measured these parameters, as well as the level of glutathione (its reduced (GSH) and oxidized (GSSG) form) and the [GSH]/[GSSG] ratio that determines the antioxidant capacity of the cells. STRs demonstrate diverse functionality and clinical relevance; therefore, we also performed an analysis of genetic variation of STRs genes that revealed a large number of polymorphisms. Although STRs still provide challenges in several fields, responding to them could not only improve the understanding of various diseases, but may also provide a way to treat them. Full article </div> </div> <div > (This article belongs to the Special Issue Hydrogen Sulfide and Polysulfides, Endogenous Mammalian Transmitters——Honorary Special Issue Commemorating the Work of Prof. Hideo Kimura) </div> ►▼ Show Figures <div ><div ><div ><p>Figure 1</p></div></div></div> </div> </div> </div> <div > <div > <div > <div > <a > <i >get_app</i> </a> </div> <div > <a > <i >subject</i> </a> <div > View online as: Abstract Page Full-Text HTML </div> </div> <div >Open AccessArticle</div> In Vitro Anti-SARS-CoV-2 Activity of Selected Metal Compounds and Potential Molecular Basis for Their Actions Based on Computational Study <div > by <span ><div >Damiano Cirri</div>, </span><span ><div >Tiziano Marzo</div>, </span><span ><div >Iogann Tolbatov</div>, </span><span ><div >Alessandro Marrone</div>, </span><span ><div >Francesco Saladini</div>, </span><span ><div >Ilaria Vicenti</div>, </span><span ><div >Filippo Dragoni</div>, </span><span ><div >Adele Boccuto</div> and </span><span ><div >Luigi Messori</div></span> </div> <div > Biomolecules <b>2021</b>, 11(12), 1858; https://doi.org/10.3390/biom11121858 - 10 Dec 2021 </div> <div > Abstract <div > Metal-based drugs represent a rich source of chemical substances of potential interest for the treatment of COVID-19. To this end, we have developed a small but representative panel of nine metal compounds, including both synthesized and commercially available complexes, suitable for medical application [...] Read more. </div> <div > Metal-based drugs represent a rich source of chemical substances of potential interest for the treatment of COVID-19. To this end, we have developed a small but representative panel of nine metal compounds, including both synthesized and commercially available complexes, suitable for medical application and tested them in vitro against the SARS-CoV-2 virus. The screening revealed that three compounds from the panel, i.e., the organogold(III) compound Aubipyc, the ruthenium(III) complex KP1019, and antimony trichloride (SbCl<sub>3</sub>), are endowed with notable antiviral properties and an acceptable cytotoxicity profile. These initial findings prompted us to perform a computational study to unveil the likely molecular basis of their antiviral actions. Calculations evidenced that the metalation of nucleophile sites in SARS-CoV-2 proteins or nucleobase strands, induced by Aubipyc, SbCl<sub>3</sub>, and KP1019, is likely to occur. Remarkably, we found that only the deprotonated forms of Cys and Sec residues can react favorably with these metallodrugs. The mechanistic implications of these findings are discussed. Full article </div> </div> <div > (This article belongs to the Special Issue Metal Binding Proteins 2022) </div> ►▼ Show Figures <div ><div ><div ><p>Figure 1</p></div></div></div> </div> </div> </div> <div > <div > <div > <div > <a > <i >attachment</i> </a> <div > Supplementary material: Supplementary File 1 (ZIP, 4545 KiB) </div> </div> <div > <a > <i >get_app</i> </a> </div> <div > <a > <i >subject</i> </a> <div > View online as: Abstract Page Full-Text HTML </div> </div> <div >Open AccessFeature PaperArticle</div> Salting-Out Approach Is Worthy of Comparison with Ultracentrifugation for Extracellular Vesicle Isolation from Tumor and Healthy Models <div > by <span ><div >Simona Serratì</div>, </span><span ><div >Antonio Palazzo</div>, </span><span ><div >Annamaria Lapenna</div>, </span><span ><div >Helena Mateos</div>, </span><span ><div >Antonia Mallardi</div>, </span><span ><div >René Massimiliano Marsano</div>, </span><span ><div >Alessandra Quarta</div>, </span><span ><div >Mario Del Rosso</div> and </span><span ><div >Amalia Azzariti</div></span> </div> <div > Biomolecules <b>2021</b>, 11(12), 1857; https://doi.org/10.3390/biom11121857 - 10 Dec 2021 </div> <div > Abstract <div > The role of extracellular vesicles (EVs) has been completely re-evaluated in the recent decades, and EVs are currently considered to be among the main players in intercellular communication. Beyond their functional aspects, there is strong interest in the development of faster and less [...] Read more. </div> <div > The role of extracellular vesicles (EVs) has been completely re-evaluated in the recent decades, and EVs are currently considered to be among the main players in intercellular communication. Beyond their functional aspects, there is strong interest in the development of faster and less expensive isolation protocols that are as reliable for post-isolation characterisations as already-established methods. Therefore, the identification of easy and accessible EV isolation techniques with a low price/performance ratio is of paramount importance. We isolated EVs from a wide spectrum of samples of biological and clinical interest by choosing two isolation techniques, based on their wide use and affordability: ultracentrifugation and salting-out. We collected EVs from human cancer and healthy cell culture media, yeast, bacteria and <i>Drosophila</i> culture media and human fluids (plasma, urine and saliva). The size distribution and concentration of EVs were measured by nanoparticle tracking analysis and dynamic light scattering, and protein depletion was measured by a colorimetric nanoplasmonic assay. Finally, the EVs were characterised by flow cytometry. Our results showed that the salting-out method had a good efficiency in EV separation and was more efficient in protein depletion than ultracentrifugation. Thus, salting-out may represent a good alternative to ultracentrifugation. Full article </div> </div> <div > (This article belongs to the Collection Molecular Biology: Feature Papers) </div> ►▼ Show Figures <div ><div ><div ><p>Figure 1</p></div></div></div> </div> </div> </div> <div > <div > <div > <div > <a > <i >attachment</i> </a> <div > Supplementary material: Supplementary File 1 (ZIP, 1850 KiB) </div> </div> <div > <a > <i >get_app</i> </a> </div> <div > <a > <i >subject</i> </a> <div > View online as: Abstract Page Full-Text HTML </div> </div> <div >Open AccessFeature PaperArticle</div> The New Pharmacological Chaperones PBXs Increase α-Galactosidase A Activity in Fabry Disease Cellular Models <div > by <span ><div >Pedro Besada</div>, </span><span ><div >María Gallardo-Gómez</div>, </span><span ><div >Tania Pérez-Márquez</div>, </span><span ><div >Lucía Patiño-Álvarez</div>, </span><span ><div >Sergio Pantano</div>, </span><span ><div >Carlos Silva-López</div>, </span><span ><div >Carmen Terán</div>, </span><span ><div >Ana Arévalo-Gómez</div>, </span><span ><div >Aurora Ruz-Zafra</div>, </span><span ><div >Julián Fernández-Martín</div> and </span><span ><div >Saida Ortolano</div></span> </div> <div > Biomolecules <b>2021</b>, 11(12), 1856; https://doi.org/10.3390/biom11121856 - 10 Dec 2021 </div> <div > Abstract <div > Fabry disease is an X-linked multisystemic disorder caused by the impairment of lysosomal α-Galactosidase A, which leads to the progressive accumulation of glycosphingolipids and to defective lysosomal metabolism. Currently, Fabry disease is treated by enzyme replacement therapy or the orally administrated pharmacological chaperone [...] Read more. </div> <div > Fabry disease is an X-linked multisystemic disorder caused by the impairment of lysosomal α-Galactosidase A, which leads to the progressive accumulation of glycosphingolipids and to defective lysosomal metabolism. Currently, Fabry disease is treated by enzyme replacement therapy or the orally administrated pharmacological chaperone Migalastat. Both therapeutic strategies present limitations, since enzyme replacement therapy has shown low half-life and bioavailability, while Migalastat is only approved for patients with specific mutations. The aim of this work was to assess the efficacy of PBX galactose analogues to stabilize α-Galactosidase A and therefore evaluate their potential use in Fabry patients with mutations that are not amenable to the treatment with Migalastat. We demonstrated that PBX compounds are safe and effective concerning stabilization of α-Galactosidase A in relevant cellular models of the disease, as assessed by enzymatic activity measurements, molecular modelling, and cell viability assays. This experimental evidence suggests that PBX compounds are promising candidates for the treatment of Fabry disease caused by mutations which affect the folding of α-Galactosidase A, even for <i>GLA</i> variants that are not amenable to the treatment with Migalastat. Full article </div> </div> <div > (This article belongs to the Special Issue Rare Diseases: From Molecular Pathways to Therapeutic Strategies) </div> ►▼ Show Figures <div ><div ><div ><p>Figure 1</p></div></div></div> </div> </div> </div> <div > <div > <div > <div > <a > <i >get_app</i> </a> </div> <div > <a > <i >subject</i> </a> <div > View online as: Abstract Page Full-Text HTML </div> </div> <div >Open AccessReview</div> DNA Nanodevice-Based Drug Delivery Systems <div > by <span ><div >Chaoyang Guan</div>, </span><span ><div >Xiaoli Zhu</div> and </span><span ><div >Chang Feng</div></span> </div> <div > Biomolecules <b>2021</b>, 11(12), 1855; https://doi.org/10.3390/biom11121855 - 10 Dec 2021 </div> <div > Abstract <div > DNA, a natural biological material, has become an ideal choice for biomedical applications, mainly owing to its good biocompatibility, ease of synthesis, modifiability, and especially programmability. In recent years, with the deepening of the understanding of the physical and chemical properties of DNA [...] Read more. </div> <div > DNA, a natural biological material, has become an ideal choice for biomedical applications, mainly owing to its good biocompatibility, ease of synthesis, modifiability, and especially programmability. In recent years, with the deepening of the understanding of the physical and chemical properties of DNA and the continuous advancement of DNA synthesis and modification technology, the biomedical applications based on DNA materials have been upgraded to version 2.0: through elaborate design and fabrication of smart-responsive DNA nanodevices, they can respond to external or internal physical or chemical stimuli so as to smartly perform certain specific functions. For tumor treatment, this advancement provides a new way to solve the problems of precise targeting, controllable release, and controllable elimination of drugs to a certain extent. Here, we review the progress of related fields over the past decade, and provide prospects for possible future development directions. Full article </div> </div> <div > (This article belongs to the Special Issue Recent Advances in Nanoparticle-Based Drug Delivery Systems for Cancer Targeted Therapy) </div> ►▼ Show Figures <div ><div ><div ><p>Figure 1</p></div></div></div> </div> </div> </div> <div > <div > <div > <div > <a > <i >attachment</i> </a> <div > Supplementary material: Supplementary File 1 (ZIP, 225 KiB) </div> </div> <div > <a > <i >get_app</i> </a> </div> <div > <a > <i >subject</i> </a> <div > View online as: Abstract Page </div> </div> <div >Open AccessArticle</div> Structural Characterization of Rat Galectin-5, an N-Tailed Monomeric Proto-Type-like Galectin <div > by <span ><div >Federico M. Ruiz</div>, </span><span ><div >Francisco J. Medrano</div>, </span><span ><div >Anna-Kristin Ludwig</div>, </span><span ><div >Herbert Kaltner</div>, </span><span ><div >Nadezhda V. Shilova</div>, </span><span ><div >Nicolai V. Bovin</div>, </span><span ><div >Hans-Joachim Gabius</div> and </span><span ><div >Antonio Romero</div></span> </div> <div > Biomolecules <b>2021</b>, 11(12), 1854; https://doi.org/10.3390/biom11121854 - 09 Dec 2021 </div> <div > Abstract <div > Galectins are multi-purpose effectors acting via interactions with distinct counterreceptors based on protein-glycan/protein recognition. These processes are emerging to involve several regions on the protein so that the availability of a detailed structural characterization of a full-length galectin is essential. We report here [...] Read more. </div> <div > Galectins are multi-purpose effectors acting via interactions with distinct counterreceptors based on protein-glycan/protein recognition. These processes are emerging to involve several regions on the protein so that the availability of a detailed structural characterization of a full-length galectin is essential. We report here the first crystallographic information on the N-terminal extension of the carbohydrate recognition domain of rat galectin-5, which is precisely described as an N-tailed proto-type-like galectin. In the ligand-free protein, the three amino-acid stretch from Ser2 to Ser5 is revealed to form an extra β-strand (F0), and the residues from Thr6 to Asn12 are part of a loop protruding from strands S1 and F0. In the ligand-bound structure, amino acids Ser2–Tyr10 switch position and are aligned to the edge of the β-sandwich. Interestingly, the signal profile in our glycan array screening shows the sugar-binding site to preferentially accommodate the histo-blood-group B (type 2) tetrasaccharide and N-acetyllactosamine-based di- and oligomers. The crystal structures revealed the characteristically preformed structural organization around the central Trp77 of the CRD with involvement of the sequence signature’s amino acids in binding. Ligand binding was also characterized calorimetrically. The presented data shows that the N-terminal extension can adopt an ordered structure and shapes the hypothesis that a ligand-induced shift in the equilibrium between flexible and ordered conformers potentially acts as a molecular switch, enabling new contacts in this region. Full article </div> </div> <div > (This article belongs to the Special Issue Cell Biology of Galectins) </div> </div> </div> </div> <div > <div > <div > <div > <a > <i >attachment</i> </a> <div > Supplementary material: Supplementary File 1 (ZIP, 894 KiB) </div> </div> <div > <a > <i >get_app</i> </a> </div> <div > <a > <i >subject</i> </a> <div > View online as: Abstract Page Full-Text HTML </div> </div> <div >Open AccessFeature PaperArticle</div> Characterization of miR-34a-Induced Epithelial–Mesenchymal Transition in Non-Small Lung Cancer Cells Focusing on p53 <div > by <span ><div >Masashi Kawami</div>, </span><span ><div >Shinnosuke Takenaka</div>, </span><span ><div >Mizuki Akai</div>, </span><span ><div >Ryoko Yumoto</div> and </span><span ><div >Mikihisa Takano</div></span> </div> <div > Biomolecules <b>2021</b>, 11(12), 1853; https://doi.org/10.3390/biom11121853 - 09 Dec 2021 </div> <div > Abstract <div > Background: Epithelial–mesenchymal transition (EMT), a phenotypic conversion of the epithelial to mesenchymal state, contributes to cancer progression. Currently, several microRNAs (miRNAs) are associated with EMT-mediated cancer progression, but the contribution of miR-34a to EMT in cancer cells remains controversial. The present study aimed [...] Read more. </div> <div > Background: Epithelial–mesenchymal transition (EMT), a phenotypic conversion of the epithelial to mesenchymal state, contributes to cancer progression. Currently, several microRNAs (miRNAs) are associated with EMT-mediated cancer progression, but the contribution of miR-34a to EMT in cancer cells remains controversial. The present study aimed to clarify the role of miR-34a in the EMT-related phenotypes of human non-small cell lung cancer (NSCLC) cell lines, A549 (p53 wild-type) and H1299 (p53-deficient). Methods: The miR-34a mimic and p53 small interfering RNA (siRNA) were transfected into the cells using Lipofectamine, and the obtained total RNA and cell lysates were used for real-time polymerase chain reaction and Western blotting analysis, respectively. Results: The introduction of the miR-34a mimic led to an increase in the mRNA and protein expression levels of α-smooth muscle actin (<i>α-SMA</i>), a mesenchymal marker gene, in A549, but not in H1299 cells. Additionally, miR-34a-induced the upregulation of p53 activity and migration was observed in A549, but not in H1299 cells. However, under the p53-knockdown condition, only α-SMA upregulation by miR-34a was abolished. Conclusion: These findings indicate a close relationship between p53 and miR-34a-induced EMT in p53-wild type NSCLC cells, which provides novel insights about the role of miR-34a in EMT-like phenotypic changes in NSCLC. Full article </div> </div> <div > (This article belongs to the Special Issue Non-coding RNAs in Cancer Biology) </div> ►▼ Show Figures <div ><div ><div ><p>Figure 1</p></div></div></div> </div> </div> </div> <div > <div > <div > <div > <a > <i >attachment</i> </a> <div > Supplementary material: Supplementary File 1 (ZIP, 60674 KiB) </div> </div> <div > <a > <i >get_app</i> </a> </div> <div > <a > <i >subject</i> </a> <div > View online as: Abstract Page Full-Text HTML </div> </div> <div >Open AccessArticle</div> <a >Cyclic Tetra-Adenylate (cA<sub>4</sub>) Recognition by Csa3; Implications for an Integrated Class 1 CRISPR-Cas Immune Response in <i>Saccharolobus solfataricus</i></a> <div > by <span ><div >Alexander A. Charbonneau</div>, </span><span ><div >Debra M. Eckert</div>, </span><span ><div >Colin C. Gauvin</div>, </span><span ><div >Nathanael G. Lintner</div> and </span><span ><div >C. Martin Lawrence</div></span> </div> <div > Biomolecules <b>2021</b>, 11(12), 1852; https://doi.org/10.3390/biom11121852 - 09 Dec 2021 </div> <div > Abstract <div > Csa3 family transcription factors are ancillary CRISPR-associated proteins composed of N-terminal CARF domains and C-terminal winged helix-turn-helix domains. The activity of Csa3 transcription factors is thought to be controlled by cyclic oligoadenyate (cOA) second messengers produced by type III CRISPR-Cas surveillance complexes. Here [...] Read more. </div> <div > Csa3 family transcription factors are ancillary CRISPR-associated proteins composed of N-terminal CARF domains and C-terminal winged helix-turn-helix domains. The activity of Csa3 transcription factors is thought to be controlled by cyclic oligoadenyate (cOA) second messengers produced by type III CRISPR-Cas surveillance complexes. Here we show that <i>Saccharolobus solfataricus</i> Csa3a recognizes cyclic tetra-adenylate (cA<sub>4</sub>) and that Csa3a lacks self-regulating “ring nuclease” activity present in some other CARF domain proteins. The crystal structure of the Csa3a/cA4 complex was also determined and the structural and thermodynamic basis for cA<sub>4</sub> recognition are described, as are conformational changes in Csa3a associated with cA<sub>4</sub> binding. We also characterized the effect of cA<sub>4</sub> on recognition of putative DNA binding sites. Csa3a binds to putative promoter sequences in a nonspecific, cooperative and cA<sub>4</sub>-independent manner, suggesting a more complex mode of transcriptional regulation. We conclude the Csa3a/cA<sub>4</sub> interaction represents a nexus between the type I and type III CRISPR-Cas systems present in <i>S. solfataricus</i>, and discuss the role of the Csa3/cA<sub>4</sub> interaction in coordinating different arms of this integrated class 1 immune system to mount a synergistic, highly orchestrated immune response. Full article </div> </div> <div > (This article belongs to the Collection Molecular Biology: Feature Papers) </div> ►▼ Show Figures <div ><div ><div ><p>Figure 1</p></div></div></div> </div> </div> </div> <div > <div > <div > <div > <a > <i >get_app</i> </a> </div> <div > <a > <i >subject</i> </a> <div > View online as: Abstract Page Full-Text HTML </div> </div> <div >Open AccessReview</div> The Role of Pumilio RNA Binding Protein in Plants <div > by <span ><div >Sung Un Huh</div></span> </div> <div > Biomolecules <b>2021</b>, 11(12), 1851; https://doi.org/10.3390/biom11121851 - 09 Dec 2021 </div> <div > Abstract <div > Eukaryotic organisms have a posttranscriptional/translational regulation system for the control of translational efficiency. RNA binding proteins (RBPs) have been known to control target genes. One type of protein, Pumilio (Pum)/Puf family RNA binding proteins, show a specific binding of 3′ untranslational region (3′ [...] Read more. </div> <div > Eukaryotic organisms have a posttranscriptional/translational regulation system for the control of translational efficiency. RNA binding proteins (RBPs) have been known to control target genes. One type of protein, Pumilio (Pum)/Puf family RNA binding proteins, show a specific binding of 3′ untranslational region (3′ UTR) of target mRNA and function as a post-transcriptional/translational regulator in eukaryotic cells. Plant Pum protein is involved in development and biotic/abiotic stresses. Interestingly, Arabidopsis Pum can control target genes in a sequence-specific manner and rRNA processing in a sequence-nonspecific manner. As shown in in silico <i>Pum</i> gene expression analysis, Arabidopsis and rice <i>Pum</i> genes are responsive to biotic/abiotic stresses. Plant Pum can commonly contribute to host gene regulation at the post-transcriptional/translational step, as can mammalian Pum. However, the function of plant Pum proteins is not yet fully known. In this review, we briefly summarize the function of plant Pum in defense, development, and environmental responses via recent research and bioinformatics data. Full article </div> </div> <div > (This article belongs to the Section Molecular Biology) </div> ►▼ Show Figures <div ><div ><div ><p>Figure 1</p></div></div></div> </div> </div> </div> <div > <div > <div > <div > <a > <i >get_app</i> </a> </div> <div > <a > <i >subject</i> </a> <div > View online as: Abstract Page Full-Text HTML </div> </div> <div >Open AccessReview</div> CD44: A Multifunctional Mediator of Cancer Progression <div > by <span ><div >Malak Hassn Mesrati</div>, </span><span ><div >Saiful Effendi Syafruddin</div>, </span><span ><div >M. Aiman Mohtar</div> and </span><span ><div >Amir Syahir</div></span> </div> <div > Biomolecules <b>2021</b>, 11(12), 1850; https://doi.org/10.3390/biom11121850 - 09 Dec 2021 </div> <div > Abstract <div > CD44, a non-kinase cell surface transmembrane glycoprotein, has been widely implicated as a cancer stem cell (CSC) marker in several cancers. Cells overexpressing CD44 possess several CSC traits, such as self-renewal and epithelial-mesenchymal transition (EMT) capability, as well as a resistance to chemo- [...] Read more. </div> <div > CD44, a non-kinase cell surface transmembrane glycoprotein, has been widely implicated as a cancer stem cell (CSC) marker in several cancers. Cells overexpressing CD44 possess several CSC traits, such as self-renewal and epithelial-mesenchymal transition (EMT) capability, as well as a resistance to chemo- and radiotherapy. The CD44 gene regularly undergoes alternative splicing, resulting in the standard (CD44s) and variant (CD44v) isoforms. The interaction of such isoforms with ligands, particularly hyaluronic acid (HA), osteopontin (OPN) and matrix metalloproteinases (MMPs), drive numerous cancer-associated signalling. However, there are contradictory results regarding whether high or low CD44 expression is associated with worsening clinicopathological features, such as a higher tumour histological grade, advanced tumour stage and poorer survival rates. Nonetheless, high CD44 expression significantly contributes to enhanced tumourigenic mechanisms, such as cell proliferation, metastasis, invasion, migration and stemness; hence, CD44 is an important clinical target. This review summarises current research regarding the different CD44 isoform structures and their roles and functions in supporting tumourigenesis and discusses CD44 expression regulation, CD44-signalling pathways and interactions involved in cancer development. The clinical significance and prognostic value of CD44 and the potential of CD44 as a therapeutic target in cancer are also addressed. Full article </div> </div> <div > (This article belongs to the Special Issue Biomarkers in Cancer) </div> ►▼ Show Figures <div ><div ><div ><p>Figure 1</p></div></div></div> </div> </div> </div> <div > <div > <div > <div > <a > <i >get_app</i> </a> </div> <div > <a > <i >subject</i> </a> <div > View online as: Abstract Page Full-Text HTML </div> </div> <div >Open AccessReview</div> The Annexin A2/S100A10 Complex: The Mutualistic Symbiosis of Two Distinct Proteins <div > by <span ><div >Alamelu Bharadwaj</div>, </span><span ><div >Emma Kempster</div> and </span><span ><div >David Morton Waisman</div></span> </div> <div > Biomolecules <b>2021</b>, 11(12), 1849; https://doi.org/10.3390/biom11121849 - 09 Dec 2021 </div> <div > Abstract <div > Mutualistic symbiosis refers to the symbiotic relationship between individuals of different species in which both individuals benefit from the association. S100A10, a member of the S100 family of Ca<sup>2+</sup>-binding proteins, exists as a tight dimer and binds two annexin A2 molecules. [...] Read more. </div> <div > Mutualistic symbiosis refers to the symbiotic relationship between individuals of different species in which both individuals benefit from the association. S100A10, a member of the S100 family of Ca<sup>2+</sup>-binding proteins, exists as a tight dimer and binds two annexin A2 molecules. This association forms the annexin A2/S100A10 complex known as AIIt, and modifies the distinct functions of both proteins. Annexin A2 is a Ca<sup>2+</sup>-binding protein that binds F-actin, phospholipid, RNA, and specific polysaccharides such as heparin. S100A10 does not bind Ca<sup>2+</sup>, but binds tPA, plasminogen, certain plasma membrane ion channels, neurotransmitter receptors, and the structural scaffold protein, AHNAK. S100A10 relies on annexin A2 for its intracellular survival: in the absence of annexin A2, it is rapidly destroyed by ubiquitin-dependent and independent proteasomal degradation. Annexin A2 requires S100A10 to increase its affinity for Ca<sup>2+</sup>, facilitating its participation in Ca<sup>2+</sup>-dependent processes such as membrane binding. S100A10 binds tissue plasminogen activator and plasminogen, and promotes plasminogen activation to plasmin, which is a process stimulated by annexin A2. In contrast, annexin A2 acts as a plasmin reductase and facilitates the autoproteolytic destruction of plasmin. This review examines the relationship between annexin A2 and S100A10, and how their mutualistic symbiosis affects the function of both proteins. Full article </div> </div> <div > (This article belongs to the Special Issue S100 Proteins—Intracellular and Extracellular Function in Norm and Pathology) </div> ►▼ Show Figures <div ><div ><div ><p>Figure 1</p></div></div></div> </div> </div> </div> <div > <div > <div > <div > <a > <i >get_app</i> </a> </div> <div > <a > <i >subject</i> </a> <div > View online as: Abstract Page Full-Text HTML </div> </div> <div >Open AccessArticle</div> Probing the Influence of Single-Site Mutations in the Central Cross-β Region of Amyloid β (1–40) Peptides <div > by <span ><div >Jacob Fritzsch</div>, </span><span ><div >Alexander Korn</div>, </span><span ><div >Dayana Surendran</div>, </span><span ><div >Martin Krueger</div>, </span><span ><div >Holger A. Scheidt</div>, </span><span ><div >Kaustubh R. Mote</div>, </span><span ><div >Perunthiruthy K. Madhu</div>, </span><span ><div >Sudipta Maiti</div> and </span><span ><div >Daniel Huster</div></span> </div> <div > Biomolecules <b>2021</b>, 11(12), 1848; https://doi.org/10.3390/biom11121848 - 09 Dec 2021 </div> <div > Abstract <div > Amyloid β (Aβ) is a peptide known to form amyloid fibrils in the brain of patients suffering from Alzheimer’s disease. A complete mechanistic understanding how Aβ peptides form neurotoxic assemblies and how they kill neurons has not yet been achieved. Previous analysis of [...] Read more. </div> <div > Amyloid β (Aβ) is a peptide known to form amyloid fibrils in the brain of patients suffering from Alzheimer’s disease. A complete mechanistic understanding how Aβ peptides form neurotoxic assemblies and how they kill neurons has not yet been achieved. Previous analysis of various Aβ<sub>40</sub> mutants could reveal the significant importance of the hydrophobic contact between the residues Phe<sub>19</sub> and Leu<sub>34</sub> for cell toxicity. For some mutations at Phe<sub>19</sub>, toxicity was completely abolished. In the current study, we assessed if perturbations introduced by mutations in the direct proximity of the Phe<sub>19</sub>/Leu<sub>34</sub> contact would have similar relevance for the fibrillation kinetics, structure, dynamics and toxicity of the Aβ assemblies. To this end, we rationally modified positions Phe<sub>20</sub> or Gly<sub>33</sub>. A small library of Aβ<sub>40</sub> peptides with Phe<sub>20</sub> mutated to Lys, Tyr or the non-proteinogenic cyclohexylalanine (Cha) or Gly<sub>33</sub> mutated to Ala was synthesized. We used electron microscopy, circular dichroism, X-ray diffraction, solid-state NMR spectroscopy, ThT fluorescence and MTT cell toxicity assays to comprehensively investigate the physicochemical properties of the Aβ fibrils formed by the modified peptides as well as toxicity to a neuronal cell line. Single mutations of either Phe<sub>20</sub> or Gly<sub>33</sub> led to relatively drastic alterations in the Aβ fibrillation kinetics but left the global, as well as the local structure, of the fibrils largely unchanged. Furthermore, the introduced perturbations caused a severe decrease or loss of cell toxicity compared to wildtype Aβ<sub>40</sub>. We suggest that perturbations at position Phe<sub>20</sub> and Gly<sub>33</sub> affect the fibrillation pathway of Aβ<sub>40</sub> and, thereby, influence the especially toxic oligomeric species manifesting so that the region around the Phe<sub>19</sub>/Leu<sub>34</sub> hydrophobic contact provides a promising site for the design of small molecules interfering with the Aβ fibrillation pathway. Full article </div> </div> <div > (This article belongs to the Special Issue Common Mechanisms in Alzheimer’s Disease and Other Neurodegenerative Disorders) </div> ►▼ Show Figures <div ><div ><div ><p>Graphical abstract</p></div></div></div> </div> </div> </div> <div > <div > <div > <div > <a > <i >get_app</i> </a> </div> <div > <a > <i >subject</i> </a> <div > View online as: Abstract Page Full-Text HTML </div> </div> <div >Open AccessReview</div> Reiterating the Emergence of Noncoding RNAs as Regulators of the Critical Hallmarks of Gall Bladder Cancer <div > by <span ><div >Varsha Rana</div>, </span><span ><div >Dey Parama</div>, </span><span ><div >Elina Khatoon</div>, </span><span ><div >Sosmitha Girisa</div>, </span><span ><div >Gautam Sethi</div> and </span><span ><div >Ajaikumar B. Kunnumakkara</div></span> </div> <div > Biomolecules <b>2021</b>, 11(12), 1847; https://doi.org/10.3390/biom11121847 - 08 Dec 2021 </div> <div > Abstract <div > Gall bladder cancer (GBC) is a rare and one of the most aggressive types of malignancies, often associated with a poor prognosis and survival. It is a highly metastatic cancer and is often not diagnosed at the initial stages, which contributes to a [...] Read more. </div> <div > Gall bladder cancer (GBC) is a rare and one of the most aggressive types of malignancies, often associated with a poor prognosis and survival. It is a highly metastatic cancer and is often not diagnosed at the initial stages, which contributes to a poor survival rate of patients. The poor diagnosis and chemoresistance associated with the disease limit the scope of the currently available surgical and nonsurgical treatment modalities. Thus, there is a need to explore novel therapeutic targets and biomarkers that will help relieve the severity of the disease and lead to advanced therapeutic strategies. Accumulating evidence has correlated the atypical expression of various noncoding RNAs (ncRNAs), including circular RNAs (circRNAs), long noncoding RNAs (lncRNAs), microRNAs (miRNAs), and small nucleolar RNAs (snoRNA) with the increased cell proliferation, epithelial–mesenchymal transition (EMT), invasion, migration, metastasis, chemoresistance, and decreased apoptosis in GBC. Numerous reports have indicated that the dysregulated expression of ncRNAs is associated with poor prognosis and lower disease-free and overall survival in GBC patients. These reports suggest that ncRNAs might be considered novel diagnostic and prognostic markers for the management of GBC. The present review recapitulates the association of various ncRNAs in the initiation and progression of GBC and the development of novel therapeutic strategies by exploring their functional and regulatory role. Full article </div> </div> ►▼ Show Figures <div ><div ><div ><p>Figure 1</p></div></div></div> </div> </div> </div> </div> <div > More Articles... </div> </div> </div> </div> <div > <div > <div > <div > <a > Submit to <i>Biomolecules</i> </a> Review for Biomolecules <div > Share </div> </div> <div > <h2 >Journal Menu</h2> ► ▼ Journal Menu <ul > <li > <ul> <li > Biomolecules Home </li> <li > Aims Scope </li> <li > Editorial Board </li> <li > Reviewer Board </li> <li > Topical Advisory Panel </li> <li > Instructions for Authors </li> <li > Special Issues </li> <li > Sections Collections </li> <li > Article Processing Charge </li> <li > Indexing Archiving </li> <li > Editor's Choice Articles </li> <li > Most Cited Viewed </li> <li > Journal Statistics </li> <li > Journal History </li> <li > Journal Awards </li> <li > Society Collaborations </li> <li > Conferences </li> <li > Editorial Office </li> </ul> </li> </ul> </div> <h2 >Journal Browser</h2> ► ▼ Journal Browser <div > <div > <ul > <li > <a > <i > arrow_forward_ios </i> Forthcoming issue </a> <a > <i > arrow_forward_ios </i> Current issue </a> </li> <div > <div > <div > <li > Vol. 11 (2021) </li> <li > Vol. 10 (2020) </li> <li > Vol. 9 (2019) </li> <li > Vol. 8 (2018) </li> <li > Vol. 7 (2017) </li> <li > Vol. 6 (2016) </li> <li > Vol. 5 (2015) </li> <li > Vol. 4 (2014) </li> <li > Vol. 3 (2013) </li> <li > Vol. 2 (2012) </li> <li > Vol. 1 (2011) </li> </div> </div> </div> </ul> </div> </div> </div> </div> <div > <div > <h2>Highly Accessed Articles</h2> </div> <div > <div > View More... </div> </div> </div> <div > <div > <h2>Latest Books</h2> </div> <div > <div > More Open Access Books... </div> </div> </div> </div> <div > <div > <div > <h2>E-Mail Alert</h2> </div> </div> <div > <div > <h2>News</h2> </div> <div > <div > 29 November 2021 Prof. Dr. Robert V. (Rob) Stahelin Appointed Editor-in-Chief of the Section “Biomacromolecules: Lipids” in Biomolecules </div> <div > 22 November 2021 720 MDPI Editorial Board Members Receiving "2021 Highly Cited Researchers" Distinction </div> <div > 16 November 2021 Topical Advisory Panel Established to Support Editorial Board </div> <div > More News Announcements... </div> </div> </div> <div > <div > <h2>Topics</h2> </div> <div > <div ><div> Topic in Genes, ncRNA, IJMS, Biomolecules, Pathogens</div> Non-coding RNAs in Disease Deadline: 31 December 2021</div> <div ><div> Topic in Applied Sciences, Biomolecules, Pharmaceuticals, Biomedicines, Antibiotics</div> Compounds with Medicinal Value Editor-in-Chief: Maria Stefania SinicropiDeadline: 31 March 2022</div> <div ><div> Topic in Biomolecules, Cancers, Cells, Current Oncology</div> Advances in Ovarian Cancer Research: From Biology to Therapeutics Editor-in-Chief: Christina M. AnnunziataDeadline: 31 May 2022</div> <div ><div> Topic in Biomolecules, Cancers, Cells, Current Oncology, Onco</div> Adaptation Mechanisms in Therapy-Resistant Breast Cancer Deadline: 31 July 2022</div> <div > More Topics </div> </div> </div> <div > <div > <h2>Conferences</h2> </div> <div > <div > Announce Your Conference </div> <div > 21 January 2022 Applied Sciences Webinar | Sensing Based on Surface Plasmons</div> <div > 16–18 February 2022 3rd MMCS: Shaping Medicinal Chemistry for the New Decade</div> <div > More Conferences... </div> </div> </div> <div > <div > <h2>Special Issues</h2> </div> <div > <div > Edit a Special Issue </div> <div ><div> Special Issue in Biomolecules</div> Prognostic and Predictive Biomarkers for Reactive Oxygen Species Related Diseases Guest Editor: Luciana BordinDeadline: 15 December 2021</div> <div ><div> Special Issue in Biomolecules</div> Beyond Lipid Rafts and Caveolae: From Caveolae Compartmentalization of Signal Transduction to Medicine Guest Editors: Shengwen Calvin Li, Massimo Sargiacomo, Jacques Couet, Eric KüblerDeadline: 31 December 2021</div> <div ><div> Special Issue in Biomolecules</div> 3D Printing of Bioactive Structures for Engineering Artificial Tissues Guest Editor: Mehdi MehraliDeadline: 1 January 2022</div> <div ><div> Special Issue in Biomolecules</div> New Developments in Histamine Research Guest Editors: Emanuela Masini, Laura LucariniDeadline: 15 January 2022</div> <div > More Special Issues </div> </div> </div> <div > <div > <h2>Topical Collections</h2> </div> <div > <div ><div> Topical Collection in Biomolecules</div> Feature Papers in Molecular Genetics Collection Editor: Jürg Bähler</div> <div ><div> Topical Collection in Biomolecules</div> Feature Papers in Bioinformatics and Systems Biology Section Collection Editor: Lukasz Kurgan</div> <div ><div> Topical Collection in Biomolecules</div> Feature Papers in Enzymology Collection Editor: Umesh Desai</div> <div ><div> Topical Collection in Biomolecules</div> Feature Papers in Biological Factors Collection Editor: Tracey Martin</div> <div > More Topical Collections </div> </div> </div> <div > <div > <h2>Jobs in Research</h2> </div> <div > <div > Post New Job Opening </div> </div> </div> </div> </div> </div> </section> <div > <div > Biomolecules, EISSN 2218-273X, Published by MDPI <span> Disclaimer <div > The statements, opinions and data contained in the journal Biomolecules are solely those of the individual authors and contributors and not of the publisher and the editor(s). MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations. </div> </span> <div > RSS Content Alert </div> </div> <div > <div > <h3> Further Information </h3> Article Processing Charges <a > Pay an Invoice </a> <a > Open Access Policy </a> <a > Contact MDPI </a> <a > Jobs at MDPI </a> </div> <div > <h3> Guidelines </h3> <a > For Authors </a> <a > For Reviewers </a> <a > For Editors </a> <a > For Librarians </a> <a > For Publishers </a> <a > For Societies </a> </div> <div > <h3> MDPI Initiatives </h3> <a > Sciforum </a> <a > MDPI Books </a> <a > Preprints </a> <a > Scilit </a> <a > SciProfiles </a> <a > Encyclopedia </a> <a > JAMS </a> <a > Proceedings Series </a> </div> <div > <h3> Follow MDPI </h3> <a > LinkedIn </a> <a > Facebook </a> <a > Twitter </a> </div> </div> <div > <div > <div > © 1996-2021 MDPI (Basel, Switzerland) unless otherwise stated </div> <div > <a > Disclaimer </a> <div > The statements, opinions and data contained in the journals are solely those of the individual authors and contributors and not of the publisher and the editor(s). MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations. </div> <a > Terms and Conditions </a> <a > Privacy Policy </a> </div> </div> </div> </div> <div > <div > We use cookies on our website to ensure you get the best experience. Read more about our cookies <a >here</a>. </div> <div > <a >Accept</a> </div> </div> <div > <div > We have just recently launched a new version of our website. Help us to further improve by taking part in this short 5 minute survey here. here. </div> <div > <a >Never show this again</a> </div> </div> </div> <div > <div > <div > <h2 >Share Link</h2> </div> <div > <a >Copy</a> </div> </div> <a > <i >clear</i> </a> </div> <div > <div > <div > <h2 >Share</h2> </div> </div> <a > <i >clear</i> </a> </div> <a >Back to TopTop</a> </body>'</script>

      </head>
        <body class="valid" valid="valid" title="valid: True, node: 1, tag: body, level: 1" node_number="1"> <div class="valid" valid="valid" title="valid: True, node: 2, tag: div, level: 2" node_number="2"> <div class="valid" valid="valid" title="valid: True, node: 3, tag: div, level: 3" node_number="3"> <div class="valid" valid="valid" title="valid: True, node: 4, tag: div, level: 4" node_number="4"> <a class="valid" valid="valid" title="valid: True, node: 5, tag: a, level: 5" node_number="5"> <h2 class="valid" valid="valid" title="valid: True, node: 6, tag: h2, level: 6" node_number="6">25th Anniversary</h2> </a> <a class="valid" valid="valid" title="valid: True, node: 7, tag: a, level: 5" node_number="7"> <h2 class="valid" valid="valid" title="valid: True, node: 8, tag: h2, level: 6" node_number="8">Journals</h2> </a> <div class="valid" valid="valid" title="valid: True, node: 9, tag: div, level: 5" node_number="9"> <div class="valid" valid="valid" title="valid: True, node: 10, tag: div, level: 6" node_number="10"> <h2 class="valid" valid="valid" title="valid: True, node: 11, tag: h2, level: 7" node_number="11">Information</h2> </div> <div class="valid" valid="valid" title="valid: True, node: 12, tag: div, level: 6" node_number="12"> <div class="valid" valid="valid" title="valid: True, node: 13, tag: div, level: 7" node_number="13"> <div class="valid" valid="valid" title="valid: True, node: 14, tag: div, level: 8" node_number="14"> <a class="valid" valid="valid" title="valid: True, node: 15, tag: a, level: 9" node_number="15">For Authors</a> <a class="valid" valid="valid" title="valid: True, node: 16, tag: a, level: 9" node_number="16">For Reviewers</a> <a class="valid" valid="valid" title="valid: True, node: 17, tag: a, level: 9" node_number="17">For Editors</a> <a class="valid" valid="valid" title="valid: True, node: 18, tag: a, level: 9" node_number="18">For Librarians</a> <a class="valid" valid="valid" title="valid: True, node: 19, tag: a, level: 9" node_number="19">For Publishers</a> <a class="valid" valid="valid" title="valid: True, node: 20, tag: a, level: 9" node_number="20">For Societies</a> </div> <div class="valid" valid="valid" title="valid: True, node: 21, tag: div, level: 8" node_number="21"> <a class="valid" valid="valid" title="valid: True, node: 22, tag: a, level: 9" node_number="22">Article Processing Charges</a> <a class="valid" valid="valid" title="valid: True, node: 23, tag: a, level: 9" node_number="23">Open Access Policy</a> <a class="valid" valid="valid" title="valid: True, node: 24, tag: a, level: 9" node_number="24">Institutional Open Access Program</a> <a class="valid" valid="valid" title="valid: True, node: 25, tag: a, level: 9" node_number="25">Editorial Process</a> <a class="valid" valid="valid" title="valid: True, node: 26, tag: a, level: 9" node_number="26">Awards</a> <a class="valid" valid="valid" title="valid: True, node: 27, tag: a, level: 9" node_number="27">Research and Publication Ethics</a> </div> </div> </div> </div> <a class="valid" valid="valid" title="valid: True, node: 28, tag: a, level: 5" node_number="28"> <h2 class="valid" valid="valid" title="valid: True, node: 29, tag: h2, level: 6" node_number="29">Author Services</h2> </a> <div class="valid" valid="valid" title="valid: True, node: 30, tag: div, level: 5" node_number="30"> <div class="valid" valid="valid" title="valid: True, node: 31, tag: div, level: 6" node_number="31"> <h2 class="valid" valid="valid" title="valid: True, node: 32, tag: h2, level: 7" node_number="32">Initiatives</h2> </div> <div class="valid" valid="valid" title="valid: True, node: 33, tag: div, level: 6" node_number="33"> <div class="valid" valid="valid" title="valid: True, node: 34, tag: div, level: 7" node_number="34"> <div class="valid" valid="valid" title="valid: True, node: 35, tag: div, level: 8" node_number="35"> <a class="valid" valid="valid" title="valid: True, node: 36, tag: a, level: 9" node_number="36">Sciforum</a> <a class="valid" valid="valid" title="valid: True, node: 37, tag: a, level: 9" node_number="37">MDPI Books</a> <a class="valid" valid="valid" title="valid: True, node: 38, tag: a, level: 9" node_number="38">Preprints</a> <a class="valid" valid="valid" title="valid: True, node: 39, tag: a, level: 9" node_number="39">Scilit</a> <a class="valid" valid="valid" title="valid: True, node: 40, tag: a, level: 9" node_number="40">SciProfiles</a> <a class="valid" valid="valid" title="valid: True, node: 41, tag: a, level: 9" node_number="41">Encyclopedia</a> <a class="valid" valid="valid" title="valid: True, node: 42, tag: a, level: 9" node_number="42">JAMS</a> <a class="valid" valid="valid" title="valid: True, node: 43, tag: a, level: 9" node_number="43">Proceedings Series</a> </div> </div> </div> </div> <a class="valid" valid="valid" title="valid: True, node: 44, tag: a, level: 5" node_number="44"> <h2 class="valid" valid="valid" title="valid: True, node: 45, tag: h2, level: 6" node_number="45">About</h2> </a> </div> <div class="valid" valid="valid" title="valid: True, node: 46, tag: div, level: 4" node_number="46"> <a class="valid" valid="valid" title="valid: True, node: 47, tag: a, level: 5" node_number="47">Sign In / Sign Up</a> </div> </div> </div> <div class="valid" valid="valid" title="valid: True, node: 48, tag: div, level: 2" node_number="48"> <h2 class="valid" valid="valid" title="valid: True, node: 49, tag: h2, level: 3" node_number="49">Notice</h2> <a class="valid" valid="valid" title="valid: True, node: 50, tag: a, level: 3" node_number="50"> <i class="valid" valid="valid" title="valid: True, node: 51, tag: i, level: 4" node_number="51">clear</i> </a> </div> <div class="valid" valid="valid" title="valid: True, node: 52, tag: div, level: 2" node_number="52"> <div class="valid" valid="valid" title="valid: True, node: 53, tag: div, level: 3" node_number="53"> <div class="valid" valid="valid" title="valid: True, node: 54, tag: div, level: 4" node_number="54"> <h2 class="valid" valid="valid" title="valid: True, node: 55, tag: h2, level: 5" node_number="55">Notice</h2> <p class="valid" valid="valid" title="valid: True, node: 56, tag: p, level: 5" node_number="56"> You are accessing a machine-readable page. In order to be human-readable, please install an RSS reader. </p> </div> </div> <div class="valid" valid="valid" title="valid: True, node: 57, tag: div, level: 3" node_number="57"> <div class="valid" valid="valid" title="valid: True, node: 58, tag: div, level: 4" node_number="58"> <a class="valid" valid="valid" title="valid: True, node: 59, tag: a, level: 5" node_number="59">Continue</a> <a class="valid" valid="valid" title="valid: True, node: 60, tag: a, level: 5" node_number="60">Cancel</a> </div> </div> <a class="valid" valid="valid" title="valid: True, node: 61, tag: a, level: 3" node_number="61"> <i class="valid" valid="valid" title="valid: True, node: 62, tag: i, level: 4" node_number="62">clear</i> </a> </div> <div class="valid" valid="valid" title="valid: True, node: 63, tag: div, level: 2" node_number="63"> <p class="valid" valid="valid" title="valid: True, node: 64, tag: p, level: 3" node_number="64"> All articles published by MDPI are made immediately available worldwide under an open access license. No special permission is required to reuse all or part of the article published by MDPI, including figures and tables. For articles published under an open access Creative Common CC BY license, any part of the article may be reused without permission provided that the original article is clearly cited. </p> </div> <div class="valid" valid="valid" title="valid: True, node: 65, tag: div, level: 2" node_number="65"> <p class="valid" valid="valid" title="valid: True, node: 66, tag: p, level: 3" node_number="66"> Feature Papers represent the most advanced research with significant potential for high impact in the field. Feature Papers are submitted upon individual invitation or recommendation by the scientific editors and undergo peer review prior to publication. </p> <p class="valid" valid="valid" title="valid: True, node: 67, tag: p, level: 3" node_number="67"> The Feature Paper can be either an original research article, a substantial novel research study that often involves several techniques or approaches, or a comprehensive review paper with concise and precise updates on the latest progress in the field that systematically reviews the most exciting advances in scientific literature. This type of paper provides an outlook on future directions of research or possible applications. </p> </div> <div class="valid" valid="valid" title="valid: True, node: 68, tag: div, level: 2" node_number="68"> <p class="valid" valid="valid" title="valid: True, node: 69, tag: p, level: 3" node_number="69"> Editor&#8217;s Choice articles are based on recommendations by the scientific editors of MDPI journals from around the world. Editors select a small number of articles recently published in the journal that they believe will be particularly interesting to authors, or important in this field. The aim is to provide a snapshot of some of the most exciting work published in the various research areas of the journal. </p> </div> <div class="valid" valid="valid" title="valid: True, node: 70, tag: div, level: 2" node_number="70"> <div class="valid" valid="valid" title="valid: True, node: 71, tag: div, level: 3" node_number="71">  </div> <section class="valid" valid="valid" title="valid: True, node: 72, tag: section, level: 3" node_number="72"> <header class="valid" valid="valid" title="valid: True, node: 73, tag: header, level: 4" node_number="73"> <div class="valid" valid="valid" title="valid: True, node: 74, tag: div, level: 5" node_number="74"> <div class="valid" valid="valid" title="valid: True, node: 75, tag: div, level: 6" node_number="75"> <div class="valid" valid="valid" title="valid: True, node: 76, tag: div, level: 7" node_number="76"> <ul class="valid" valid="valid" title="valid: True, node: 77, tag: ul, level: 8" node_number="77"> <li class="valid" valid="valid" title="valid: True, node: 78, tag: li, level: 9" node_number="78"> <a class="valid" valid="valid" title="valid: True, node: 79, tag: a, level: 10" node_number="79">25th Anniversary</a> </li> <li class="valid" valid="valid" title="valid: True, node: 80, tag: li, level: 9" node_number="80"> <a class="valid" valid="valid" title="valid: True, node: 81, tag: a, level: 10" node_number="81">Journals</a> </li> <li class="valid" valid="valid" title="valid: True, node: 82, tag: li, level: 9" node_number="82"> <a class="valid" valid="valid" title="valid: True, node: 83, tag: a, level: 10" node_number="83">Information</a> <ul class="valid" valid="valid" title="valid: True, node: 84, tag: ul, level: 10" node_number="84"> <li class="valid" valid="valid" title="valid: True, node: 85, tag: li, level: 11" node_number="85"> <div class="valid" valid="valid" title="valid: True, node: 86, tag: div, level: 12" node_number="86"> <div class="valid" valid="valid" title="valid: True, node: 87, tag: div, level: 13" node_number="87"> <ul class="valid" valid="valid" title="valid: True, node: 88, tag: ul, level: 14" node_number="88"> <li title="valid: False, node: 89, tag: li, level: 15" node_number="89"> <a title="valid: False, node: 90, tag: a, level: 16" node_number="90">For Authors</a> </li> <li title="valid: False, node: 91, tag: li, level: 15" node_number="91"> <a title="valid: False, node: 92, tag: a, level: 16" node_number="92">For Reviewers</a> </li> <li title="valid: False, node: 93, tag: li, level: 15" node_number="93"> <a title="valid: False, node: 94, tag: a, level: 16" node_number="94">For Editors</a> </li> <li title="valid: False, node: 95, tag: li, level: 15" node_number="95"> <a title="valid: False, node: 96, tag: a, level: 16" node_number="96">For Librarians</a> </li> <li title="valid: False, node: 97, tag: li, level: 15" node_number="97"> <a title="valid: False, node: 98, tag: a, level: 16" node_number="98">For Publishers</a> </li> <li title="valid: False, node: 99, tag: li, level: 15" node_number="99"> <a title="valid: False, node: 100, tag: a, level: 16" node_number="100">For Societies</a> </li> </ul> </div> <div class="valid" valid="valid" title="valid: True, node: 101, tag: div, level: 13" node_number="101"> <ul class="valid" valid="valid" title="valid: True, node: 102, tag: ul, level: 14" node_number="102"> <li title="valid: False, node: 103, tag: li, level: 15" node_number="103"> <a title="valid: False, node: 104, tag: a, level: 16" node_number="104">Article Processing Charges</a> </li> <li title="valid: False, node: 105, tag: li, level: 15" node_number="105"> <a title="valid: False, node: 106, tag: a, level: 16" node_number="106">Open Access Policy</a> </li> <li title="valid: False, node: 107, tag: li, level: 15" node_number="107"> <a title="valid: False, node: 108, tag: a, level: 16" node_number="108">Institutional Open Access Program</a> </li> <li title="valid: False, node: 109, tag: li, level: 15" node_number="109"> <a title="valid: False, node: 110, tag: a, level: 16" node_number="110">Editorial Process</a> </li> <li title="valid: False, node: 111, tag: li, level: 15" node_number="111"> <a title="valid: False, node: 112, tag: a, level: 16" node_number="112">Awards</a> </li> <li title="valid: False, node: 113, tag: li, level: 15" node_number="113"> <a title="valid: False, node: 114, tag: a, level: 16" node_number="114">Research and Publication Ethics</a> </li> </ul> </div> </div> </li> </ul> </li> <li class="valid" valid="valid" title="valid: True, node: 115, tag: li, level: 9" node_number="115"> <a class="valid" valid="valid" title="valid: True, node: 116, tag: a, level: 10" node_number="116">Author Services</a> </li> <li class="valid" valid="valid" title="valid: True, node: 117, tag: li, level: 9" node_number="117"> <a class="valid" valid="valid" title="valid: True, node: 118, tag: a, level: 10" node_number="118">Initiatives</a> <ul class="valid" valid="valid" title="valid: True, node: 119, tag: ul, level: 10" node_number="119"> <li class="valid" valid="valid" title="valid: True, node: 120, tag: li, level: 11" node_number="120"> <div class="valid" valid="valid" title="valid: True, node: 121, tag: div, level: 12" node_number="121"> <div class="valid" valid="valid" title="valid: True, node: 122, tag: div, level: 13" node_number="122"> <ul class="valid" valid="valid" title="valid: True, node: 123, tag: ul, level: 14" node_number="123"> <li title="valid: False, node: 124, tag: li, level: 15" node_number="124"> <a title="valid: False, node: 125, tag: a, level: 16" node_number="125"> Sciforum </a> </li> <li title="valid: False, node: 126, tag: li, level: 15" node_number="126"> <a title="valid: False, node: 127, tag: a, level: 16" node_number="127"> MDPI Books </a> </li> <li title="valid: False, node: 128, tag: li, level: 15" node_number="128"> <a title="valid: False, node: 129, tag: a, level: 16" node_number="129"> Preprints </a> </li> <li title="valid: False, node: 130, tag: li, level: 15" node_number="130"> <a title="valid: False, node: 131, tag: a, level: 16" node_number="131"> Scilit </a> </li> <li title="valid: False, node: 132, tag: li, level: 15" node_number="132"> <a title="valid: False, node: 133, tag: a, level: 16" node_number="133"> SciProfiles </a> </li> <li title="valid: False, node: 134, tag: li, level: 15" node_number="134"> <a title="valid: False, node: 135, tag: a, level: 16" node_number="135"> Encyclopedia </a> </li> <li title="valid: False, node: 136, tag: li, level: 15" node_number="136"> <a title="valid: False, node: 137, tag: a, level: 16" node_number="137"> JAMS </a> </li> <li title="valid: False, node: 138, tag: li, level: 15" node_number="138"> <a title="valid: False, node: 139, tag: a, level: 16" node_number="139"> Proceedings Series </a> </li> </ul> </div> </div> </li> </ul> </li> <li class="valid" valid="valid" title="valid: True, node: 140, tag: li, level: 9" node_number="140"> <a class="valid" valid="valid" title="valid: True, node: 141, tag: a, level: 10" node_number="141">About</a> </li> </ul> </div> <div class="valid" valid="valid" title="valid: True, node: 142, tag: div, level: 7" node_number="142"> <div class="valid" valid="valid" title="valid: True, node: 143, tag: div, level: 8" node_number="143"> <a class="valid" valid="valid" title="valid: True, node: 144, tag: a, level: 9" node_number="144">Sign In / Sign Up</a> <a class="valid" valid="valid" title="valid: True, node: 145, tag: a, level: 9" node_number="145">Submit</a> </div> </div> </div> </div> <div class="valid" valid="valid" title="valid: True, node: 146, tag: div, level: 5" node_number="146"> <div class="valid" valid="valid" title="valid: True, node: 147, tag: div, level: 6" node_number="147"> <div class="valid" valid="valid" title="valid: True, node: 148, tag: div, level: 7" node_number="148"> <div class="valid" valid="valid" title="valid: True, node: 149, tag: div, level: 8" node_number="149"> <a class="valid" valid="valid" title="valid: True, node: 150, tag: a, level: 9" node_number="150"> Covered in: PubMed </a> </div></div> <div class="valid" valid="valid" title="valid: True, node: 151, tag: div, level: 7" node_number="151"> <div class="valid" valid="valid" title="valid: True, node: 152, tag: div, level: 8" node_number="152"> <a class="valid" valid="valid" title="valid: True, node: 153, tag: a, level: 9" node_number="153"> IMPACTFACTOR 4.879 </a> </div> </div> </div> <div class="valid" valid="valid" title="valid: True, node: 154, tag: div, level: 6" node_number="154"> Journals </div> <div class="valid" valid="valid" title="valid: True, node: 155, tag: div, level: 6" node_number="155"> Biomolecules </div> </div> </header> <div class="valid" valid="valid" title="valid: True, node: 156, tag: div, level: 4" node_number="156"> <div class="valid" valid="valid" title="valid: True, node: 157, tag: div, level: 5" node_number="157"> <div class="valid" valid="valid" title="valid: True, node: 158, tag: div, level: 6" node_number="158"> <div class="valid" valid="valid" title="valid: True, node: 159, tag: div, level: 7" node_number="159"> <div class="valid" valid="valid" title="valid: True, node: 160, tag: div, level: 8" node_number="160"> <ul class="valid" valid="valid" title="valid: True, node: 161, tag: ul, level: 9" node_number="161"> <li class="valid" valid="valid" title="valid: True, node: 162, tag: li, level: 10" node_number="162"> <a class="valid" valid="valid" title="valid: True, node: 163, tag: a, level: 11" node_number="163"> <div class="valid" valid="valid" title="valid: True, node: 164, tag: div, level: 12" node_number="164"> Clinical Perspectives of Single-Cell RNA Sequencing </div> </a> </li> <li class="valid" valid="valid" title="valid: True, node: 165, tag: li, level: 10" node_number="165"> <a class="valid" valid="valid" title="valid: True, node: 166, tag: a, level: 11" node_number="166"> <div class="valid" valid="valid" title="valid: True, node: 167, tag: div, level: 12" node_number="167"> The Bigger Picture: Why Oral Mucosa Heals Better Than Skin </div> </a> </li> <li class="valid" valid="valid" title="valid: True, node: 168, tag: li, level: 10" node_number="168"> <a class="valid" valid="valid" title="valid: True, node: 169, tag: a, level: 11" node_number="169"> <div class="valid" valid="valid" title="valid: True, node: 170, tag: div, level: 12" node_number="170"> Pathophysiological Roles of Histamine Receptors in Cancer Progression: Implications and Perspectives as Potential Molecular Targets </div> </a> </li> <li class="valid" valid="valid" title="valid: True, node: 171, tag: li, level: 10" node_number="171"> <a class="valid" valid="valid" title="valid: True, node: 172, tag: a, level: 11" node_number="172"> <div class="valid" valid="valid" title="valid: True, node: 173, tag: div, level: 12" node_number="173"> TGF&#946;-Neurotrophin Interactions in Heart, Retina, and Brain </div> </a> </li> <li class="valid" valid="valid" title="valid: True, node: 174, tag: li, level: 10" node_number="174"> <a class="valid" valid="valid" title="valid: True, node: 175, tag: a, level: 11" node_number="175"> <div class="valid" valid="valid" title="valid: True, node: 176, tag: div, level: 12" node_number="176"> Insight into Calcium-Binding Motifs of Intrinsically Disordered Proteins </div> </a> </li> </ul> </div> </div> <div class="valid" valid="valid" title="valid: True, node: 177, tag: div, level: 7" node_number="177"> <div class="valid" valid="valid" title="valid: True, node: 178, tag: div, level: 8" node_number="178"> <h2 class="valid" valid="valid" title="valid: True, node: 179, tag: h2, level: 9" node_number="179">Journal Description</h2> </div> <div class="valid" valid="valid" title="valid: True, node: 180, tag: div, level: 8" node_number="180"> <div class="valid" valid="valid" title="valid: True, node: 181, tag: div, level: 9" node_number="181"> <h1 class="valid" valid="valid" title="valid: True, node: 182, tag: h1, level: 10" node_number="182"> Biomolecules </h1> <div class="valid" valid="valid" title="valid: True, node: 183, tag: div, level: 10" node_number="183"> Biomolecules is a <a class="valid" valid="valid" title="valid: True, node: 184, tag: a, level: 11" node_number="184">peer-reviewed</a>,&#160;open access journal on structures and functions of bioactive and biogenic substances, molecular mechanisms with biological and medical implications as well as biomaterials and their applications.&#160;Biomolecules is published monthly&#160;online by MDPI. The&#160;<a class="valid" valid="valid" title="valid: True, node: 185, tag: a, level: 11" node_number="185">Spanish Society for Biochemistry and Molecular Biology (SEBBM)</a> is affiliated with Biomolecules and their members receive discounts on the article processing charges. <ul class="valid" valid="valid" title="valid: True, node: 186, tag: ul, level: 11" node_number="186"> <li class="valid" valid="valid" title="valid: True, node: 187, tag: li, level: 12" node_number="187">Open Access&#8212; free for readers, with <a class="valid" valid="valid" title="valid: True, node: 188, tag: a, level: 13" node_number="188">article processing charges (APC)</a> paid by authors or their institutions.</li> <li class="valid" valid="valid" title="valid: True, node: 189, tag: li, level: 12" node_number="189">High Visibility:&#160;indexed within <a class="valid" valid="valid" title="valid: True, node: 190, tag: a, level: 13" node_number="190">Scopus</a>, <a class="valid" valid="valid" title="valid: True, node: 191, tag: a, level: 13" node_number="191">SCIE (Web of Science)</a>, <a class="valid" valid="valid" title="valid: True, node: 192, tag: a, level: 13" node_number="192">PubMed</a>, <a class="valid" valid="valid" title="valid: True, node: 193, tag: a, level: 13" node_number="193">MEDLINE</a>, <a class="valid" valid="valid" title="valid: True, node: 194, tag: a, level: 13" node_number="194">PMC</a>, <a class="valid" valid="valid" title="valid: True, node: 195, tag: a, level: 13" node_number="195">Embase</a>, <a class="valid" valid="valid" title="valid: True, node: 196, tag: a, level: 13" node_number="196">CAPlus / SciFinder</a>, and many <a class="valid" valid="valid" title="valid: True, node: 197, tag: a, level: 13" node_number="197">other databases</a>.</li> <li class="valid" valid="valid" title="valid: True, node: 198, tag: li, level: 12" node_number="198">Journal Rank:&#160;<a class="valid" valid="valid" title="valid: True, node: 199, tag: a, level: 13" node_number="199">JCR</a>&#160;- Q2 (Biochemistry Molecular Biology)</li> <li class="valid" valid="valid" title="valid: True, node: 200, tag: li, level: 12" node_number="200">Rapid Publication: manuscripts are peer-reviewed and a first decision provided to authors approximately 16.3 days after submission; acceptance to publication is undertaken in 2.9 days (median values for papers published in this journal in the first half of 2021).</li> <li class="valid" valid="valid" title="valid: True, node: 201, tag: li, level: 12" node_number="201">Recognition of Reviewers: reviewers who provide timely, thorough peer-review reports receive vouchers entitling them to a discount on the APC of their next publication in any MDPI journal, in appreciation of the work done.</li> <li class="valid" valid="valid" title="valid: True, node: 202, tag: li, level: 12" node_number="202">Testimonials: See what our authors say about Biomolecules.</li> <li class="valid" valid="valid" title="valid: True, node: 203, tag: li, level: 12" node_number="203">Sections:&#160;published in&#160;twenty <a class="valid" valid="valid" title="valid: True, node: 204, tag: a, level: 13" node_number="204">topical sections</a>.</li> <li class="valid" valid="valid" title="valid: True, node: 205, tag: li, level: 12" node_number="205">Companion journal:&#160;<a class="valid" valid="valid" title="valid: True, node: 206, tag: a, level: 13" node_number="206">Receptors</a></li> </ul> </div> <div class="valid" valid="valid" title="valid: True, node: 207, tag: div, level: 10" node_number="207"> Impact Factor: 4.879 (2020) ; 5-Year Impact Factor: 5.362 (2020) </div> <div class="valid" valid="valid" title="valid: True, node: 208, tag: div, level: 10" node_number="208"> <a class="valid" valid="valid" title="valid: True, node: 209, tag: a, level: 11" node_number="209"> <i class="valid" valid="valid" title="valid: True, node: 210, tag: i, level: 12" node_number="210">subject</i> Imprint Information </a> <a class="valid" valid="valid" title="valid: True, node: 211, tag: a, level: 11" node_number="211"> <i class="valid" valid="valid" title="valid: True, node: 212, tag: i, level: 12" node_number="212">get_app</i> Journal Flyer </a> <a class="valid" valid="valid" title="valid: True, node: 213, tag: a, level: 11" node_number="213"> Open Access </a> ISSN: 2218-273X </div> </div> </div> </div> <div class="valid" valid="valid" title="valid: True, node: 214, tag: div, level: 7" node_number="214"> <div class="valid" valid="valid" title="valid: True, node: 215, tag: div, level: 8" node_number="215"> <h2 class="valid" valid="valid" title="valid: True, node: 216, tag: h2, level: 9" node_number="216">Latest Articles</h2> </div> <div class="valid" valid="valid" title="valid: True, node: 217, tag: div, level: 8" node_number="217"> <div class="valid" valid="valid" title="valid: True, node: 218, tag: div, level: 9" node_number="218"> <div class="valid" valid="valid" title="valid: True, node: 219, tag: div, level: 10" node_number="219"> <div class="valid" valid="valid" title="valid: True, node: 220, tag: div, level: 11" node_number="220"> <div class="valid" valid="valid" title="valid: True, node: 221, tag: div, level: 12" node_number="221"> <a class="valid" valid="valid" title="valid: True, node: 222, tag: a, level: 13" node_number="222"> <i class="valid" valid="valid" title="valid: True, node: 223, tag: i, level: 14" node_number="223">get_app</i> </a> </div> <div class="valid" valid="valid" title="valid: True, node: 224, tag: div, level: 12" node_number="224"> <a class="valid" valid="valid" title="valid: True, node: 225, tag: a, level: 13" node_number="225"> <i class="valid" valid="valid" title="valid: True, node: 226, tag: i, level: 14" node_number="226">subject</i> </a> <div class="valid" valid="valid" title="valid: True, node: 227, tag: div, level: 13" node_number="227"> View online as: <a class="valid" valid="valid" title="valid: True, node: 228, tag: a, level: 14" node_number="228">Abstract Page</a> <a class="valid" valid="valid" title="valid: True, node: 229, tag: a, level: 14" node_number="229">Full-Text HTML</a> </div> </div> <div class="valid" valid="valid" title="valid: True, node: 230, tag: div, level: 12" node_number="230">Open AccessReview</div> Erectile Function and Sexual Behavior: A Review of the Role of Nitric Oxide in the Central Nervous System <div class="valid" valid="valid" title="valid: True, node: 231, tag: div, level: 12" node_number="231"> by <span class="valid" valid="valid" title="valid: True, node: 232, tag: span, level: 13" node_number="232"><div class="valid" valid="valid" title="valid: True, node: 233, tag: div, level: 14" node_number="233">Maria Rosaria Melis</div> and </span><span class="valid" valid="valid" title="valid: True, node: 234, tag: span, level: 13" node_number="234"><div class="valid" valid="valid" title="valid: True, node: 235, tag: div, level: 14" node_number="235">Antonio Argiolas</div></span> </div> <div class="valid" valid="valid" title="valid: True, node: 236, tag: div, level: 12" node_number="236"> Biomolecules <b class="valid" valid="valid" title="valid: True, node: 237, tag: b, level: 13" node_number="237">2021</b>, 11(12), 1866; https://doi.org/10.3390/biom11121866 (registering&#160;DOI) - 11 Dec 2021 </div> <div class="valid" valid="valid" title="valid: True, node: 238, tag: div, level: 12" node_number="238"> Abstract <div class="valid" valid="valid" title="valid: True, node: 239, tag: div, level: 13" node_number="239"> Nitric oxide (NO), the neuromodulator/neurotransmitter formed from l-arginine by neuronal, endothelial and inducible NO synthases, is involved in numerous functions across the body, from the control of arterial blood pressure to penile erection, and at central level from energy homeostasis regulation to [...] Read more. </div> <div class="valid" valid="valid" title="valid: True, node: 240, tag: div, level: 13" node_number="240"> Nitric oxide (NO), the neuromodulator/neurotransmitter formed from l-arginine by neuronal, endothelial and inducible NO synthases, is involved in numerous functions across the body, from the control of arterial blood pressure to penile erection, and at central level from energy homeostasis regulation to memory, learning and sexual behavior. The aim of this work is to review earlier studies showing that NO plays a role in erectile function and sexual behavior in the hypothalamus and its paraventricular nucleus and the medial preoptic area, and integrate these findings with those of recent studies on this matter. This revisitation shows that NO influences erectile function and sexual behavior in males and females by acting not only in the paraventricular nucleus and medial preoptic area but also in extrahypothalamic brain areas, often with different mechanisms. Most importantly, since these areas are strictly interconnected with the paraventricular nucleus and medial preoptic area, send to and receive neural projections from the spinal cord, in which sexual communication between brain and genital apparatus takes place, this review reveals that central NO participates in concert with neurotransmitters/neuropeptides to a neural circuit controlling both the consummatory (penile erection, copulation, lordosis) and appetitive components (sexual motivation, arousal, reward) of sexual behavior. Full article </div> </div> <div class="valid" valid="valid" title="valid: True, node: 241, tag: div, level: 12" node_number="241"> (This article belongs to the Section Biological Factors) </div> &#9658;&#9660; Show Figures <div class="valid" valid="valid" title="valid: True, node: 242, tag: div, level: 12" node_number="242"><div class="valid" valid="valid" title="valid: True, node: 243, tag: div, level: 13" node_number="243"><div class="valid" valid="valid" title="valid: True, node: 244, tag: div, level: 14" node_number="244"><p title="valid: False, node: 245, tag: p, level: 15" node_number="245">Figure 1</p></div></div></div> </div> </div> </div> <div class="valid" valid="valid" title="valid: True, node: 246, tag: div, level: 9" node_number="246"> <div class="valid" valid="valid" title="valid: True, node: 247, tag: div, level: 10" node_number="247"> <div class="valid" valid="valid" title="valid: True, node: 248, tag: div, level: 11" node_number="248"> <div class="valid" valid="valid" title="valid: True, node: 249, tag: div, level: 12" node_number="249"> <div class="valid" valid="valid" title="valid: True, node: 250, tag: div, level: 13" node_number="250"> <a class="valid" valid="valid" title="valid: True, node: 251, tag: a, level: 14" node_number="251"> <i title="valid: False, node: 252, tag: i, level: 15" node_number="252">get_app</i> </a> </div> <div class="valid" valid="valid" title="valid: True, node: 253, tag: div, level: 13" node_number="253"> <a class="valid" valid="valid" title="valid: True, node: 254, tag: a, level: 14" node_number="254"> <i title="valid: False, node: 255, tag: i, level: 15" node_number="255">subject</i> </a> <div class="valid" valid="valid" title="valid: True, node: 256, tag: div, level: 14" node_number="256"> View online as: Abstract Page Full-Text HTML </div> </div> <div class="valid" valid="valid" title="valid: True, node: 257, tag: div, level: 13" node_number="257">Open AccessArticle</div> The Effect of Three-Month Vitamin D Supplementation on the Levels of Homocysteine Metabolism Markers and Inflammatory Cytokines in Sera of Psoriatic Patients <div class="valid" valid="valid" title="valid: True, node: 258, tag: div, level: 13" node_number="258"> by <span class="valid" valid="valid" title="valid: True, node: 259, tag: span, level: 14" node_number="259"><div title="valid: False, node: 260, tag: div, level: 15" node_number="260">Alma Prtina</div>, </span><span class="valid" valid="valid" title="valid: True, node: 261, tag: span, level: 14" node_number="261"><div title="valid: False, node: 262, tag: div, level: 15" node_number="262">Nela Ra&#353;eta Simovi&#263;</div>, </span><span class="valid" valid="valid" title="valid: True, node: 263, tag: span, level: 14" node_number="263"><div title="valid: False, node: 264, tag: div, level: 15" node_number="264">Tatjana Milivojac</div>, </span><span class="valid" valid="valid" title="valid: True, node: 265, tag: span, level: 14" node_number="265"><div title="valid: False, node: 266, tag: div, level: 15" node_number="266">Milorad Vujni&#263;</div>, </span><span class="valid" valid="valid" title="valid: True, node: 267, tag: span, level: 14" node_number="267"><div title="valid: False, node: 268, tag: div, level: 15" node_number="268">Milkica Grabe&#382;</div>, </span><span class="valid" valid="valid" title="valid: True, node: 269, tag: span, level: 14" node_number="269"><div title="valid: False, node: 270, tag: div, level: 15" node_number="270">Dragan Djuric</div>, </span><span class="valid" valid="valid" title="valid: True, node: 271, tag: span, level: 14" node_number="271"><div title="valid: False, node: 272, tag: div, level: 15" node_number="272">Milo&#353; P. Stojiljkovi&#263;</div>, </span><span class="valid" valid="valid" title="valid: True, node: 273, tag: span, level: 14" node_number="273"><div title="valid: False, node: 274, tag: div, level: 15" node_number="274">Valentina Soldat Stankovi&#263;</div>, </span><span class="valid" valid="valid" title="valid: True, node: 275, tag: span, level: 14" node_number="275"><div title="valid: False, node: 276, tag: div, level: 15" node_number="276">Miodrag J. &#268;oli&#263;</div> and </span><span class="valid" valid="valid" title="valid: True, node: 277, tag: span, level: 14" node_number="277"><div title="valid: False, node: 278, tag: div, level: 15" node_number="278">Ranko &#352;krbi&#263;</div></span> </div> <div class="valid" valid="valid" title="valid: True, node: 279, tag: div, level: 13" node_number="279"> Biomolecules <b class="valid" valid="valid" title="valid: True, node: 280, tag: b, level: 14" node_number="280">2021</b>, 11(12), 1865; https://doi.org/10.3390/biom11121865 (registering&#160;DOI) - 11 Dec 2021 </div> <div class="valid" valid="valid" title="valid: True, node: 281, tag: div, level: 13" node_number="281"> Abstract <div class="valid" valid="valid" title="valid: True, node: 282, tag: div, level: 14" node_number="282"> Psoriasis is an autoimmune and inflammatory skin disease. Psoriatic patients express higher levels of plasma homocysteine (Hcy) concentration and pro-inflammatory mediators than healthy people; this is frequently associated with vitamin D deficiency. The aim of this clinical study was to investigate the effects [...] Read more. </div> <div class="valid" valid="valid" title="valid: True, node: 283, tag: div, level: 14" node_number="283"> Psoriasis is an autoimmune and inflammatory skin disease. Psoriatic patients express higher levels of plasma homocysteine (Hcy) concentration and pro-inflammatory mediators than healthy people; this is frequently associated with vitamin D deficiency. The aim of this clinical study was to investigate the effects of high doses of vitamin D supplementation on the parameters of Hcy metabolism and cytokines in sera of psoriatic patients. This prospective study was conducted on 40 psoriatic patients who had the vitamin D deficiency. All patients received vitamin D 5000 IU/day for three months. Clinical and biochemical measurements were taken at baseline and at follow up (3 months). The results showed that the severity of clinical features, measured by the psoriasis area severity index (PASI) score, were considerably improved in patients after vitamin D supplementation. After vitamin D supplementation, most of the patients (<i title="valid: False, node: 284, tag: i, level: 15" node_number="284">n</i> = 25 or 62.5%) had mild clinical form (<i title="valid: False, node: 285, tag: i, level: 15" node_number="285">p</i> &lt; 0.001). After twelve weeks of intervention period, there were significant increases in vitamin D and B<sub title="valid: False, node: 286, tag: sub, level: 15" node_number="286">12</sub> serum levels in comparison to the levels that had been measured at the beginning of the study (56.77 &#177; 14.66 nmol/L and 301.08 &#177; 95.02 pg/mL vs. 103.85 &#177; 32.20 nmol/L and 362.81 &#177; 118.56 pg/mL, respectively; <i title="valid: False, node: 287, tag: i, level: 15" node_number="287">p</i> &lt; 0.001). Moreover, serum levels of Hcy and folate were significantly lower at the end of the study in comparison with the initial levels (12.45 &#177; 1.92 &#181;mol/L and 8.01 &#177; 3.88 mg/mL vs. 10.38 &#177; 1.66 &#181;mol/L and 6.27 &#177; 2.60 mg/mL, respectively). High doses of vitamin D supplementation led to a significant decrease in pro-inflammatory cytokines (IFN-&#612;, TNF-&#945;, IL-1&#946;, IL-6, IL-8, and IL-17) and high-sensitivity C-reactive protein (hsCRP), whereas the production of anti-inflammatory cytokines (IL-10, IL-5) was up-regulated. In conclusion, supplementation with high doses of vitamin D could be one of the possible preventive and therapeutic measures to reduce systemic inflammation in psoriatic patients. Full article </div> </div> <div class="valid" valid="valid" title="valid: True, node: 288, tag: div, level: 13" node_number="288"> (This article belongs to the Special Issue Homocysteine: Biochemistry, Molecular Biology, and Role in Disease 2021) </div> &#9658;&#9660; Show Figures <div class="valid" valid="valid" title="valid: True, node: 289, tag: div, level: 13" node_number="289"><div class="valid" valid="valid" title="valid: True, node: 290, tag: div, level: 14" node_number="290"><div title="valid: False, node: 291, tag: div, level: 15" node_number="291"><p title="valid: False, node: 292, tag: p, level: 16" node_number="292">Figure 1</p></div></div></div> </div> </div> </div> <div class="valid" valid="valid" title="valid: True, node: 293, tag: div, level: 10" node_number="293"> <div class="valid" valid="valid" title="valid: True, node: 294, tag: div, level: 11" node_number="294"> <div class="valid" valid="valid" title="valid: True, node: 295, tag: div, level: 12" node_number="295"> <div class="valid" valid="valid" title="valid: True, node: 296, tag: div, level: 13" node_number="296"> <a class="valid" valid="valid" title="valid: True, node: 297, tag: a, level: 14" node_number="297"> <i title="valid: False, node: 298, tag: i, level: 15" node_number="298">get_app</i> </a> </div> <div class="valid" valid="valid" title="valid: True, node: 299, tag: div, level: 13" node_number="299"> <a class="valid" valid="valid" title="valid: True, node: 300, tag: a, level: 14" node_number="300"> <i title="valid: False, node: 301, tag: i, level: 15" node_number="301">subject</i> </a> <div class="valid" valid="valid" title="valid: True, node: 302, tag: div, level: 14" node_number="302"> View online as: Abstract Page Full-Text HTML </div> </div> <div class="valid" valid="valid" title="valid: True, node: 303, tag: div, level: 13" node_number="303">Open AccessCommunication</div> <a class="valid" valid="valid" title="valid: True, node: 304, tag: a, level: 13" node_number="304">Activation of the &#945;1&#946;2&#947;2L GABA<sub class="valid" valid="valid" title="valid: True, node: 305, tag: sub, level: 14" node_number="305">A</sub> Receptor by Physiological Agonists</a> <div class="valid" valid="valid" title="valid: True, node: 306, tag: div, level: 13" node_number="306"> by <span class="valid" valid="valid" title="valid: True, node: 307, tag: span, level: 14" node_number="307"><div title="valid: False, node: 308, tag: div, level: 15" node_number="308">Spencer R. Pierce</div>, </span><span class="valid" valid="valid" title="valid: True, node: 309, tag: span, level: 14" node_number="309"><div title="valid: False, node: 310, tag: div, level: 15" node_number="310">Allison L. Germann</div> and </span><span class="valid" valid="valid" title="valid: True, node: 311, tag: span, level: 14" node_number="311"><div title="valid: False, node: 312, tag: div, level: 15" node_number="312">Gustav Akk</div></span> </div> <div class="valid" valid="valid" title="valid: True, node: 313, tag: div, level: 13" node_number="313"> Biomolecules <b class="valid" valid="valid" title="valid: True, node: 314, tag: b, level: 14" node_number="314">2021</b>, 11(12), 1864; https://doi.org/10.3390/biom11121864 (registering&#160;DOI) - 11 Dec 2021 </div> <div class="valid" valid="valid" title="valid: True, node: 315, tag: div, level: 13" node_number="315"> Abstract <div class="valid" valid="valid" title="valid: True, node: 316, tag: div, level: 14" node_number="316"> The Cl<sup title="valid: False, node: 317, tag: sup, level: 15" node_number="317">&#8722;</sup> permeable GABA<sub title="valid: False, node: 318, tag: sub, level: 15" node_number="318">A</sub> receptor is a major contributor to cellular inhibition in the brain. The receptor is normally activated by synaptically-released or ambient GABA but is sensitive to a number of physiological compounds such as &#946;-alanine, taurine, and neurosteroids that, [...] Read more. </div> <div class="valid" valid="valid" title="valid: True, node: 319, tag: div, level: 14" node_number="319"> The Cl<sup title="valid: False, node: 320, tag: sup, level: 15" node_number="320">&#8722;</sup> permeable GABA<sub title="valid: False, node: 321, tag: sub, level: 15" node_number="321">A</sub> receptor is a major contributor to cellular inhibition in the brain. The receptor is normally activated by synaptically-released or ambient GABA but is sensitive to a number of physiological compounds such as &#946;-alanine, taurine, and neurosteroids that, to various degrees, activate the receptor and modulate responses either to the transmitter or to each other. Here, we describe &#945;1&#946;2&#947;2L GABA<sub title="valid: False, node: 322, tag: sub, level: 15" node_number="322">A</sub> receptor activation and modulation by combinations of orthosteric and allosteric activators. The overall goal was to gain insight into how changes in the levels of endogenous agonists modulate receptor activity and influence cellular inhibition. Experimental observations and simulations are described in the framework of a cyclic concerted transition model. We also provide general analytical solutions for the analysis of electrophysiological data collected in the presence of combinations of active compounds. Full article </div> </div> <div class="valid" valid="valid" title="valid: True, node: 323, tag: div, level: 13" node_number="323"> (This article belongs to the Collection Feature Papers in Chemical Biology) </div> &#9658;&#9660; Show Figures <div class="valid" valid="valid" title="valid: True, node: 324, tag: div, level: 13" node_number="324"><div class="valid" valid="valid" title="valid: True, node: 325, tag: div, level: 14" node_number="325"><div title="valid: False, node: 326, tag: div, level: 15" node_number="326"><p title="valid: False, node: 327, tag: p, level: 16" node_number="327">Figure 1</p></div></div></div> </div> </div> </div> <div class="valid" valid="valid" title="valid: True, node: 328, tag: div, level: 10" node_number="328"> <div class="valid" valid="valid" title="valid: True, node: 329, tag: div, level: 11" node_number="329"> <div class="valid" valid="valid" title="valid: True, node: 330, tag: div, level: 12" node_number="330"> <div class="valid" valid="valid" title="valid: True, node: 331, tag: div, level: 13" node_number="331"> <a class="valid" valid="valid" title="valid: True, node: 332, tag: a, level: 14" node_number="332"> <i title="valid: False, node: 333, tag: i, level: 15" node_number="333">get_app</i> </a> </div> <div class="valid" valid="valid" title="valid: True, node: 334, tag: div, level: 13" node_number="334"> <a class="valid" valid="valid" title="valid: True, node: 335, tag: a, level: 14" node_number="335"> <i title="valid: False, node: 336, tag: i, level: 15" node_number="336">subject</i> </a> <div class="valid" valid="valid" title="valid: True, node: 337, tag: div, level: 14" node_number="337"> View online as: Abstract Page Full-Text HTML </div> </div> <div class="valid" valid="valid" title="valid: True, node: 338, tag: div, level: 13" node_number="338">Open AccessArticle</div> The Association of Serum Circulating Neuropeptide Q and Chemerin Levels with Cardiometabolic Risk Factors among Patients with Metabolic Syndrome <div class="valid" valid="valid" title="valid: True, node: 339, tag: div, level: 13" node_number="339"> by <span class="valid" valid="valid" title="valid: True, node: 340, tag: span, level: 14" node_number="340"><div title="valid: False, node: 341, tag: div, level: 15" node_number="341">Marta Pelczy&#324;ska</div>, </span><span class="valid" valid="valid" title="valid: True, node: 342, tag: span, level: 14" node_number="342"><div title="valid: False, node: 343, tag: div, level: 15" node_number="343">Aniceta Ada Mikulska</div>, </span><span class="valid" valid="valid" title="valid: True, node: 344, tag: span, level: 14" node_number="344"><div title="valid: False, node: 345, tag: div, level: 15" node_number="345">Krystyna Czy&#380;ewska</div>, </span><span class="valid" valid="valid" title="valid: True, node: 346, tag: span, level: 14" node_number="346"><div title="valid: False, node: 347, tag: div, level: 15" node_number="347">Pawe&#322; Bogda&#324;ski</div> and </span><span class="valid" valid="valid" title="valid: True, node: 348, tag: span, level: 14" node_number="348"><div title="valid: False, node: 349, tag: div, level: 15" node_number="349">Teresa Grzelak</div></span> </div> <div class="valid" valid="valid" title="valid: True, node: 350, tag: div, level: 13" node_number="350"> Biomolecules <b class="valid" valid="valid" title="valid: True, node: 351, tag: b, level: 14" node_number="351">2021</b>, 11(12), 1863; https://doi.org/10.3390/biom11121863 (registering&#160;DOI) - 10 Dec 2021 </div> <div class="valid" valid="valid" title="valid: True, node: 352, tag: div, level: 13" node_number="352"> Abstract <div class="valid" valid="valid" title="valid: True, node: 353, tag: div, level: 14" node_number="353"> The potential involvement of neuropeptide Q (NPQ) and chemerin (CHEM) in metabolic disorders is yet to be fully elucidated. The aim of this study was to evaluate serum concentrations of NPQ and CHEM and to establish their relationship with cardiometabolic risk factors among [...] Read more. </div> <div class="valid" valid="valid" title="valid: True, node: 354, tag: div, level: 14" node_number="354"> The potential involvement of neuropeptide Q (NPQ) and chemerin (CHEM) in metabolic disorders is yet to be fully elucidated. The aim of this study was to evaluate serum concentrations of NPQ and CHEM and to establish their relationship with cardiometabolic risk factors among individuals with metabolic syndrome. A total of 66 patients with metabolic syndrome (MetS) and 83 healthy volunteers (non-MetS) underwent biochemical, blood pressure, and anthropometric measurements. The concentration of NPQ in the MetS group was significantly lower (0.47 (0.34 ; 0.54) vs. 0.52 (0.43 ; 0.60) ng/mL, <i title="valid: False, node: 355, tag: i, level: 15" node_number="355">p</i> = 0.015) than in non-MetS, while there were no differences in CHEM level. In the entire study population, we observed several negative correlations between NPQ concentration and waist-hip ratio (WHR), visceral adipose tissue, diastolic blood pressure (DBP), triglycerides (TG) along with a positive correlation with high-density lipoprotein (HDL), total muscle mass, and CHEM. Moreover, a negative correlation was observed in the MetS group between NPQ and glycemia. CHEM showed no significant correlations with cardiometabolic risk factors in the study population. In a multiple regression model, the total muscle mass proved to be an independent factor determining NPQ concentration in the population (<i title="valid: False, node: 356, tag: i, level: 15" node_number="356">p</i> &lt; 0.00000001, <i title="valid: False, node: 357, tag: i, level: 15" node_number="357">R</i><sup title="valid: False, node: 358, tag: sup, level: 15" node_number="358">2</sup><i title="valid: False, node: 359, tag: i, level: 15" node_number="359"><sub title="valid: False, node: 360, tag: sub, level: 16" node_number="360">adj</sub></i> = 28.6%). NPQ seems to protect against metabolic disorders correlated with obesity. Thus, it is worth considering NPQ level as a candidate protective biomarker of metabolic syndrome complications. Full article </div> </div> <div class="valid" valid="valid" title="valid: True, node: 361, tag: div, level: 13" node_number="361"> (This article belongs to the Special Issue Obesity, Adipose Tissue and Cardiovascular Diseases) </div> </div> </div> </div> <div class="valid" valid="valid" title="valid: True, node: 362, tag: div, level: 10" node_number="362"> <div class="valid" valid="valid" title="valid: True, node: 363, tag: div, level: 11" node_number="363"> <div class="valid" valid="valid" title="valid: True, node: 364, tag: div, level: 12" node_number="364"> <div class="valid" valid="valid" title="valid: True, node: 365, tag: div, level: 13" node_number="365"> <a class="valid" valid="valid" title="valid: True, node: 366, tag: a, level: 14" node_number="366"> <i title="valid: False, node: 367, tag: i, level: 15" node_number="367">attachment</i> </a> <div class="valid" valid="valid" title="valid: True, node: 368, tag: div, level: 14" node_number="368"> Supplementary material: Supplementary File 1 (ZIP, 1023 KiB) </div> </div> <div class="valid" valid="valid" title="valid: True, node: 369, tag: div, level: 13" node_number="369"> <a class="valid" valid="valid" title="valid: True, node: 370, tag: a, level: 14" node_number="370"> <i title="valid: False, node: 371, tag: i, level: 15" node_number="371">get_app</i> </a> </div> <div class="valid" valid="valid" title="valid: True, node: 372, tag: div, level: 13" node_number="372"> <a class="valid" valid="valid" title="valid: True, node: 373, tag: a, level: 14" node_number="373"> <i title="valid: False, node: 374, tag: i, level: 15" node_number="374">subject</i> </a> <div class="valid" valid="valid" title="valid: True, node: 375, tag: div, level: 14" node_number="375"> View online as: Abstract Page </div> </div> <div class="valid" valid="valid" title="valid: True, node: 376, tag: div, level: 13" node_number="376">Open AccessArticle</div> AlphaFold-Predicted Structures of KCTD Proteins Unravel Previously Undetected Relationships among the Members of the Family <div class="valid" valid="valid" title="valid: True, node: 377, tag: div, level: 13" node_number="377"> by <span class="valid" valid="valid" title="valid: True, node: 378, tag: span, level: 14" node_number="378"><div title="valid: False, node: 379, tag: div, level: 15" node_number="379">Luciana Esposito</div>, </span><span class="valid" valid="valid" title="valid: True, node: 380, tag: span, level: 14" node_number="380"><div title="valid: False, node: 381, tag: div, level: 15" node_number="381">Nicole Balasco</div>, </span><span class="valid" valid="valid" title="valid: True, node: 382, tag: span, level: 14" node_number="382"><div title="valid: False, node: 383, tag: div, level: 15" node_number="383">Giovanni Smaldone</div>, </span><span class="valid" valid="valid" title="valid: True, node: 384, tag: span, level: 14" node_number="384"><div title="valid: False, node: 385, tag: div, level: 15" node_number="385">Rita Berisio</div>, </span><span class="valid" valid="valid" title="valid: True, node: 386, tag: span, level: 14" node_number="386"><div title="valid: False, node: 387, tag: div, level: 15" node_number="387">Alessia Ruggiero</div> and </span><span class="valid" valid="valid" title="valid: True, node: 388, tag: span, level: 14" node_number="388"><div title="valid: False, node: 389, tag: div, level: 15" node_number="389">Luigi Vitagliano</div></span> </div> <div class="valid" valid="valid" title="valid: True, node: 390, tag: div, level: 13" node_number="390"> Biomolecules <b class="valid" valid="valid" title="valid: True, node: 391, tag: b, level: 14" node_number="391">2021</b>, 11(12), 1862; https://doi.org/10.3390/biom11121862 - 10 Dec 2021 </div> <div class="valid" valid="valid" title="valid: True, node: 392, tag: div, level: 13" node_number="392"> Abstract <div class="valid" valid="valid" title="valid: True, node: 393, tag: div, level: 14" node_number="393"> One of the most striking features of KCTD proteins is their involvement in apparently unrelated yet fundamental physio-pathological processes. Unfortunately, comprehensive structure&#8211;function relationships for this protein family have been hampered by the scarcity of the structural data available. This scenario is rapidly changing [...] Read more. </div> <div class="valid" valid="valid" title="valid: True, node: 394, tag: div, level: 14" node_number="394"> One of the most striking features of KCTD proteins is their involvement in apparently unrelated yet fundamental physio-pathological processes. Unfortunately, comprehensive structure&#8211;function relationships for this protein family have been hampered by the scarcity of the structural data available. This scenario is rapidly changing due to the release of the protein three-dimensional models predicted by AlphaFold (AF). Here, we exploited the structural information contained in the AF database to gain insights into the relationships among the members of the KCTD family with the aim of facilitating the definition of the structural and molecular basis of key roles that these proteins play in many biological processes. The most important finding that emerged from this investigation is the discovery that, in addition to the BTB domain, the vast majority of these proteins also share a structurally similar domain in the C-terminal region despite the absence of general sequence similarities detectable in this region. Using this domain as reference, we generated a novel and comprehensive structure-based pseudo-phylogenetic tree that unraveled previously undetected similarities among the protein family. In particular, we generated a new clustering of the KCTD proteins that will represent a solid ground for interpreting their many functions. Full article </div> </div> <div class="valid" valid="valid" title="valid: True, node: 395, tag: div, level: 13" node_number="395"> (This article belongs to the Section Biomacromolecules: Proteins) </div> </div> </div> </div> <div class="valid" valid="valid" title="valid: True, node: 396, tag: div, level: 10" node_number="396"> <div class="valid" valid="valid" title="valid: True, node: 397, tag: div, level: 11" node_number="397"> <div class="valid" valid="valid" title="valid: True, node: 398, tag: div, level: 12" node_number="398"> <div class="valid" valid="valid" title="valid: True, node: 399, tag: div, level: 13" node_number="399"> <a class="valid" valid="valid" title="valid: True, node: 400, tag: a, level: 14" node_number="400"> <i title="valid: False, node: 401, tag: i, level: 15" node_number="401">get_app</i> </a> </div> <div class="valid" valid="valid" title="valid: True, node: 402, tag: div, level: 13" node_number="402"> <a class="valid" valid="valid" title="valid: True, node: 403, tag: a, level: 14" node_number="403"> <i title="valid: False, node: 404, tag: i, level: 15" node_number="404">subject</i> </a> <div class="valid" valid="valid" title="valid: True, node: 405, tag: div, level: 14" node_number="405"> View online as: Abstract Page </div> </div> <div class="valid" valid="valid" title="valid: True, node: 406, tag: div, level: 13" node_number="406">Open AccessArticle</div> The Effects of Angiotensin II or Angiotensin 1-7 on Rat Pial Microcirculation during Hypoperfusion and Reperfusion Injury: Role of Redox Stress <div class="valid" valid="valid" title="valid: True, node: 407, tag: div, level: 13" node_number="407"> by <span class="valid" valid="valid" title="valid: True, node: 408, tag: span, level: 14" node_number="408"><div title="valid: False, node: 409, tag: div, level: 15" node_number="409">Dominga Lapi</div>, </span><span class="valid" valid="valid" title="valid: True, node: 410, tag: span, level: 14" node_number="410"><div title="valid: False, node: 411, tag: div, level: 15" node_number="411">Maurizio Cammalleri</div>, </span><span class="valid" valid="valid" title="valid: True, node: 412, tag: span, level: 14" node_number="412"><div title="valid: False, node: 413, tag: div, level: 15" node_number="413">Massimo Dal Monte</div>, </span><span class="valid" valid="valid" title="valid: True, node: 414, tag: span, level: 14" node_number="414"><div title="valid: False, node: 415, tag: div, level: 15" node_number="415">Martina Di Maro</div>, </span><span class="valid" valid="valid" title="valid: True, node: 416, tag: span, level: 14" node_number="416"><div title="valid: False, node: 417, tag: div, level: 15" node_number="417">Maria Rosaria Santillo</div>, </span><span class="valid" valid="valid" title="valid: True, node: 418, tag: span, level: 14" node_number="418"><div title="valid: False, node: 419, tag: div, level: 15" node_number="419">Anna Belfiore</div>, </span><span class="valid" valid="valid" title="valid: True, node: 420, tag: span, level: 14" node_number="420"><div title="valid: False, node: 421, tag: div, level: 15" node_number="421">Gilda Nasti</div>, </span><span class="valid" valid="valid" title="valid: True, node: 422, tag: span, level: 14" node_number="422"><div title="valid: False, node: 423, tag: div, level: 15" node_number="423">Simona Damiano</div>, </span><span class="valid" valid="valid" title="valid: True, node: 424, tag: span, level: 14" node_number="424"><div title="valid: False, node: 425, tag: div, level: 15" node_number="425">Rossella Trio</div>, </span><span class="valid" valid="valid" title="valid: True, node: 426, tag: span, level: 14" node_number="426"><div title="valid: False, node: 427, tag: div, level: 15" node_number="427">Martina Chiurazzi</div>, </span><span class="valid" valid="valid" title="valid: True, node: 428, tag: span, level: 14" node_number="428"><div title="valid: False, node: 429, tag: div, level: 15" node_number="429">Barbara De Conno</div>, </span><span class="valid" valid="valid" title="valid: True, node: 430, tag: span, level: 14" node_number="430"><div title="valid: False, node: 431, tag: div, level: 15" node_number="431">Nicola Serao</div>, </span><span class="valid" valid="valid" title="valid: True, node: 432, tag: span, level: 14" node_number="432"><div title="valid: False, node: 433, tag: div, level: 15" node_number="433">Paolo Mondola</div>, </span><span class="valid" valid="valid" title="valid: True, node: 434, tag: span, level: 14" node_number="434"><div title="valid: False, node: 435, tag: div, level: 15" node_number="435">Antonio Colantuoni</div> and </span><span class="valid" valid="valid" title="valid: True, node: 436, tag: span, level: 14" node_number="436"><div title="valid: False, node: 437, tag: div, level: 15" node_number="437">Bruna Guida</div></span> </div> <div class="valid" valid="valid" title="valid: True, node: 438, tag: div, level: 13" node_number="438"> Biomolecules <b class="valid" valid="valid" title="valid: True, node: 439, tag: b, level: 14" node_number="439">2021</b>, 11(12), 1861; https://doi.org/10.3390/biom11121861 (registering&#160;DOI) - 10 Dec 2021 </div> <div class="valid" valid="valid" title="valid: True, node: 440, tag: div, level: 13" node_number="440"> Abstract <div class="valid" valid="valid" title="valid: True, node: 441, tag: div, level: 14" node_number="441"> Renin&#8211;angiotensin systems produce angiotensin II (Ang II) and angiotensin 1-7 (Ang 1-7), which are able to induce opposite effects on circulation. This study in vivo assessed the effects induced by Ang II or Ang 1-7 on rat pial microcirculation during hypoperfusion&#8211;reperfusion, clarifying the [...] Read more. </div> <div class="valid" valid="valid" title="valid: True, node: 442, tag: div, level: 14" node_number="442"> Renin&#8211;angiotensin systems produce angiotensin II (Ang II) and angiotensin 1-7 (Ang 1-7), which are able to induce opposite effects on circulation. This study in vivo assessed the effects induced by Ang II or Ang 1-7 on rat pial microcirculation during hypoperfusion&#8211;reperfusion, clarifying the mechanisms causing the imbalance between Ang II and Ang 1-7. The fluorescence microscopy was used to quantify the microvascular parameters. Hypoperfusion and reperfusion caused vasoconstriction, disruption of blood&#8211;brain barrier, reduction of capillary perfusion and an increase in reactive oxygen species production. Rats treated with Ang II showed exacerbated microvascular damage with stronger vasoconstriction compared to hypoperfused rats, a further increase in leakage, higher decrease in capillary perfusion and marker oxidative stress. Candesartan cilexetil (specific Ang II type 1 receptor (AT<sub title="valid: False, node: 443, tag: sub, level: 15" node_number="443">1</sub>R) antagonist) administration prior to Ang II prevented the effects induced by Ang II, blunting the hypoperfusion&#8211;reperfusion injury. Ang 1-7 or ACE2 activator administration, preserved the pial microcirculation from hypoperfusion&#8211;reperfusion damage. These effects of Ang 1-7 were blunted by a Mas (Mas oncogene-encoded protein) receptor antagonist, while Ang II type 2 receptor antagonists did not affect Ang 1-7-induced changes. In conclusion, Ang II and Ang 1-7 triggered different mechanisms through AT<sub title="valid: False, node: 444, tag: sub, level: 15" node_number="444">1</sub>R or MAS receptors able to affect cerebral microvascular injury. Full article </div> </div> <div class="valid" valid="valid" title="valid: True, node: 445, tag: div, level: 13" node_number="445"> (This article belongs to the Special Issue Feature Papers in Section&#160;Molecular&#160;Medicine) </div> </div> </div> </div> <div class="valid" valid="valid" title="valid: True, node: 446, tag: div, level: 10" node_number="446"> <div class="valid" valid="valid" title="valid: True, node: 447, tag: div, level: 11" node_number="447"> <div class="valid" valid="valid" title="valid: True, node: 448, tag: div, level: 12" node_number="448"> <div class="valid" valid="valid" title="valid: True, node: 449, tag: div, level: 13" node_number="449"> <a class="valid" valid="valid" title="valid: True, node: 450, tag: a, level: 14" node_number="450"> <i title="valid: False, node: 451, tag: i, level: 15" node_number="451">get_app</i> </a> </div> <div class="valid" valid="valid" title="valid: True, node: 452, tag: div, level: 13" node_number="452"> <a class="valid" valid="valid" title="valid: True, node: 453, tag: a, level: 14" node_number="453"> <i title="valid: False, node: 454, tag: i, level: 15" node_number="454">subject</i> </a> <div class="valid" valid="valid" title="valid: True, node: 455, tag: div, level: 14" node_number="455"> View online as: Abstract Page </div> </div> <div class="valid" valid="valid" title="valid: True, node: 456, tag: div, level: 13" node_number="456">Open AccessReview</div> A Review on Microbial Products and Their Perspective Application as Antimicrobial Agents <div class="valid" valid="valid" title="valid: True, node: 457, tag: div, level: 13" node_number="457"> by <span class="valid" valid="valid" title="valid: True, node: 458, tag: span, level: 14" node_number="458"><div title="valid: False, node: 459, tag: div, level: 15" node_number="459">Alka Rani</div>, </span><span class="valid" valid="valid" title="valid: True, node: 460, tag: span, level: 14" node_number="460"><div title="valid: False, node: 461, tag: div, level: 15" node_number="461">Khem Chand Saini</div>, </span><span class="valid" valid="valid" title="valid: True, node: 462, tag: span, level: 14" node_number="462"><div title="valid: False, node: 463, tag: div, level: 15" node_number="463">Felix Bast</div>, </span><span class="valid" valid="valid" title="valid: True, node: 464, tag: span, level: 14" node_number="464"><div title="valid: False, node: 465, tag: div, level: 15" node_number="465">Sunita Varjani</div>, </span><span class="valid" valid="valid" title="valid: True, node: 466, tag: span, level: 14" node_number="466"><div title="valid: False, node: 467, tag: div, level: 15" node_number="467">Sanjeet Mehariya</div>, </span><span class="valid" valid="valid" title="valid: True, node: 468, tag: span, level: 14" node_number="468"><div title="valid: False, node: 469, tag: div, level: 15" node_number="469">Shashi Kant Bhatia</div>, </span><span class="valid" valid="valid" title="valid: True, node: 470, tag: span, level: 14" node_number="470"><div title="valid: False, node: 471, tag: div, level: 15" node_number="471">Neeta Sharma</div> and </span><span class="valid" valid="valid" title="valid: True, node: 472, tag: span, level: 14" node_number="472"><div title="valid: False, node: 473, tag: div, level: 15" node_number="473">Christiane Funk</div></span> </div> <div class="valid" valid="valid" title="valid: True, node: 474, tag: div, level: 13" node_number="474"> Biomolecules <b class="valid" valid="valid" title="valid: True, node: 475, tag: b, level: 14" node_number="475">2021</b>, 11(12), 1860; https://doi.org/10.3390/biom11121860 (registering&#160;DOI) - 10 Dec 2021 </div> <div class="valid" valid="valid" title="valid: True, node: 476, tag: div, level: 13" node_number="476"> Abstract <div class="valid" valid="valid" title="valid: True, node: 477, tag: div, level: 14" node_number="477"> <b title="valid: False, node: 478, tag: b, level: 15" node_number="478"> </b>Microorganisms including actinomycetes, archaea, bacteria, fungi, yeast, and microalgae are an auspicious source of vital bioactive compounds. In this review, the existing research regarding antimicrobial molecules from microorganisms is summarized. The potential antimicrobial compounds from actinomycetes, particularly <i title="valid: False, node: 479, tag: i, level: 15" node_number="479">Streptomyces</i> spp.; archaea; fungi including endophytic, [...] Read more. </div> <div class="valid" valid="valid" title="valid: True, node: 480, tag: div, level: 14" node_number="480"> <b title="valid: False, node: 481, tag: b, level: 15" node_number="481"> </b>Microorganisms including actinomycetes, archaea, bacteria, fungi, yeast, and microalgae are an auspicious source of vital bioactive compounds. In this review, the existing research regarding antimicrobial molecules from microorganisms is summarized. The potential antimicrobial compounds from actinomycetes, particularly <i title="valid: False, node: 482, tag: i, level: 15" node_number="482">Streptomyces</i> spp.; archaea; fungi including endophytic, filamentous, and marine-derived fungi, mushroom; and microalgae are briefly described. Furthermore, this review briefly summarizes bacteriocins, halocins, sulfolobicin, etc., that target multiple-drug resistant pathogens and considers next-generation antibiotics. This review highlights the possibility of using microorganisms as an antimicrobial resource for biotechnological, nutraceutical, and pharmaceutical applications. However, more investigations are required to isolate, separate, purify, and characterize these bioactive compounds and transfer these primary drugs into clinically approved antibiotics. Full article </div> </div> <div class="valid" valid="valid" title="valid: True, node: 483, tag: div, level: 13" node_number="483"> (This article belongs to the Topic Compounds with Medicinal Value) </div> </div> </div> </div> <div class="valid" valid="valid" title="valid: True, node: 484, tag: div, level: 10" node_number="484"> <div class="valid" valid="valid" title="valid: True, node: 485, tag: div, level: 11" node_number="485"> <div class="valid" valid="valid" title="valid: True, node: 486, tag: div, level: 12" node_number="486"> <div class="valid" valid="valid" title="valid: True, node: 487, tag: div, level: 13" node_number="487"> <a class="valid" valid="valid" title="valid: True, node: 488, tag: a, level: 14" node_number="488"> <i title="valid: False, node: 489, tag: i, level: 15" node_number="489">get_app</i> </a> </div> <div class="valid" valid="valid" title="valid: True, node: 490, tag: div, level: 13" node_number="490"> <a class="valid" valid="valid" title="valid: True, node: 491, tag: a, level: 14" node_number="491"> <i title="valid: False, node: 492, tag: i, level: 15" node_number="492">subject</i> </a> <div class="valid" valid="valid" title="valid: True, node: 493, tag: div, level: 14" node_number="493"> View online as: Abstract Page Full-Text HTML </div> </div> <div class="valid" valid="valid" title="valid: True, node: 494, tag: div, level: 13" node_number="494">Open AccessArticle</div> The Expression and Activity of Rhodanese, 3-Mercaptopyruvate Sulfurtransferase, Cystathionine &#947;-Lyase in the Most Frequently Chosen Cellular Research Models <div class="valid" valid="valid" title="valid: True, node: 495, tag: div, level: 13" node_number="495"> by <span class="valid" valid="valid" title="valid: True, node: 496, tag: span, level: 14" node_number="496"><div title="valid: False, node: 497, tag: div, level: 15" node_number="497">Marta Kaczor-Kami&#324;ska</div>, </span><span class="valid" valid="valid" title="valid: True, node: 498, tag: span, level: 14" node_number="498"><div title="valid: False, node: 499, tag: div, level: 15" node_number="499">Kamil Kaminski</div> and </span><span class="valid" valid="valid" title="valid: True, node: 500, tag: span, level: 14" node_number="500"><div title="valid: False, node: 501, tag: div, level: 15" node_number="501">Maria Wr&#243;bel</div></span> </div> <div class="valid" valid="valid" title="valid: True, node: 502, tag: div, level: 13" node_number="502"> Biomolecules <b class="valid" valid="valid" title="valid: True, node: 503, tag: b, level: 14" node_number="503">2021</b>, 11(12), 1859; https://doi.org/10.3390/biom11121859 - 10 Dec 2021 </div> <div class="valid" valid="valid" title="valid: True, node: 504, tag: div, level: 13" node_number="504"> Abstract <div class="valid" valid="valid" title="valid: True, node: 505, tag: div, level: 14" node_number="505"> This paper provides information concerning the activity and expression levels of three sulfurtransferases (STRs): rhodanese (TST, EC: 2.8.1.1), 3-mercaptopyruvate sulfurtransferase (MPST, EC: 2.8.1.2) and cystathionine &#947;-lyase (CTH, EC: 4.4.1.1) in various cell lines. Since very limited data are available in the scientific literature [...] Read more. </div> <div class="valid" valid="valid" title="valid: True, node: 506, tag: div, level: 14" node_number="506"> This paper provides information concerning the activity and expression levels of three sulfurtransferases (STRs): rhodanese (TST, EC: 2.8.1.1), 3-mercaptopyruvate sulfurtransferase (MPST, EC: 2.8.1.2) and cystathionine &#947;-lyase (CTH, EC: 4.4.1.1) in various cell lines. Since very limited data are available in the scientific literature on this subject, the available data are included in this paper. These shortages often force the researchers to carry out their own screening tests that allow them to choose an appropriate model for their further studies. This work supplements the existing deficiencies in this area and presents the activity and expression of STRs in the eight most frequently chosen cell lines: the mouse mammary gland cell line (NMuNG, ATCC: CRL-1636), mouse mammary gland tumor (4T1, ATCC: CRL-2539), mouse fibroblast (MEF, ATCC: SCRC-1008), mouse melanoma (B16-F1, ATCC: CRL-6323), human colorectal adenocarcinoma (Caco-2, ATCC: HTB-37), human embryonic kidney (HEK-293, ATCC: CRL-1573), human osteosarcoma (MG-63, ATCC: CRL-1427) and rat myocardium (H9c2, ATCC: CRL-1446). Changes in STRs activity are directly related to the bioavailability of cysteine and the sulfane sulfur level, and thus the present authors also measured these parameters, as well as the level of glutathione (its reduced (GSH) and oxidized (GSSG) form) and the [GSH]/[GSSG] ratio that determines the antioxidant capacity of the cells. STRs demonstrate diverse functionality and clinical relevance; therefore, we also performed an analysis of genetic variation of STRs genes that revealed a large number of polymorphisms. Although STRs still provide challenges in several fields, responding to them could not only improve the understanding of various diseases, but may also provide a way to treat them. Full article </div> </div> <div class="valid" valid="valid" title="valid: True, node: 507, tag: div, level: 13" node_number="507"> (This article belongs to the Special Issue Hydrogen Sulfide and Polysulfides, Endogenous Mammalian Transmitters&#8212;&#8212;Honorary Special Issue Commemorating the Work of Prof. Hideo Kimura) </div> &#9658;&#9660; Show Figures <div class="valid" valid="valid" title="valid: True, node: 508, tag: div, level: 13" node_number="508"><div class="valid" valid="valid" title="valid: True, node: 509, tag: div, level: 14" node_number="509"><div title="valid: False, node: 510, tag: div, level: 15" node_number="510"><p title="valid: False, node: 511, tag: p, level: 16" node_number="511">Figure 1</p></div></div></div> </div> </div> </div> <div class="valid" valid="valid" title="valid: True, node: 512, tag: div, level: 10" node_number="512"> <div class="valid" valid="valid" title="valid: True, node: 513, tag: div, level: 11" node_number="513"> <div class="valid" valid="valid" title="valid: True, node: 514, tag: div, level: 12" node_number="514"> <div class="valid" valid="valid" title="valid: True, node: 515, tag: div, level: 13" node_number="515"> <a class="valid" valid="valid" title="valid: True, node: 516, tag: a, level: 14" node_number="516"> <i title="valid: False, node: 517, tag: i, level: 15" node_number="517">get_app</i> </a> </div> <div class="valid" valid="valid" title="valid: True, node: 518, tag: div, level: 13" node_number="518"> <a class="valid" valid="valid" title="valid: True, node: 519, tag: a, level: 14" node_number="519"> <i title="valid: False, node: 520, tag: i, level: 15" node_number="520">subject</i> </a> <div class="valid" valid="valid" title="valid: True, node: 521, tag: div, level: 14" node_number="521"> View online as: Abstract Page Full-Text HTML </div> </div> <div class="valid" valid="valid" title="valid: True, node: 522, tag: div, level: 13" node_number="522">Open AccessArticle</div> In Vitro Anti-SARS-CoV-2 Activity of Selected Metal Compounds and Potential Molecular Basis for Their Actions Based on Computational Study <div class="valid" valid="valid" title="valid: True, node: 523, tag: div, level: 13" node_number="523"> by <span class="valid" valid="valid" title="valid: True, node: 524, tag: span, level: 14" node_number="524"><div title="valid: False, node: 525, tag: div, level: 15" node_number="525">Damiano Cirri</div>, </span><span class="valid" valid="valid" title="valid: True, node: 526, tag: span, level: 14" node_number="526"><div title="valid: False, node: 527, tag: div, level: 15" node_number="527">Tiziano Marzo</div>, </span><span class="valid" valid="valid" title="valid: True, node: 528, tag: span, level: 14" node_number="528"><div title="valid: False, node: 529, tag: div, level: 15" node_number="529">Iogann Tolbatov</div>, </span><span class="valid" valid="valid" title="valid: True, node: 530, tag: span, level: 14" node_number="530"><div title="valid: False, node: 531, tag: div, level: 15" node_number="531">Alessandro Marrone</div>, </span><span class="valid" valid="valid" title="valid: True, node: 532, tag: span, level: 14" node_number="532"><div title="valid: False, node: 533, tag: div, level: 15" node_number="533">Francesco Saladini</div>, </span><span class="valid" valid="valid" title="valid: True, node: 534, tag: span, level: 14" node_number="534"><div title="valid: False, node: 535, tag: div, level: 15" node_number="535">Ilaria Vicenti</div>, </span><span class="valid" valid="valid" title="valid: True, node: 536, tag: span, level: 14" node_number="536"><div title="valid: False, node: 537, tag: div, level: 15" node_number="537">Filippo Dragoni</div>, </span><span class="valid" valid="valid" title="valid: True, node: 538, tag: span, level: 14" node_number="538"><div title="valid: False, node: 539, tag: div, level: 15" node_number="539">Adele Boccuto</div> and </span><span class="valid" valid="valid" title="valid: True, node: 540, tag: span, level: 14" node_number="540"><div title="valid: False, node: 541, tag: div, level: 15" node_number="541">Luigi Messori</div></span> </div> <div class="valid" valid="valid" title="valid: True, node: 542, tag: div, level: 13" node_number="542"> Biomolecules <b class="valid" valid="valid" title="valid: True, node: 543, tag: b, level: 14" node_number="543">2021</b>, 11(12), 1858; https://doi.org/10.3390/biom11121858 - 10 Dec 2021 </div> <div class="valid" valid="valid" title="valid: True, node: 544, tag: div, level: 13" node_number="544"> Abstract <div class="valid" valid="valid" title="valid: True, node: 545, tag: div, level: 14" node_number="545"> Metal-based drugs represent a rich source of chemical substances of potential interest for the treatment of COVID-19. To this end, we have developed a small but representative panel of nine metal compounds, including both synthesized and commercially available complexes, suitable for medical application [...] Read more. </div> <div class="valid" valid="valid" title="valid: True, node: 546, tag: div, level: 14" node_number="546"> Metal-based drugs represent a rich source of chemical substances of potential interest for the treatment of COVID-19. To this end, we have developed a small but representative panel of nine metal compounds, including both synthesized and commercially available complexes, suitable for medical application and tested them in vitro against the SARS-CoV-2 virus. The screening revealed that three compounds from the panel, i.e., the organogold(III) compound Aubipyc, the ruthenium(III) complex KP1019, and antimony trichloride (SbCl<sub title="valid: False, node: 547, tag: sub, level: 15" node_number="547">3</sub>), are endowed with notable antiviral properties and an acceptable cytotoxicity profile. These initial findings prompted us to perform a computational study to unveil the likely molecular basis of their antiviral actions. Calculations evidenced that the metalation of nucleophile sites in SARS-CoV-2 proteins or nucleobase strands, induced by Aubipyc, SbCl<sub title="valid: False, node: 548, tag: sub, level: 15" node_number="548">3</sub>, and KP1019, is likely to occur. Remarkably, we found that only the deprotonated forms of Cys and Sec residues can react favorably with these metallodrugs. The mechanistic implications of these findings are discussed. Full article </div> </div> <div class="valid" valid="valid" title="valid: True, node: 549, tag: div, level: 13" node_number="549"> (This article belongs to the Special Issue Metal Binding Proteins 2022) </div> &#9658;&#9660; Show Figures <div class="valid" valid="valid" title="valid: True, node: 550, tag: div, level: 13" node_number="550"><div class="valid" valid="valid" title="valid: True, node: 551, tag: div, level: 14" node_number="551"><div title="valid: False, node: 552, tag: div, level: 15" node_number="552"><p title="valid: False, node: 553, tag: p, level: 16" node_number="553">Figure 1</p></div></div></div> </div> </div> </div> <div class="valid" valid="valid" title="valid: True, node: 554, tag: div, level: 10" node_number="554"> <div class="valid" valid="valid" title="valid: True, node: 555, tag: div, level: 11" node_number="555"> <div class="valid" valid="valid" title="valid: True, node: 556, tag: div, level: 12" node_number="556"> <div class="valid" valid="valid" title="valid: True, node: 557, tag: div, level: 13" node_number="557"> <a class="valid" valid="valid" title="valid: True, node: 558, tag: a, level: 14" node_number="558"> <i title="valid: False, node: 559, tag: i, level: 15" node_number="559">attachment</i> </a> <div class="valid" valid="valid" title="valid: True, node: 560, tag: div, level: 14" node_number="560"> Supplementary material: Supplementary File 1 (ZIP, 4545 KiB) </div> </div> <div class="valid" valid="valid" title="valid: True, node: 561, tag: div, level: 13" node_number="561"> <a class="valid" valid="valid" title="valid: True, node: 562, tag: a, level: 14" node_number="562"> <i title="valid: False, node: 563, tag: i, level: 15" node_number="563">get_app</i> </a> </div> <div class="valid" valid="valid" title="valid: True, node: 564, tag: div, level: 13" node_number="564"> <a class="valid" valid="valid" title="valid: True, node: 565, tag: a, level: 14" node_number="565"> <i title="valid: False, node: 566, tag: i, level: 15" node_number="566">subject</i> </a> <div class="valid" valid="valid" title="valid: True, node: 567, tag: div, level: 14" node_number="567"> View online as: Abstract Page Full-Text HTML </div> </div> <div class="valid" valid="valid" title="valid: True, node: 568, tag: div, level: 13" node_number="568">Open AccessFeature PaperArticle</div> Salting-Out Approach Is Worthy of Comparison with Ultracentrifugation for Extracellular Vesicle Isolation from Tumor and Healthy Models <div class="valid" valid="valid" title="valid: True, node: 569, tag: div, level: 13" node_number="569"> by <span class="valid" valid="valid" title="valid: True, node: 570, tag: span, level: 14" node_number="570"><div title="valid: False, node: 571, tag: div, level: 15" node_number="571">Simona Serrat&#236;</div>, </span><span class="valid" valid="valid" title="valid: True, node: 572, tag: span, level: 14" node_number="572"><div title="valid: False, node: 573, tag: div, level: 15" node_number="573">Antonio Palazzo</div>, </span><span class="valid" valid="valid" title="valid: True, node: 574, tag: span, level: 14" node_number="574"><div title="valid: False, node: 575, tag: div, level: 15" node_number="575">Annamaria Lapenna</div>, </span><span class="valid" valid="valid" title="valid: True, node: 576, tag: span, level: 14" node_number="576"><div title="valid: False, node: 577, tag: div, level: 15" node_number="577">Helena Mateos</div>, </span><span class="valid" valid="valid" title="valid: True, node: 578, tag: span, level: 14" node_number="578"><div title="valid: False, node: 579, tag: div, level: 15" node_number="579">Antonia Mallardi</div>, </span><span class="valid" valid="valid" title="valid: True, node: 580, tag: span, level: 14" node_number="580"><div title="valid: False, node: 581, tag: div, level: 15" node_number="581">Ren&#233; Massimiliano Marsano</div>, </span><span class="valid" valid="valid" title="valid: True, node: 582, tag: span, level: 14" node_number="582"><div title="valid: False, node: 583, tag: div, level: 15" node_number="583">Alessandra Quarta</div>, </span><span class="valid" valid="valid" title="valid: True, node: 584, tag: span, level: 14" node_number="584"><div title="valid: False, node: 585, tag: div, level: 15" node_number="585">Mario Del Rosso</div> and </span><span class="valid" valid="valid" title="valid: True, node: 586, tag: span, level: 14" node_number="586"><div title="valid: False, node: 587, tag: div, level: 15" node_number="587">Amalia Azzariti</div></span> </div> <div class="valid" valid="valid" title="valid: True, node: 588, tag: div, level: 13" node_number="588"> Biomolecules <b class="valid" valid="valid" title="valid: True, node: 589, tag: b, level: 14" node_number="589">2021</b>, 11(12), 1857; https://doi.org/10.3390/biom11121857 - 10 Dec 2021 </div> <div class="valid" valid="valid" title="valid: True, node: 590, tag: div, level: 13" node_number="590"> Abstract <div class="valid" valid="valid" title="valid: True, node: 591, tag: div, level: 14" node_number="591"> The role of extracellular vesicles (EVs) has been completely re-evaluated in the recent decades, and EVs are currently considered to be among the main players in intercellular communication. Beyond their functional aspects, there is strong interest in the development of faster and less [...] Read more. </div> <div class="valid" valid="valid" title="valid: True, node: 592, tag: div, level: 14" node_number="592"> The role of extracellular vesicles (EVs) has been completely re-evaluated in the recent decades, and EVs are currently considered to be among the main players in intercellular communication. Beyond their functional aspects, there is strong interest in the development of faster and less expensive isolation protocols that are as reliable for post-isolation characterisations as already-established methods. Therefore, the identification of easy and accessible EV isolation techniques with a low price/performance ratio is of paramount importance. We isolated EVs from a wide spectrum of samples of biological and clinical interest by choosing two isolation techniques, based on their wide use and affordability: ultracentrifugation and salting-out. We collected EVs from human cancer and healthy cell culture media, yeast, bacteria and <i title="valid: False, node: 593, tag: i, level: 15" node_number="593">Drosophila</i> culture media and human fluids (plasma, urine and saliva). The size distribution and concentration of EVs were measured by nanoparticle tracking analysis and dynamic light scattering, and protein depletion was measured by a colorimetric nanoplasmonic assay. Finally, the EVs were characterised by flow cytometry. Our results showed that the salting-out method had a good efficiency in EV separation and was more efficient in protein depletion than ultracentrifugation. Thus, salting-out may represent a good alternative to ultracentrifugation. Full article </div> </div> <div class="valid" valid="valid" title="valid: True, node: 594, tag: div, level: 13" node_number="594"> (This article belongs to the Collection Molecular Biology: Feature Papers) </div> &#9658;&#9660; Show Figures <div class="valid" valid="valid" title="valid: True, node: 595, tag: div, level: 13" node_number="595"><div class="valid" valid="valid" title="valid: True, node: 596, tag: div, level: 14" node_number="596"><div title="valid: False, node: 597, tag: div, level: 15" node_number="597"><p title="valid: False, node: 598, tag: p, level: 16" node_number="598">Figure 1</p></div></div></div> </div> </div> </div> <div class="valid" valid="valid" title="valid: True, node: 599, tag: div, level: 10" node_number="599"> <div class="valid" valid="valid" title="valid: True, node: 600, tag: div, level: 11" node_number="600"> <div class="valid" valid="valid" title="valid: True, node: 601, tag: div, level: 12" node_number="601"> <div class="valid" valid="valid" title="valid: True, node: 602, tag: div, level: 13" node_number="602"> <a class="valid" valid="valid" title="valid: True, node: 603, tag: a, level: 14" node_number="603"> <i title="valid: False, node: 604, tag: i, level: 15" node_number="604">attachment</i> </a> <div class="valid" valid="valid" title="valid: True, node: 605, tag: div, level: 14" node_number="605"> Supplementary material: Supplementary File 1 (ZIP, 1850 KiB) </div> </div> <div class="valid" valid="valid" title="valid: True, node: 606, tag: div, level: 13" node_number="606"> <a class="valid" valid="valid" title="valid: True, node: 607, tag: a, level: 14" node_number="607"> <i title="valid: False, node: 608, tag: i, level: 15" node_number="608">get_app</i> </a> </div> <div class="valid" valid="valid" title="valid: True, node: 609, tag: div, level: 13" node_number="609"> <a class="valid" valid="valid" title="valid: True, node: 610, tag: a, level: 14" node_number="610"> <i title="valid: False, node: 611, tag: i, level: 15" node_number="611">subject</i> </a> <div class="valid" valid="valid" title="valid: True, node: 612, tag: div, level: 14" node_number="612"> View online as: Abstract Page Full-Text HTML </div> </div> <div class="valid" valid="valid" title="valid: True, node: 613, tag: div, level: 13" node_number="613">Open AccessFeature PaperArticle</div> The New Pharmacological Chaperones PBXs Increase &#945;-Galactosidase A Activity in Fabry Disease Cellular Models <div class="valid" valid="valid" title="valid: True, node: 614, tag: div, level: 13" node_number="614"> by <span class="valid" valid="valid" title="valid: True, node: 615, tag: span, level: 14" node_number="615"><div title="valid: False, node: 616, tag: div, level: 15" node_number="616">Pedro Besada</div>, </span><span class="valid" valid="valid" title="valid: True, node: 617, tag: span, level: 14" node_number="617"><div title="valid: False, node: 618, tag: div, level: 15" node_number="618">Mar&#237;a Gallardo-G&#243;mez</div>, </span><span class="valid" valid="valid" title="valid: True, node: 619, tag: span, level: 14" node_number="619"><div title="valid: False, node: 620, tag: div, level: 15" node_number="620">Tania P&#233;rez-M&#225;rquez</div>, </span><span class="valid" valid="valid" title="valid: True, node: 621, tag: span, level: 14" node_number="621"><div title="valid: False, node: 622, tag: div, level: 15" node_number="622">Luc&#237;a Pati&#241;o-&#193;lvarez</div>, </span><span class="valid" valid="valid" title="valid: True, node: 623, tag: span, level: 14" node_number="623"><div title="valid: False, node: 624, tag: div, level: 15" node_number="624">Sergio Pantano</div>, </span><span class="valid" valid="valid" title="valid: True, node: 625, tag: span, level: 14" node_number="625"><div title="valid: False, node: 626, tag: div, level: 15" node_number="626">Carlos Silva-L&#243;pez</div>, </span><span class="valid" valid="valid" title="valid: True, node: 627, tag: span, level: 14" node_number="627"><div title="valid: False, node: 628, tag: div, level: 15" node_number="628">Carmen Ter&#225;n</div>, </span><span class="valid" valid="valid" title="valid: True, node: 629, tag: span, level: 14" node_number="629"><div title="valid: False, node: 630, tag: div, level: 15" node_number="630">Ana Ar&#233;valo-G&#243;mez</div>, </span><span class="valid" valid="valid" title="valid: True, node: 631, tag: span, level: 14" node_number="631"><div title="valid: False, node: 632, tag: div, level: 15" node_number="632">Aurora Ruz-Zafra</div>, </span><span class="valid" valid="valid" title="valid: True, node: 633, tag: span, level: 14" node_number="633"><div title="valid: False, node: 634, tag: div, level: 15" node_number="634">Juli&#225;n Fern&#225;ndez-Mart&#237;n</div> and </span><span class="valid" valid="valid" title="valid: True, node: 635, tag: span, level: 14" node_number="635"><div title="valid: False, node: 636, tag: div, level: 15" node_number="636">Saida Ortolano</div></span> </div> <div class="valid" valid="valid" title="valid: True, node: 637, tag: div, level: 13" node_number="637"> Biomolecules <b class="valid" valid="valid" title="valid: True, node: 638, tag: b, level: 14" node_number="638">2021</b>, 11(12), 1856; https://doi.org/10.3390/biom11121856 - 10 Dec 2021 </div> <div class="valid" valid="valid" title="valid: True, node: 639, tag: div, level: 13" node_number="639"> Abstract <div class="valid" valid="valid" title="valid: True, node: 640, tag: div, level: 14" node_number="640"> Fabry disease is an X-linked multisystemic disorder caused by the impairment of lysosomal &#945;-Galactosidase A, which leads to the progressive accumulation of glycosphingolipids and to defective lysosomal metabolism. Currently, Fabry disease is treated by enzyme replacement therapy or the orally administrated pharmacological chaperone [...] Read more. </div> <div class="valid" valid="valid" title="valid: True, node: 641, tag: div, level: 14" node_number="641"> Fabry disease is an X-linked multisystemic disorder caused by the impairment of lysosomal &#945;-Galactosidase A, which leads to the progressive accumulation of glycosphingolipids and to defective lysosomal metabolism. Currently, Fabry disease is treated by enzyme replacement therapy or the orally administrated pharmacological chaperone Migalastat. Both therapeutic strategies present limitations, since enzyme replacement therapy has shown low half-life and bioavailability, while Migalastat is only approved for patients with specific mutations. The aim of this work was to assess the efficacy of PBX galactose analogues to stabilize &#945;-Galactosidase A and therefore evaluate their potential use in Fabry patients with mutations that are not amenable to the treatment with Migalastat. We demonstrated that PBX compounds are safe and effective concerning stabilization of &#945;-Galactosidase A in relevant cellular models of the disease, as assessed by enzymatic activity measurements, molecular modelling, and cell viability assays. This experimental evidence suggests that PBX compounds are promising candidates for the treatment of Fabry disease caused by mutations which affect the folding of &#945;-Galactosidase A, even for <i title="valid: False, node: 642, tag: i, level: 15" node_number="642">GLA</i> variants that are not amenable to the treatment with Migalastat. Full article </div> </div> <div class="valid" valid="valid" title="valid: True, node: 643, tag: div, level: 13" node_number="643"> (This article belongs to the Special Issue Rare Diseases: From Molecular Pathways to Therapeutic Strategies) </div> &#9658;&#9660; Show Figures <div class="valid" valid="valid" title="valid: True, node: 644, tag: div, level: 13" node_number="644"><div class="valid" valid="valid" title="valid: True, node: 645, tag: div, level: 14" node_number="645"><div title="valid: False, node: 646, tag: div, level: 15" node_number="646"><p title="valid: False, node: 647, tag: p, level: 16" node_number="647">Figure 1</p></div></div></div> </div> </div> </div> <div class="valid" valid="valid" title="valid: True, node: 648, tag: div, level: 10" node_number="648"> <div class="valid" valid="valid" title="valid: True, node: 649, tag: div, level: 11" node_number="649"> <div class="valid" valid="valid" title="valid: True, node: 650, tag: div, level: 12" node_number="650"> <div class="valid" valid="valid" title="valid: True, node: 651, tag: div, level: 13" node_number="651"> <a class="valid" valid="valid" title="valid: True, node: 652, tag: a, level: 14" node_number="652"> <i title="valid: False, node: 653, tag: i, level: 15" node_number="653">get_app</i> </a> </div> <div class="valid" valid="valid" title="valid: True, node: 654, tag: div, level: 13" node_number="654"> <a class="valid" valid="valid" title="valid: True, node: 655, tag: a, level: 14" node_number="655"> <i title="valid: False, node: 656, tag: i, level: 15" node_number="656">subject</i> </a> <div class="valid" valid="valid" title="valid: True, node: 657, tag: div, level: 14" node_number="657"> View online as: Abstract Page Full-Text HTML </div> </div> <div class="valid" valid="valid" title="valid: True, node: 658, tag: div, level: 13" node_number="658">Open AccessReview</div> DNA Nanodevice-Based Drug Delivery Systems <div class="valid" valid="valid" title="valid: True, node: 659, tag: div, level: 13" node_number="659"> by <span class="valid" valid="valid" title="valid: True, node: 660, tag: span, level: 14" node_number="660"><div title="valid: False, node: 661, tag: div, level: 15" node_number="661">Chaoyang Guan</div>, </span><span class="valid" valid="valid" title="valid: True, node: 662, tag: span, level: 14" node_number="662"><div title="valid: False, node: 663, tag: div, level: 15" node_number="663">Xiaoli Zhu</div> and </span><span class="valid" valid="valid" title="valid: True, node: 664, tag: span, level: 14" node_number="664"><div title="valid: False, node: 665, tag: div, level: 15" node_number="665">Chang Feng</div></span> </div> <div class="valid" valid="valid" title="valid: True, node: 666, tag: div, level: 13" node_number="666"> Biomolecules <b class="valid" valid="valid" title="valid: True, node: 667, tag: b, level: 14" node_number="667">2021</b>, 11(12), 1855; https://doi.org/10.3390/biom11121855 - 10 Dec 2021 </div> <div class="valid" valid="valid" title="valid: True, node: 668, tag: div, level: 13" node_number="668"> Abstract <div class="valid" valid="valid" title="valid: True, node: 669, tag: div, level: 14" node_number="669"> DNA, a natural biological material, has become an ideal choice for biomedical applications, mainly owing to its good biocompatibility, ease of synthesis, modifiability, and especially programmability. In recent years, with the deepening of the understanding of the physical and chemical properties of DNA [...] Read more. </div> <div class="valid" valid="valid" title="valid: True, node: 670, tag: div, level: 14" node_number="670"> DNA, a natural biological material, has become an ideal choice for biomedical applications, mainly owing to its good biocompatibility, ease of synthesis, modifiability, and especially programmability. In recent years, with the deepening of the understanding of the physical and chemical properties of DNA and the continuous advancement of DNA synthesis and modification technology, the biomedical applications based on DNA materials have been upgraded to version 2.0: through elaborate design and fabrication of smart-responsive DNA nanodevices, they can respond to external or internal physical or chemical stimuli so as to smartly perform certain specific functions. For tumor treatment, this advancement provides a new way to solve the problems of precise targeting, controllable release, and controllable elimination of drugs to a certain extent. Here, we review the progress of related fields over the past decade, and provide prospects for possible future development directions. Full article </div> </div> <div class="valid" valid="valid" title="valid: True, node: 671, tag: div, level: 13" node_number="671"> (This article belongs to the Special Issue Recent Advances in Nanoparticle-Based Drug Delivery Systems for Cancer Targeted Therapy) </div> &#9658;&#9660; Show Figures <div class="valid" valid="valid" title="valid: True, node: 672, tag: div, level: 13" node_number="672"><div class="valid" valid="valid" title="valid: True, node: 673, tag: div, level: 14" node_number="673"><div title="valid: False, node: 674, tag: div, level: 15" node_number="674"><p title="valid: False, node: 675, tag: p, level: 16" node_number="675">Figure 1</p></div></div></div> </div> </div> </div> <div class="valid" valid="valid" title="valid: True, node: 676, tag: div, level: 10" node_number="676"> <div class="valid" valid="valid" title="valid: True, node: 677, tag: div, level: 11" node_number="677"> <div class="valid" valid="valid" title="valid: True, node: 678, tag: div, level: 12" node_number="678"> <div class="valid" valid="valid" title="valid: True, node: 679, tag: div, level: 13" node_number="679"> <a class="valid" valid="valid" title="valid: True, node: 680, tag: a, level: 14" node_number="680"> <i title="valid: False, node: 681, tag: i, level: 15" node_number="681">attachment</i> </a> <div class="valid" valid="valid" title="valid: True, node: 682, tag: div, level: 14" node_number="682"> Supplementary material: Supplementary File 1 (ZIP, 225 KiB) </div> </div> <div class="valid" valid="valid" title="valid: True, node: 683, tag: div, level: 13" node_number="683"> <a class="valid" valid="valid" title="valid: True, node: 684, tag: a, level: 14" node_number="684"> <i title="valid: False, node: 685, tag: i, level: 15" node_number="685">get_app</i> </a> </div> <div class="valid" valid="valid" title="valid: True, node: 686, tag: div, level: 13" node_number="686"> <a class="valid" valid="valid" title="valid: True, node: 687, tag: a, level: 14" node_number="687"> <i title="valid: False, node: 688, tag: i, level: 15" node_number="688">subject</i> </a> <div class="valid" valid="valid" title="valid: True, node: 689, tag: div, level: 14" node_number="689"> View online as: Abstract Page </div> </div> <div class="valid" valid="valid" title="valid: True, node: 690, tag: div, level: 13" node_number="690">Open AccessArticle</div> Structural Characterization of Rat Galectin-5, an N-Tailed Monomeric Proto-Type-like Galectin <div class="valid" valid="valid" title="valid: True, node: 691, tag: div, level: 13" node_number="691"> by <span class="valid" valid="valid" title="valid: True, node: 692, tag: span, level: 14" node_number="692"><div title="valid: False, node: 693, tag: div, level: 15" node_number="693">Federico M. Ruiz</div>, </span><span class="valid" valid="valid" title="valid: True, node: 694, tag: span, level: 14" node_number="694"><div title="valid: False, node: 695, tag: div, level: 15" node_number="695">Francisco J. Medrano</div>, </span><span class="valid" valid="valid" title="valid: True, node: 696, tag: span, level: 14" node_number="696"><div title="valid: False, node: 697, tag: div, level: 15" node_number="697">Anna-Kristin Ludwig</div>, </span><span class="valid" valid="valid" title="valid: True, node: 698, tag: span, level: 14" node_number="698"><div title="valid: False, node: 699, tag: div, level: 15" node_number="699">Herbert Kaltner</div>, </span><span class="valid" valid="valid" title="valid: True, node: 700, tag: span, level: 14" node_number="700"><div title="valid: False, node: 701, tag: div, level: 15" node_number="701">Nadezhda V. Shilova</div>, </span><span class="valid" valid="valid" title="valid: True, node: 702, tag: span, level: 14" node_number="702"><div title="valid: False, node: 703, tag: div, level: 15" node_number="703">Nicolai V. Bovin</div>, </span><span class="valid" valid="valid" title="valid: True, node: 704, tag: span, level: 14" node_number="704"><div title="valid: False, node: 705, tag: div, level: 15" node_number="705">Hans-Joachim Gabius</div> and </span><span class="valid" valid="valid" title="valid: True, node: 706, tag: span, level: 14" node_number="706"><div title="valid: False, node: 707, tag: div, level: 15" node_number="707">Antonio Romero</div></span> </div> <div class="valid" valid="valid" title="valid: True, node: 708, tag: div, level: 13" node_number="708"> Biomolecules <b class="valid" valid="valid" title="valid: True, node: 709, tag: b, level: 14" node_number="709">2021</b>, 11(12), 1854; https://doi.org/10.3390/biom11121854 - 09 Dec 2021 </div> <div class="valid" valid="valid" title="valid: True, node: 710, tag: div, level: 13" node_number="710"> Abstract <div class="valid" valid="valid" title="valid: True, node: 711, tag: div, level: 14" node_number="711"> Galectins are multi-purpose effectors acting via interactions with distinct counterreceptors based on protein-glycan/protein recognition. These processes are emerging to involve several regions on the protein so that the availability of a detailed structural characterization of a full-length galectin is essential. We report here [...] Read more. </div> <div class="valid" valid="valid" title="valid: True, node: 712, tag: div, level: 14" node_number="712"> Galectins are multi-purpose effectors acting via interactions with distinct counterreceptors based on protein-glycan/protein recognition. These processes are emerging to involve several regions on the protein so that the availability of a detailed structural characterization of a full-length galectin is essential. We report here the first crystallographic information on the N-terminal extension of the carbohydrate recognition domain of rat galectin-5, which is precisely described as an N-tailed proto-type-like galectin. In the ligand-free protein, the three amino-acid stretch from Ser2 to Ser5 is revealed to form an extra &#946;-strand (F0), and the residues from Thr6 to Asn12 are part of a loop protruding from strands S1 and F0. In the ligand-bound structure, amino acids Ser2&#8211;Tyr10 switch position and are aligned to the edge of the &#946;-sandwich. Interestingly, the signal profile in our glycan array screening shows the sugar-binding site to preferentially accommodate the histo-blood-group B (type 2) tetrasaccharide and N-acetyllactosamine-based di- and oligomers. The crystal structures revealed the characteristically preformed structural organization around the central Trp77 of the CRD with involvement of the sequence signature&#8217;s amino acids in binding. Ligand binding was also characterized calorimetrically. The presented data shows that the N-terminal extension can adopt an ordered structure and shapes the hypothesis that a ligand-induced shift in the equilibrium between flexible and ordered conformers potentially acts as a molecular switch, enabling new contacts in this region. Full article </div> </div> <div class="valid" valid="valid" title="valid: True, node: 713, tag: div, level: 13" node_number="713"> (This article belongs to the Special Issue Cell Biology of Galectins) </div> </div> </div> </div> <div class="valid" valid="valid" title="valid: True, node: 714, tag: div, level: 10" node_number="714"> <div class="valid" valid="valid" title="valid: True, node: 715, tag: div, level: 11" node_number="715"> <div class="valid" valid="valid" title="valid: True, node: 716, tag: div, level: 12" node_number="716"> <div class="valid" valid="valid" title="valid: True, node: 717, tag: div, level: 13" node_number="717"> <a class="valid" valid="valid" title="valid: True, node: 718, tag: a, level: 14" node_number="718"> <i title="valid: False, node: 719, tag: i, level: 15" node_number="719">attachment</i> </a> <div class="valid" valid="valid" title="valid: True, node: 720, tag: div, level: 14" node_number="720"> Supplementary material: Supplementary File 1 (ZIP, 894 KiB) </div> </div> <div class="valid" valid="valid" title="valid: True, node: 721, tag: div, level: 13" node_number="721"> <a class="valid" valid="valid" title="valid: True, node: 722, tag: a, level: 14" node_number="722"> <i title="valid: False, node: 723, tag: i, level: 15" node_number="723">get_app</i> </a> </div> <div class="valid" valid="valid" title="valid: True, node: 724, tag: div, level: 13" node_number="724"> <a class="valid" valid="valid" title="valid: True, node: 725, tag: a, level: 14" node_number="725"> <i title="valid: False, node: 726, tag: i, level: 15" node_number="726">subject</i> </a> <div class="valid" valid="valid" title="valid: True, node: 727, tag: div, level: 14" node_number="727"> View online as: Abstract Page Full-Text HTML </div> </div> <div class="valid" valid="valid" title="valid: True, node: 728, tag: div, level: 13" node_number="728">Open AccessFeature PaperArticle</div> Characterization of miR-34a-Induced Epithelial&#8211;Mesenchymal Transition in Non-Small Lung Cancer Cells Focusing on p53 <div class="valid" valid="valid" title="valid: True, node: 729, tag: div, level: 13" node_number="729"> by <span class="valid" valid="valid" title="valid: True, node: 730, tag: span, level: 14" node_number="730"><div title="valid: False, node: 731, tag: div, level: 15" node_number="731">Masashi Kawami</div>, </span><span class="valid" valid="valid" title="valid: True, node: 732, tag: span, level: 14" node_number="732"><div title="valid: False, node: 733, tag: div, level: 15" node_number="733">Shinnosuke Takenaka</div>, </span><span class="valid" valid="valid" title="valid: True, node: 734, tag: span, level: 14" node_number="734"><div title="valid: False, node: 735, tag: div, level: 15" node_number="735">Mizuki Akai</div>, </span><span class="valid" valid="valid" title="valid: True, node: 736, tag: span, level: 14" node_number="736"><div title="valid: False, node: 737, tag: div, level: 15" node_number="737">Ryoko Yumoto</div> and </span><span class="valid" valid="valid" title="valid: True, node: 738, tag: span, level: 14" node_number="738"><div title="valid: False, node: 739, tag: div, level: 15" node_number="739">Mikihisa Takano</div></span> </div> <div class="valid" valid="valid" title="valid: True, node: 740, tag: div, level: 13" node_number="740"> Biomolecules <b class="valid" valid="valid" title="valid: True, node: 741, tag: b, level: 14" node_number="741">2021</b>, 11(12), 1853; https://doi.org/10.3390/biom11121853 - 09 Dec 2021 </div> <div class="valid" valid="valid" title="valid: True, node: 742, tag: div, level: 13" node_number="742"> Abstract <div class="valid" valid="valid" title="valid: True, node: 743, tag: div, level: 14" node_number="743"> Background: Epithelial&#8211;mesenchymal transition (EMT), a phenotypic conversion of the epithelial to mesenchymal state, contributes to cancer progression. Currently, several microRNAs (miRNAs) are associated with EMT-mediated cancer progression, but the contribution of miR-34a to EMT in cancer cells remains controversial. The present study aimed [...] Read more. </div> <div class="valid" valid="valid" title="valid: True, node: 744, tag: div, level: 14" node_number="744"> Background: Epithelial&#8211;mesenchymal transition (EMT), a phenotypic conversion of the epithelial to mesenchymal state, contributes to cancer progression. Currently, several microRNAs (miRNAs) are associated with EMT-mediated cancer progression, but the contribution of miR-34a to EMT in cancer cells remains controversial. The present study aimed to clarify the role of miR-34a in the EMT-related phenotypes of human non-small cell lung cancer (NSCLC) cell lines, A549 (p53 wild-type) and H1299 (p53-deficient). Methods: The miR-34a mimic and p53 small interfering RNA (siRNA) were transfected into the cells using Lipofectamine, and the obtained total RNA and cell lysates were used for real-time polymerase chain reaction and Western blotting analysis, respectively. Results: The introduction of the miR-34a mimic led to an increase in the mRNA and protein expression levels of &#945;-smooth muscle actin (<i title="valid: False, node: 745, tag: i, level: 15" node_number="745">&#945;-SMA</i>), a mesenchymal marker gene, in A549, but not in H1299 cells. Additionally, miR-34a-induced the upregulation of p53 activity and migration was observed in A549, but not in H1299 cells. However, under the p53-knockdown condition, only &#945;-SMA upregulation by miR-34a was abolished. Conclusion: These findings indicate a close relationship between p53 and miR-34a-induced EMT in p53-wild type NSCLC cells, which provides novel insights about the role of miR-34a in EMT-like phenotypic changes in NSCLC. Full article </div> </div> <div class="valid" valid="valid" title="valid: True, node: 746, tag: div, level: 13" node_number="746"> (This article belongs to the Special Issue Non-coding RNAs in Cancer Biology) </div> &#9658;&#9660; Show Figures <div class="valid" valid="valid" title="valid: True, node: 747, tag: div, level: 13" node_number="747"><div class="valid" valid="valid" title="valid: True, node: 748, tag: div, level: 14" node_number="748"><div title="valid: False, node: 749, tag: div, level: 15" node_number="749"><p title="valid: False, node: 750, tag: p, level: 16" node_number="750">Figure 1</p></div></div></div> </div> </div> </div> <div class="valid" valid="valid" title="valid: True, node: 751, tag: div, level: 10" node_number="751"> <div class="valid" valid="valid" title="valid: True, node: 752, tag: div, level: 11" node_number="752"> <div class="valid" valid="valid" title="valid: True, node: 753, tag: div, level: 12" node_number="753"> <div class="valid" valid="valid" title="valid: True, node: 754, tag: div, level: 13" node_number="754"> <a class="valid" valid="valid" title="valid: True, node: 755, tag: a, level: 14" node_number="755"> <i title="valid: False, node: 756, tag: i, level: 15" node_number="756">attachment</i> </a> <div class="valid" valid="valid" title="valid: True, node: 757, tag: div, level: 14" node_number="757"> Supplementary material: Supplementary File 1 (ZIP, 60674 KiB) </div> </div> <div class="valid" valid="valid" title="valid: True, node: 758, tag: div, level: 13" node_number="758"> <a class="valid" valid="valid" title="valid: True, node: 759, tag: a, level: 14" node_number="759"> <i title="valid: False, node: 760, tag: i, level: 15" node_number="760">get_app</i> </a> </div> <div class="valid" valid="valid" title="valid: True, node: 761, tag: div, level: 13" node_number="761"> <a class="valid" valid="valid" title="valid: True, node: 762, tag: a, level: 14" node_number="762"> <i title="valid: False, node: 763, tag: i, level: 15" node_number="763">subject</i> </a> <div class="valid" valid="valid" title="valid: True, node: 764, tag: div, level: 14" node_number="764"> View online as: Abstract Page Full-Text HTML </div> </div> <div class="valid" valid="valid" title="valid: True, node: 765, tag: div, level: 13" node_number="765">Open AccessArticle</div> <a class="valid" valid="valid" title="valid: True, node: 766, tag: a, level: 13" node_number="766">Cyclic Tetra-Adenylate (cA<sub class="valid" valid="valid" title="valid: True, node: 767, tag: sub, level: 14" node_number="767">4</sub>) Recognition by Csa3; Implications for an Integrated Class 1 CRISPR-Cas Immune Response in <i class="valid" valid="valid" title="valid: True, node: 768, tag: i, level: 14" node_number="768">Saccharolobus solfataricus</i></a> <div class="valid" valid="valid" title="valid: True, node: 769, tag: div, level: 13" node_number="769"> by <span class="valid" valid="valid" title="valid: True, node: 770, tag: span, level: 14" node_number="770"><div title="valid: False, node: 771, tag: div, level: 15" node_number="771">Alexander A. Charbonneau</div>, </span><span class="valid" valid="valid" title="valid: True, node: 772, tag: span, level: 14" node_number="772"><div title="valid: False, node: 773, tag: div, level: 15" node_number="773">Debra M. Eckert</div>, </span><span class="valid" valid="valid" title="valid: True, node: 774, tag: span, level: 14" node_number="774"><div title="valid: False, node: 775, tag: div, level: 15" node_number="775">Colin C. Gauvin</div>, </span><span class="valid" valid="valid" title="valid: True, node: 776, tag: span, level: 14" node_number="776"><div title="valid: False, node: 777, tag: div, level: 15" node_number="777">Nathanael G. Lintner</div> and </span><span class="valid" valid="valid" title="valid: True, node: 778, tag: span, level: 14" node_number="778"><div title="valid: False, node: 779, tag: div, level: 15" node_number="779">C. Martin Lawrence</div></span> </div> <div class="valid" valid="valid" title="valid: True, node: 780, tag: div, level: 13" node_number="780"> Biomolecules <b class="valid" valid="valid" title="valid: True, node: 781, tag: b, level: 14" node_number="781">2021</b>, 11(12), 1852; https://doi.org/10.3390/biom11121852 - 09 Dec 2021 </div> <div class="valid" valid="valid" title="valid: True, node: 782, tag: div, level: 13" node_number="782"> Abstract <div class="valid" valid="valid" title="valid: True, node: 783, tag: div, level: 14" node_number="783"> Csa3 family transcription factors are ancillary CRISPR-associated proteins composed of N-terminal CARF domains and C-terminal winged helix-turn-helix domains. The activity of Csa3 transcription factors is thought to be controlled by cyclic oligoadenyate (cOA) second messengers produced by type III CRISPR-Cas surveillance complexes. Here [...] Read more. </div> <div class="valid" valid="valid" title="valid: True, node: 784, tag: div, level: 14" node_number="784"> Csa3 family transcription factors are ancillary CRISPR-associated proteins composed of N-terminal CARF domains and C-terminal winged helix-turn-helix domains. The activity of Csa3 transcription factors is thought to be controlled by cyclic oligoadenyate (cOA) second messengers produced by type III CRISPR-Cas surveillance complexes. Here we show that <i title="valid: False, node: 785, tag: i, level: 15" node_number="785">Saccharolobus solfataricus</i> Csa3a recognizes cyclic tetra-adenylate (cA<sub title="valid: False, node: 786, tag: sub, level: 15" node_number="786">4</sub>) and that Csa3a lacks self-regulating &#8220;ring nuclease&#8221; activity present in some other CARF domain proteins. The crystal structure of the Csa3a/cA4 complex was also determined and the structural and thermodynamic basis for cA<sub title="valid: False, node: 787, tag: sub, level: 15" node_number="787">4</sub> recognition are described, as are conformational changes in Csa3a associated with cA<sub title="valid: False, node: 788, tag: sub, level: 15" node_number="788">4</sub> binding. We also characterized the effect of cA<sub title="valid: False, node: 789, tag: sub, level: 15" node_number="789">4</sub> on recognition of putative DNA binding sites. Csa3a binds to putative promoter sequences in a nonspecific, cooperative and cA<sub title="valid: False, node: 790, tag: sub, level: 15" node_number="790">4</sub>-independent manner, suggesting a more complex mode of transcriptional regulation. We conclude the Csa3a/cA<sub title="valid: False, node: 791, tag: sub, level: 15" node_number="791">4</sub> interaction represents a nexus between the type I and type III CRISPR-Cas systems present in <i title="valid: False, node: 792, tag: i, level: 15" node_number="792">S. solfataricus</i>, and discuss the role of the Csa3/cA<sub title="valid: False, node: 793, tag: sub, level: 15" node_number="793">4</sub> interaction in coordinating different arms of this integrated class 1 immune system to mount a synergistic, highly orchestrated immune response. Full article </div> </div> <div class="valid" valid="valid" title="valid: True, node: 794, tag: div, level: 13" node_number="794"> (This article belongs to the Collection Molecular Biology: Feature Papers) </div> &#9658;&#9660; Show Figures <div class="valid" valid="valid" title="valid: True, node: 795, tag: div, level: 13" node_number="795"><div class="valid" valid="valid" title="valid: True, node: 796, tag: div, level: 14" node_number="796"><div title="valid: False, node: 797, tag: div, level: 15" node_number="797"><p title="valid: False, node: 798, tag: p, level: 16" node_number="798">Figure 1</p></div></div></div> </div> </div> </div> <div class="valid" valid="valid" title="valid: True, node: 799, tag: div, level: 10" node_number="799"> <div class="valid" valid="valid" title="valid: True, node: 800, tag: div, level: 11" node_number="800"> <div class="valid" valid="valid" title="valid: True, node: 801, tag: div, level: 12" node_number="801"> <div class="valid" valid="valid" title="valid: True, node: 802, tag: div, level: 13" node_number="802"> <a class="valid" valid="valid" title="valid: True, node: 803, tag: a, level: 14" node_number="803"> <i title="valid: False, node: 804, tag: i, level: 15" node_number="804">get_app</i> </a> </div> <div class="valid" valid="valid" title="valid: True, node: 805, tag: div, level: 13" node_number="805"> <a class="valid" valid="valid" title="valid: True, node: 806, tag: a, level: 14" node_number="806"> <i title="valid: False, node: 807, tag: i, level: 15" node_number="807">subject</i> </a> <div class="valid" valid="valid" title="valid: True, node: 808, tag: div, level: 14" node_number="808"> View online as: Abstract Page Full-Text HTML </div> </div> <div class="valid" valid="valid" title="valid: True, node: 809, tag: div, level: 13" node_number="809">Open AccessReview</div> The Role of Pumilio RNA Binding Protein in Plants <div class="valid" valid="valid" title="valid: True, node: 810, tag: div, level: 13" node_number="810"> by <span class="valid" valid="valid" title="valid: True, node: 811, tag: span, level: 14" node_number="811"><div title="valid: False, node: 812, tag: div, level: 15" node_number="812">Sung Un Huh</div></span> </div> <div class="valid" valid="valid" title="valid: True, node: 813, tag: div, level: 13" node_number="813"> Biomolecules <b class="valid" valid="valid" title="valid: True, node: 814, tag: b, level: 14" node_number="814">2021</b>, 11(12), 1851; https://doi.org/10.3390/biom11121851 - 09 Dec 2021 </div> <div class="valid" valid="valid" title="valid: True, node: 815, tag: div, level: 13" node_number="815"> Abstract <div class="valid" valid="valid" title="valid: True, node: 816, tag: div, level: 14" node_number="816"> Eukaryotic organisms have a posttranscriptional/translational regulation system for the control of translational efficiency. RNA binding proteins (RBPs) have been known to control target genes. One type of protein, Pumilio (Pum)/Puf family RNA binding proteins, show a specific binding of 3&#8242; untranslational region (3&#8242; [...] Read more. </div> <div class="valid" valid="valid" title="valid: True, node: 817, tag: div, level: 14" node_number="817"> Eukaryotic organisms have a posttranscriptional/translational regulation system for the control of translational efficiency. RNA binding proteins (RBPs) have been known to control target genes. One type of protein, Pumilio (Pum)/Puf family RNA binding proteins, show a specific binding of 3&#8242; untranslational region (3&#8242; UTR) of target mRNA and function as a post-transcriptional/translational regulator in eukaryotic cells. Plant Pum protein is involved in development and biotic/abiotic stresses. Interestingly, Arabidopsis Pum can control target genes in a sequence-specific manner and rRNA processing in a sequence-nonspecific manner. As shown in in silico <i title="valid: False, node: 818, tag: i, level: 15" node_number="818">Pum</i> gene expression analysis, Arabidopsis and rice <i title="valid: False, node: 819, tag: i, level: 15" node_number="819">Pum</i> genes are responsive to biotic/abiotic stresses. Plant Pum can commonly contribute to host gene regulation at the post-transcriptional/translational step, as can mammalian Pum. However, the function of plant Pum proteins is not yet fully known. In this review, we briefly summarize the function of plant Pum in defense, development, and environmental responses via recent research and bioinformatics data. Full article </div> </div> <div class="valid" valid="valid" title="valid: True, node: 820, tag: div, level: 13" node_number="820"> (This article belongs to the Section Molecular Biology) </div> &#9658;&#9660; Show Figures <div class="valid" valid="valid" title="valid: True, node: 821, tag: div, level: 13" node_number="821"><div class="valid" valid="valid" title="valid: True, node: 822, tag: div, level: 14" node_number="822"><div title="valid: False, node: 823, tag: div, level: 15" node_number="823"><p title="valid: False, node: 824, tag: p, level: 16" node_number="824">Figure 1</p></div></div></div> </div> </div> </div> <div class="valid" valid="valid" title="valid: True, node: 825, tag: div, level: 10" node_number="825"> <div class="valid" valid="valid" title="valid: True, node: 826, tag: div, level: 11" node_number="826"> <div class="valid" valid="valid" title="valid: True, node: 827, tag: div, level: 12" node_number="827"> <div class="valid" valid="valid" title="valid: True, node: 828, tag: div, level: 13" node_number="828"> <a class="valid" valid="valid" title="valid: True, node: 829, tag: a, level: 14" node_number="829"> <i title="valid: False, node: 830, tag: i, level: 15" node_number="830">get_app</i> </a> </div> <div class="valid" valid="valid" title="valid: True, node: 831, tag: div, level: 13" node_number="831"> <a class="valid" valid="valid" title="valid: True, node: 832, tag: a, level: 14" node_number="832"> <i title="valid: False, node: 833, tag: i, level: 15" node_number="833">subject</i> </a> <div class="valid" valid="valid" title="valid: True, node: 834, tag: div, level: 14" node_number="834"> View online as: Abstract Page Full-Text HTML </div> </div> <div class="valid" valid="valid" title="valid: True, node: 835, tag: div, level: 13" node_number="835">Open AccessReview</div> CD44: A Multifunctional Mediator of Cancer Progression <div class="valid" valid="valid" title="valid: True, node: 836, tag: div, level: 13" node_number="836"> by <span class="valid" valid="valid" title="valid: True, node: 837, tag: span, level: 14" node_number="837"><div title="valid: False, node: 838, tag: div, level: 15" node_number="838">Malak Hassn Mesrati</div>, </span><span class="valid" valid="valid" title="valid: True, node: 839, tag: span, level: 14" node_number="839"><div title="valid: False, node: 840, tag: div, level: 15" node_number="840">Saiful Effendi Syafruddin</div>, </span><span class="valid" valid="valid" title="valid: True, node: 841, tag: span, level: 14" node_number="841"><div title="valid: False, node: 842, tag: div, level: 15" node_number="842">M. Aiman Mohtar</div> and </span><span class="valid" valid="valid" title="valid: True, node: 843, tag: span, level: 14" node_number="843"><div title="valid: False, node: 844, tag: div, level: 15" node_number="844">Amir Syahir</div></span> </div> <div class="valid" valid="valid" title="valid: True, node: 845, tag: div, level: 13" node_number="845"> Biomolecules <b class="valid" valid="valid" title="valid: True, node: 846, tag: b, level: 14" node_number="846">2021</b>, 11(12), 1850; https://doi.org/10.3390/biom11121850 - 09 Dec 2021 </div> <div class="valid" valid="valid" title="valid: True, node: 847, tag: div, level: 13" node_number="847"> Abstract <div class="valid" valid="valid" title="valid: True, node: 848, tag: div, level: 14" node_number="848"> CD44, a non-kinase cell surface transmembrane glycoprotein, has been widely implicated as a cancer stem cell (CSC) marker in several cancers. Cells overexpressing CD44 possess several CSC traits, such as self-renewal and epithelial-mesenchymal transition (EMT) capability, as well as a resistance to chemo- [...] Read more. </div> <div class="valid" valid="valid" title="valid: True, node: 849, tag: div, level: 14" node_number="849"> CD44, a non-kinase cell surface transmembrane glycoprotein, has been widely implicated as a cancer stem cell (CSC) marker in several cancers. Cells overexpressing CD44 possess several CSC traits, such as self-renewal and epithelial-mesenchymal transition (EMT) capability, as well as a resistance to chemo- and radiotherapy. The CD44 gene regularly undergoes alternative splicing, resulting in the standard (CD44s) and variant (CD44v) isoforms. The interaction of such isoforms with ligands, particularly hyaluronic acid (HA), osteopontin (OPN) and matrix metalloproteinases (MMPs), drive numerous cancer-associated signalling. However, there are contradictory results regarding whether high or low CD44 expression is associated with worsening clinicopathological features, such as a higher tumour histological grade, advanced tumour stage and poorer survival rates. Nonetheless, high CD44 expression significantly contributes to enhanced tumourigenic mechanisms, such as cell proliferation, metastasis, invasion, migration and stemness; hence, CD44 is an important clinical target. This review summarises current research regarding the different CD44 isoform structures and their roles and functions in supporting tumourigenesis and discusses CD44 expression regulation, CD44-signalling pathways and interactions involved in cancer development. The clinical significance and prognostic value of CD44 and the potential of CD44 as a therapeutic target in cancer are also addressed. Full article </div> </div> <div class="valid" valid="valid" title="valid: True, node: 850, tag: div, level: 13" node_number="850"> (This article belongs to the Special Issue Biomarkers in Cancer) </div> &#9658;&#9660; Show Figures <div class="valid" valid="valid" title="valid: True, node: 851, tag: div, level: 13" node_number="851"><div class="valid" valid="valid" title="valid: True, node: 852, tag: div, level: 14" node_number="852"><div title="valid: False, node: 853, tag: div, level: 15" node_number="853"><p title="valid: False, node: 854, tag: p, level: 16" node_number="854">Figure 1</p></div></div></div> </div> </div> </div> <div class="valid" valid="valid" title="valid: True, node: 855, tag: div, level: 10" node_number="855"> <div class="valid" valid="valid" title="valid: True, node: 856, tag: div, level: 11" node_number="856"> <div class="valid" valid="valid" title="valid: True, node: 857, tag: div, level: 12" node_number="857"> <div class="valid" valid="valid" title="valid: True, node: 858, tag: div, level: 13" node_number="858"> <a class="valid" valid="valid" title="valid: True, node: 859, tag: a, level: 14" node_number="859"> <i title="valid: False, node: 860, tag: i, level: 15" node_number="860">get_app</i> </a> </div> <div class="valid" valid="valid" title="valid: True, node: 861, tag: div, level: 13" node_number="861"> <a class="valid" valid="valid" title="valid: True, node: 862, tag: a, level: 14" node_number="862"> <i title="valid: False, node: 863, tag: i, level: 15" node_number="863">subject</i> </a> <div class="valid" valid="valid" title="valid: True, node: 864, tag: div, level: 14" node_number="864"> View online as: Abstract Page Full-Text HTML </div> </div> <div class="valid" valid="valid" title="valid: True, node: 865, tag: div, level: 13" node_number="865">Open AccessReview</div> The Annexin A2/S100A10 Complex: The Mutualistic Symbiosis of Two Distinct Proteins <div class="valid" valid="valid" title="valid: True, node: 866, tag: div, level: 13" node_number="866"> by <span class="valid" valid="valid" title="valid: True, node: 867, tag: span, level: 14" node_number="867"><div title="valid: False, node: 868, tag: div, level: 15" node_number="868">Alamelu Bharadwaj</div>, </span><span class="valid" valid="valid" title="valid: True, node: 869, tag: span, level: 14" node_number="869"><div title="valid: False, node: 870, tag: div, level: 15" node_number="870">Emma Kempster</div> and </span><span class="valid" valid="valid" title="valid: True, node: 871, tag: span, level: 14" node_number="871"><div title="valid: False, node: 872, tag: div, level: 15" node_number="872">David Morton Waisman</div></span> </div> <div class="valid" valid="valid" title="valid: True, node: 873, tag: div, level: 13" node_number="873"> Biomolecules <b class="valid" valid="valid" title="valid: True, node: 874, tag: b, level: 14" node_number="874">2021</b>, 11(12), 1849; https://doi.org/10.3390/biom11121849 - 09 Dec 2021 </div> <div class="valid" valid="valid" title="valid: True, node: 875, tag: div, level: 13" node_number="875"> Abstract <div class="valid" valid="valid" title="valid: True, node: 876, tag: div, level: 14" node_number="876"> Mutualistic symbiosis refers to the symbiotic relationship between individuals of different species in which both individuals benefit from the association. S100A10, a member of the S100 family of Ca<sup title="valid: False, node: 877, tag: sup, level: 15" node_number="877">2+</sup>-binding proteins, exists as a tight dimer and binds two annexin A2 molecules. [...] Read more. </div> <div class="valid" valid="valid" title="valid: True, node: 878, tag: div, level: 14" node_number="878"> Mutualistic symbiosis refers to the symbiotic relationship between individuals of different species in which both individuals benefit from the association. S100A10, a member of the S100 family of Ca<sup title="valid: False, node: 879, tag: sup, level: 15" node_number="879">2+</sup>-binding proteins, exists as a tight dimer and binds two annexin A2 molecules. This association forms the annexin A2/S100A10 complex known as AIIt, and modifies the distinct functions of both proteins. Annexin A2 is a Ca<sup title="valid: False, node: 880, tag: sup, level: 15" node_number="880">2+</sup>-binding protein that binds F-actin, phospholipid, RNA, and specific polysaccharides such as heparin. S100A10 does not bind Ca<sup title="valid: False, node: 881, tag: sup, level: 15" node_number="881">2+</sup>, but binds tPA, plasminogen, certain plasma membrane ion channels, neurotransmitter receptors, and the structural scaffold protein, AHNAK. S100A10 relies on annexin A2 for its intracellular survival: in the absence of annexin A2, it is rapidly destroyed by ubiquitin-dependent and independent proteasomal degradation. Annexin A2 requires S100A10 to increase its affinity for Ca<sup title="valid: False, node: 882, tag: sup, level: 15" node_number="882">2+</sup>, facilitating its participation in Ca<sup title="valid: False, node: 883, tag: sup, level: 15" node_number="883">2+</sup>-dependent processes such as membrane binding. S100A10 binds tissue plasminogen activator and plasminogen, and promotes plasminogen activation to plasmin, which is a process stimulated by annexin A2. In contrast, annexin A2 acts as a plasmin reductase and facilitates the autoproteolytic destruction of plasmin. This review examines the relationship between annexin A2 and S100A10, and how their mutualistic symbiosis affects the function of both proteins. Full article </div> </div> <div class="valid" valid="valid" title="valid: True, node: 884, tag: div, level: 13" node_number="884"> (This article belongs to the Special Issue S100 Proteins&#8212;Intracellular and Extracellular Function in Norm and Pathology) </div> &#9658;&#9660; Show Figures <div class="valid" valid="valid" title="valid: True, node: 885, tag: div, level: 13" node_number="885"><div class="valid" valid="valid" title="valid: True, node: 886, tag: div, level: 14" node_number="886"><div title="valid: False, node: 887, tag: div, level: 15" node_number="887"><p title="valid: False, node: 888, tag: p, level: 16" node_number="888">Figure 1</p></div></div></div> </div> </div> </div> <div class="valid" valid="valid" title="valid: True, node: 889, tag: div, level: 10" node_number="889"> <div class="valid" valid="valid" title="valid: True, node: 890, tag: div, level: 11" node_number="890"> <div class="valid" valid="valid" title="valid: True, node: 891, tag: div, level: 12" node_number="891"> <div class="valid" valid="valid" title="valid: True, node: 892, tag: div, level: 13" node_number="892"> <a class="valid" valid="valid" title="valid: True, node: 893, tag: a, level: 14" node_number="893"> <i title="valid: False, node: 894, tag: i, level: 15" node_number="894">get_app</i> </a> </div> <div class="valid" valid="valid" title="valid: True, node: 895, tag: div, level: 13" node_number="895"> <a class="valid" valid="valid" title="valid: True, node: 896, tag: a, level: 14" node_number="896"> <i title="valid: False, node: 897, tag: i, level: 15" node_number="897">subject</i> </a> <div class="valid" valid="valid" title="valid: True, node: 898, tag: div, level: 14" node_number="898"> View online as: Abstract Page Full-Text HTML </div> </div> <div class="valid" valid="valid" title="valid: True, node: 899, tag: div, level: 13" node_number="899">Open AccessArticle</div> Probing the Influence of Single-Site Mutations in the Central Cross-&#946; Region of Amyloid &#946; (1&#8211;40) Peptides <div class="valid" valid="valid" title="valid: True, node: 900, tag: div, level: 13" node_number="900"> by <span class="valid" valid="valid" title="valid: True, node: 901, tag: span, level: 14" node_number="901"><div title="valid: False, node: 902, tag: div, level: 15" node_number="902">Jacob Fritzsch</div>, </span><span class="valid" valid="valid" title="valid: True, node: 903, tag: span, level: 14" node_number="903"><div title="valid: False, node: 904, tag: div, level: 15" node_number="904">Alexander Korn</div>, </span><span class="valid" valid="valid" title="valid: True, node: 905, tag: span, level: 14" node_number="905"><div title="valid: False, node: 906, tag: div, level: 15" node_number="906">Dayana Surendran</div>, </span><span class="valid" valid="valid" title="valid: True, node: 907, tag: span, level: 14" node_number="907"><div title="valid: False, node: 908, tag: div, level: 15" node_number="908">Martin Krueger</div>, </span><span class="valid" valid="valid" title="valid: True, node: 909, tag: span, level: 14" node_number="909"><div title="valid: False, node: 910, tag: div, level: 15" node_number="910">Holger A. Scheidt</div>, </span><span class="valid" valid="valid" title="valid: True, node: 911, tag: span, level: 14" node_number="911"><div title="valid: False, node: 912, tag: div, level: 15" node_number="912">Kaustubh R. Mote</div>, </span><span class="valid" valid="valid" title="valid: True, node: 913, tag: span, level: 14" node_number="913"><div title="valid: False, node: 914, tag: div, level: 15" node_number="914">Perunthiruthy K. Madhu</div>, </span><span class="valid" valid="valid" title="valid: True, node: 915, tag: span, level: 14" node_number="915"><div title="valid: False, node: 916, tag: div, level: 15" node_number="916">Sudipta Maiti</div> and </span><span class="valid" valid="valid" title="valid: True, node: 917, tag: span, level: 14" node_number="917"><div title="valid: False, node: 918, tag: div, level: 15" node_number="918">Daniel Huster</div></span> </div> <div class="valid" valid="valid" title="valid: True, node: 919, tag: div, level: 13" node_number="919"> Biomolecules <b class="valid" valid="valid" title="valid: True, node: 920, tag: b, level: 14" node_number="920">2021</b>, 11(12), 1848; https://doi.org/10.3390/biom11121848 - 09 Dec 2021 </div> <div class="valid" valid="valid" title="valid: True, node: 921, tag: div, level: 13" node_number="921"> Abstract <div class="valid" valid="valid" title="valid: True, node: 922, tag: div, level: 14" node_number="922"> Amyloid &#946; (A&#946;) is a peptide known to form amyloid fibrils in the brain of patients suffering from Alzheimer&#8217;s disease. A complete mechanistic understanding how A&#946; peptides form neurotoxic assemblies and how they kill neurons has not yet been achieved. Previous analysis of [...] Read more. </div> <div class="valid" valid="valid" title="valid: True, node: 923, tag: div, level: 14" node_number="923"> Amyloid &#946; (A&#946;) is a peptide known to form amyloid fibrils in the brain of patients suffering from Alzheimer&#8217;s disease. A complete mechanistic understanding how A&#946; peptides form neurotoxic assemblies and how they kill neurons has not yet been achieved. Previous analysis of various A&#946;<sub title="valid: False, node: 924, tag: sub, level: 15" node_number="924">40</sub> mutants could reveal the significant importance of the hydrophobic contact between the residues Phe<sub title="valid: False, node: 925, tag: sub, level: 15" node_number="925">19</sub> and Leu<sub title="valid: False, node: 926, tag: sub, level: 15" node_number="926">34</sub> for cell toxicity. For some mutations at Phe<sub title="valid: False, node: 927, tag: sub, level: 15" node_number="927">19</sub>, toxicity was completely abolished. In the current study, we assessed if perturbations introduced by mutations in the direct proximity of the Phe<sub title="valid: False, node: 928, tag: sub, level: 15" node_number="928">19</sub>/Leu<sub title="valid: False, node: 929, tag: sub, level: 15" node_number="929">34</sub> contact would have similar relevance for the fibrillation kinetics, structure, dynamics and toxicity of the A&#946; assemblies. To this end, we rationally modified positions Phe<sub title="valid: False, node: 930, tag: sub, level: 15" node_number="930">20</sub> or Gly<sub title="valid: False, node: 931, tag: sub, level: 15" node_number="931">33</sub>. A small library of A&#946;<sub title="valid: False, node: 932, tag: sub, level: 15" node_number="932">40</sub> peptides with Phe<sub title="valid: False, node: 933, tag: sub, level: 15" node_number="933">20</sub> mutated to Lys, Tyr or the non-proteinogenic cyclohexylalanine (Cha) or Gly<sub title="valid: False, node: 934, tag: sub, level: 15" node_number="934">33</sub> mutated to Ala was synthesized. We used electron microscopy, circular dichroism, X-ray diffraction, solid-state NMR spectroscopy, ThT fluorescence and MTT cell toxicity assays to comprehensively investigate the physicochemical properties of the A&#946; fibrils formed by the modified peptides as well as toxicity to a neuronal cell line. Single mutations of either Phe<sub title="valid: False, node: 935, tag: sub, level: 15" node_number="935">20</sub> or Gly<sub title="valid: False, node: 936, tag: sub, level: 15" node_number="936">33</sub> led to relatively drastic alterations in the A&#946; fibrillation kinetics but left the global, as well as the local structure, of the fibrils largely unchanged. Furthermore, the introduced perturbations caused a severe decrease or loss of cell toxicity compared to wildtype A&#946;<sub title="valid: False, node: 937, tag: sub, level: 15" node_number="937">40</sub>. We suggest that perturbations at position Phe<sub title="valid: False, node: 938, tag: sub, level: 15" node_number="938">20</sub> and Gly<sub title="valid: False, node: 939, tag: sub, level: 15" node_number="939">33</sub> affect the fibrillation pathway of A&#946;<sub title="valid: False, node: 940, tag: sub, level: 15" node_number="940">40</sub> and, thereby, influence the especially toxic oligomeric species manifesting so that the region around the Phe<sub title="valid: False, node: 941, tag: sub, level: 15" node_number="941">19</sub>/Leu<sub title="valid: False, node: 942, tag: sub, level: 15" node_number="942">34</sub> hydrophobic contact provides a promising site for the design of small molecules interfering with the A&#946; fibrillation pathway. Full article </div> </div> <div class="valid" valid="valid" title="valid: True, node: 943, tag: div, level: 13" node_number="943"> (This article belongs to the Special Issue Common Mechanisms in Alzheimer&#8217;s Disease and Other Neurodegenerative Disorders) </div> &#9658;&#9660; Show Figures <div class="valid" valid="valid" title="valid: True, node: 944, tag: div, level: 13" node_number="944"><div class="valid" valid="valid" title="valid: True, node: 945, tag: div, level: 14" node_number="945"><div title="valid: False, node: 946, tag: div, level: 15" node_number="946"><p title="valid: False, node: 947, tag: p, level: 16" node_number="947">Graphical abstract</p></div></div></div> </div> </div> </div> <div class="valid" valid="valid" title="valid: True, node: 948, tag: div, level: 10" node_number="948"> <div class="valid" valid="valid" title="valid: True, node: 949, tag: div, level: 11" node_number="949"> <div class="valid" valid="valid" title="valid: True, node: 950, tag: div, level: 12" node_number="950"> <div class="valid" valid="valid" title="valid: True, node: 951, tag: div, level: 13" node_number="951"> <a class="valid" valid="valid" title="valid: True, node: 952, tag: a, level: 14" node_number="952"> <i title="valid: False, node: 953, tag: i, level: 15" node_number="953">get_app</i> </a> </div> <div class="valid" valid="valid" title="valid: True, node: 954, tag: div, level: 13" node_number="954"> <a class="valid" valid="valid" title="valid: True, node: 955, tag: a, level: 14" node_number="955"> <i title="valid: False, node: 956, tag: i, level: 15" node_number="956">subject</i> </a> <div class="valid" valid="valid" title="valid: True, node: 957, tag: div, level: 14" node_number="957"> View online as: Abstract Page Full-Text HTML </div> </div> <div class="valid" valid="valid" title="valid: True, node: 958, tag: div, level: 13" node_number="958">Open AccessReview</div> Reiterating the Emergence of Noncoding RNAs as Regulators of the Critical Hallmarks of Gall Bladder Cancer <div class="valid" valid="valid" title="valid: True, node: 959, tag: div, level: 13" node_number="959"> by <span class="valid" valid="valid" title="valid: True, node: 960, tag: span, level: 14" node_number="960"><div title="valid: False, node: 961, tag: div, level: 15" node_number="961">Varsha Rana</div>, </span><span class="valid" valid="valid" title="valid: True, node: 962, tag: span, level: 14" node_number="962"><div title="valid: False, node: 963, tag: div, level: 15" node_number="963">Dey Parama</div>, </span><span class="valid" valid="valid" title="valid: True, node: 964, tag: span, level: 14" node_number="964"><div title="valid: False, node: 965, tag: div, level: 15" node_number="965">Elina Khatoon</div>, </span><span class="valid" valid="valid" title="valid: True, node: 966, tag: span, level: 14" node_number="966"><div title="valid: False, node: 967, tag: div, level: 15" node_number="967">Sosmitha Girisa</div>, </span><span class="valid" valid="valid" title="valid: True, node: 968, tag: span, level: 14" node_number="968"><div title="valid: False, node: 969, tag: div, level: 15" node_number="969">Gautam Sethi</div> and </span><span class="valid" valid="valid" title="valid: True, node: 970, tag: span, level: 14" node_number="970"><div title="valid: False, node: 971, tag: div, level: 15" node_number="971">Ajaikumar B. Kunnumakkara</div></span> </div> <div class="valid" valid="valid" title="valid: True, node: 972, tag: div, level: 13" node_number="972"> Biomolecules <b class="valid" valid="valid" title="valid: True, node: 973, tag: b, level: 14" node_number="973">2021</b>, 11(12), 1847; https://doi.org/10.3390/biom11121847 - 08 Dec 2021 </div> <div class="valid" valid="valid" title="valid: True, node: 974, tag: div, level: 13" node_number="974"> Abstract <div class="valid" valid="valid" title="valid: True, node: 975, tag: div, level: 14" node_number="975"> Gall bladder cancer (GBC) is a rare and one of the most aggressive types of malignancies, often associated with a poor prognosis and survival. It is a highly metastatic cancer and is often not diagnosed at the initial stages, which contributes to a [...] Read more. </div> <div class="valid" valid="valid" title="valid: True, node: 976, tag: div, level: 14" node_number="976"> Gall bladder cancer (GBC) is a rare and one of the most aggressive types of malignancies, often associated with a poor prognosis and survival. It is a highly metastatic cancer and is often not diagnosed at the initial stages, which contributes to a poor survival rate of patients. The poor diagnosis and chemoresistance associated with the disease limit the scope of the currently available surgical and nonsurgical treatment modalities. Thus, there is a need to explore novel therapeutic targets and biomarkers that will help relieve the severity of the disease and lead to advanced therapeutic strategies. Accumulating evidence has correlated the atypical expression of various noncoding RNAs (ncRNAs), including circular RNAs (circRNAs), long noncoding RNAs (lncRNAs), microRNAs (miRNAs), and small nucleolar RNAs (snoRNA) with the increased cell proliferation, epithelial&#8211;mesenchymal transition (EMT), invasion, migration, metastasis, chemoresistance, and decreased apoptosis in GBC. Numerous reports have indicated that the dysregulated expression of ncRNAs is associated with poor prognosis and lower disease-free and overall survival in GBC patients. These reports suggest that ncRNAs might be considered novel diagnostic and prognostic markers for the management of GBC. The present review recapitulates the association of various ncRNAs in the initiation and progression of GBC and the development of novel therapeutic strategies by exploring their functional and regulatory role. Full article </div> </div> &#9658;&#9660; Show Figures <div class="valid" valid="valid" title="valid: True, node: 977, tag: div, level: 13" node_number="977"><div class="valid" valid="valid" title="valid: True, node: 978, tag: div, level: 14" node_number="978"><div title="valid: False, node: 979, tag: div, level: 15" node_number="979"><p title="valid: False, node: 980, tag: p, level: 16" node_number="980">Figure 1</p></div></div></div> </div> </div> </div> </div> <div class="valid" valid="valid" title="valid: True, node: 981, tag: div, level: 9" node_number="981"> More Articles... </div> </div> </div> </div> <div class="valid" valid="valid" title="valid: True, node: 982, tag: div, level: 6" node_number="982"> <div class="valid" valid="valid" title="valid: True, node: 983, tag: div, level: 7" node_number="983"> <div class="valid" valid="valid" title="valid: True, node: 984, tag: div, level: 8" node_number="984"> <div class="valid" valid="valid" title="valid: True, node: 985, tag: div, level: 9" node_number="985"> <a class="valid" valid="valid" title="valid: True, node: 986, tag: a, level: 10" node_number="986"> Submit to <i class="valid" valid="valid" title="valid: True, node: 987, tag: i, level: 11" node_number="987">Biomolecules</i> </a> Review for Biomolecules <div class="valid" valid="valid" title="valid: True, node: 988, tag: div, level: 10" node_number="988"> Share </div> </div> <div class="valid" valid="valid" title="valid: True, node: 989, tag: div, level: 9" node_number="989"> <h2 class="valid" valid="valid" title="valid: True, node: 990, tag: h2, level: 10" node_number="990">Journal Menu</h2> &#9658; &#9660; Journal Menu <ul class="valid" valid="valid" title="valid: True, node: 991, tag: ul, level: 10" node_number="991"> <li class="valid" valid="valid" title="valid: True, node: 992, tag: li, level: 11" node_number="992"> <ul class="valid" valid="valid" title="valid: True, node: 993, tag: ul, level: 12" node_number="993"> <li class="valid" valid="valid" title="valid: True, node: 994, tag: li, level: 13" node_number="994"> Biomolecules Home </li> <li class="valid" valid="valid" title="valid: True, node: 995, tag: li, level: 13" node_number="995"> Aims Scope </li> <li class="valid" valid="valid" title="valid: True, node: 996, tag: li, level: 13" node_number="996"> Editorial Board </li> <li class="valid" valid="valid" title="valid: True, node: 997, tag: li, level: 13" node_number="997"> Reviewer Board </li> <li class="valid" valid="valid" title="valid: True, node: 998, tag: li, level: 13" node_number="998"> Topical Advisory Panel </li> <li class="valid" valid="valid" title="valid: True, node: 999, tag: li, level: 13" node_number="999"> Instructions for Authors </li> <li class="valid" valid="valid" title="valid: True, node: 1000, tag: li, level: 13" node_number="1000"> Special Issues </li> <li class="valid" valid="valid" title="valid: True, node: 1001, tag: li, level: 13" node_number="1001"> Sections Collections </li> <li class="valid" valid="valid" title="valid: True, node: 1002, tag: li, level: 13" node_number="1002"> Article Processing Charge </li> <li class="valid" valid="valid" title="valid: True, node: 1003, tag: li, level: 13" node_number="1003"> Indexing Archiving </li> <li class="valid" valid="valid" title="valid: True, node: 1004, tag: li, level: 13" node_number="1004"> Editor's Choice Articles </li> <li class="valid" valid="valid" title="valid: True, node: 1005, tag: li, level: 13" node_number="1005"> Most Cited Viewed </li> <li class="valid" valid="valid" title="valid: True, node: 1006, tag: li, level: 13" node_number="1006"> Journal Statistics </li> <li class="valid" valid="valid" title="valid: True, node: 1007, tag: li, level: 13" node_number="1007"> Journal History </li> <li class="valid" valid="valid" title="valid: True, node: 1008, tag: li, level: 13" node_number="1008"> Journal Awards </li> <li class="valid" valid="valid" title="valid: True, node: 1009, tag: li, level: 13" node_number="1009"> Society Collaborations </li> <li class="valid" valid="valid" title="valid: True, node: 1010, tag: li, level: 13" node_number="1010"> Conferences </li> <li class="valid" valid="valid" title="valid: True, node: 1011, tag: li, level: 13" node_number="1011"> Editorial Office </li> </ul> </li> </ul> </div> <h2 class="valid" valid="valid" title="valid: True, node: 1012, tag: h2, level: 9" node_number="1012">Journal Browser</h2> &#9658; &#9660; Journal Browser <div class="valid" valid="valid" title="valid: True, node: 1013, tag: div, level: 9" node_number="1013"> <div class="valid" valid="valid" title="valid: True, node: 1014, tag: div, level: 10" node_number="1014"> <ul class="valid" valid="valid" title="valid: True, node: 1015, tag: ul, level: 11" node_number="1015"> <li class="valid" valid="valid" title="valid: True, node: 1016, tag: li, level: 12" node_number="1016"> <a class="valid" valid="valid" title="valid: True, node: 1017, tag: a, level: 13" node_number="1017"> <i class="valid" valid="valid" title="valid: True, node: 1018, tag: i, level: 14" node_number="1018"> arrow_forward_ios </i> Forthcoming issue </a> <a class="valid" valid="valid" title="valid: True, node: 1019, tag: a, level: 13" node_number="1019"> <i class="valid" valid="valid" title="valid: True, node: 1020, tag: i, level: 14" node_number="1020"> arrow_forward_ios </i> Current issue </a> </li> <div class="valid" valid="valid" title="valid: True, node: 1021, tag: div, level: 12" node_number="1021"> <div class="valid" valid="valid" title="valid: True, node: 1022, tag: div, level: 13" node_number="1022"> <div class="valid" valid="valid" title="valid: True, node: 1023, tag: div, level: 14" node_number="1023"> <li title="valid: False, node: 1024, tag: li, level: 15" node_number="1024"> Vol.&#160;11&#160;(2021) </li> <li title="valid: False, node: 1025, tag: li, level: 15" node_number="1025"> Vol.&#160;10&#160;(2020) </li> <li title="valid: False, node: 1026, tag: li, level: 15" node_number="1026"> Vol.&#160;9&#160;(2019) </li> <li title="valid: False, node: 1027, tag: li, level: 15" node_number="1027"> Vol.&#160;8&#160;(2018) </li> <li title="valid: False, node: 1028, tag: li, level: 15" node_number="1028"> Vol.&#160;7&#160;(2017) </li> <li title="valid: False, node: 1029, tag: li, level: 15" node_number="1029"> Vol.&#160;6&#160;(2016) </li> <li title="valid: False, node: 1030, tag: li, level: 15" node_number="1030"> Vol.&#160;5&#160;(2015) </li> <li title="valid: False, node: 1031, tag: li, level: 15" node_number="1031"> Vol.&#160;4&#160;(2014) </li> <li title="valid: False, node: 1032, tag: li, level: 15" node_number="1032"> Vol.&#160;3&#160;(2013) </li> <li title="valid: False, node: 1033, tag: li, level: 15" node_number="1033"> Vol.&#160;2&#160;(2012) </li> <li title="valid: False, node: 1034, tag: li, level: 15" node_number="1034"> Vol.&#160;1&#160;(2011) </li> </div> </div> </div> </ul> </div> </div> </div> </div> <div class="valid" valid="valid" title="valid: True, node: 1035, tag: div, level: 7" node_number="1035"> <div class="valid" valid="valid" title="valid: True, node: 1036, tag: div, level: 8" node_number="1036"> <h2 class="valid" valid="valid" title="valid: True, node: 1037, tag: h2, level: 9" node_number="1037">Highly Accessed Articles</h2> </div> <div class="valid" valid="valid" title="valid: True, node: 1038, tag: div, level: 8" node_number="1038"> <div class="valid" valid="valid" title="valid: True, node: 1039, tag: div, level: 9" node_number="1039"> View More... </div> </div> </div> <div class="valid" valid="valid" title="valid: True, node: 1040, tag: div, level: 7" node_number="1040"> <div class="valid" valid="valid" title="valid: True, node: 1041, tag: div, level: 8" node_number="1041"> <h2 class="valid" valid="valid" title="valid: True, node: 1042, tag: h2, level: 9" node_number="1042">Latest Books</h2> </div> <div class="valid" valid="valid" title="valid: True, node: 1043, tag: div, level: 8" node_number="1043"> <div class="valid" valid="valid" title="valid: True, node: 1044, tag: div, level: 9" node_number="1044"> More Open Access Books... </div> </div> </div> </div> <div class="valid" valid="valid" title="valid: True, node: 1045, tag: div, level: 6" node_number="1045"> <div class="valid" valid="valid" title="valid: True, node: 1046, tag: div, level: 7" node_number="1046"> <div class="valid" valid="valid" title="valid: True, node: 1047, tag: div, level: 8" node_number="1047"> <h2 class="valid" valid="valid" title="valid: True, node: 1048, tag: h2, level: 9" node_number="1048">E-Mail Alert</h2> </div> </div> <div class="valid" valid="valid" title="valid: True, node: 1049, tag: div, level: 7" node_number="1049"> <div class="valid" valid="valid" title="valid: True, node: 1050, tag: div, level: 8" node_number="1050"> <h2 class="valid" valid="valid" title="valid: True, node: 1051, tag: h2, level: 9" node_number="1051">News</h2> </div> <div class="valid" valid="valid" title="valid: True, node: 1052, tag: div, level: 8" node_number="1052"> <div class="valid" valid="valid" title="valid: True, node: 1053, tag: div, level: 9" node_number="1053"> 29 November 2021 Prof. Dr. Robert V. (Rob) Stahelin Appointed Editor-in-Chief of the Section &#8220;Biomacromolecules: Lipids&#8221; in Biomolecules </div> <div class="valid" valid="valid" title="valid: True, node: 1054, tag: div, level: 9" node_number="1054"> 22 November 2021 720 MDPI Editorial Board Members Receiving "2021 Highly Cited Researchers" Distinction </div> <div class="valid" valid="valid" title="valid: True, node: 1055, tag: div, level: 9" node_number="1055"> 16 November 2021 Topical Advisory Panel Established to Support Editorial Board </div> <div class="valid" valid="valid" title="valid: True, node: 1056, tag: div, level: 9" node_number="1056"> More News Announcements... </div> </div> </div> <div class="valid" valid="valid" title="valid: True, node: 1057, tag: div, level: 7" node_number="1057"> <div class="valid" valid="valid" title="valid: True, node: 1058, tag: div, level: 8" node_number="1058"> <h2 class="valid" valid="valid" title="valid: True, node: 1059, tag: h2, level: 9" node_number="1059">Topics</h2> </div> <div class="valid" valid="valid" title="valid: True, node: 1060, tag: div, level: 8" node_number="1060"> <div class="valid" valid="valid" title="valid: True, node: 1061, tag: div, level: 9" node_number="1061"><div class="valid" valid="valid" title="valid: True, node: 1062, tag: div, level: 10" node_number="1062"> Topic in Genes, ncRNA, IJMS, Biomolecules, Pathogens</div> Non-coding RNAs in Disease Deadline: 31 December 2021</div> <div class="valid" valid="valid" title="valid: True, node: 1063, tag: div, level: 9" node_number="1063"><div class="valid" valid="valid" title="valid: True, node: 1064, tag: div, level: 10" node_number="1064"> Topic in Applied Sciences, Biomolecules, Pharmaceuticals, Biomedicines, Antibiotics</div> Compounds with Medicinal Value Editor-in-Chief: Maria Stefania SinicropiDeadline: 31 March 2022</div> <div class="valid" valid="valid" title="valid: True, node: 1065, tag: div, level: 9" node_number="1065"><div class="valid" valid="valid" title="valid: True, node: 1066, tag: div, level: 10" node_number="1066"> Topic in Biomolecules, Cancers, Cells, Current Oncology</div> Advances in Ovarian Cancer Research: From Biology to Therapeutics Editor-in-Chief: Christina M. AnnunziataDeadline: 31 May 2022</div> <div class="valid" valid="valid" title="valid: True, node: 1067, tag: div, level: 9" node_number="1067"><div class="valid" valid="valid" title="valid: True, node: 1068, tag: div, level: 10" node_number="1068"> Topic in Biomolecules, Cancers, Cells, Current Oncology, Onco</div> Adaptation Mechanisms in Therapy-Resistant Breast Cancer Deadline: 31 July 2022</div> <div class="valid" valid="valid" title="valid: True, node: 1069, tag: div, level: 9" node_number="1069"> More Topics </div> </div> </div> <div class="valid" valid="valid" title="valid: True, node: 1070, tag: div, level: 7" node_number="1070"> <div class="valid" valid="valid" title="valid: True, node: 1071, tag: div, level: 8" node_number="1071"> <h2 class="valid" valid="valid" title="valid: True, node: 1072, tag: h2, level: 9" node_number="1072">Conferences</h2> </div> <div class="valid" valid="valid" title="valid: True, node: 1073, tag: div, level: 8" node_number="1073"> <div class="valid" valid="valid" title="valid: True, node: 1074, tag: div, level: 9" node_number="1074"> Announce Your Conference </div> <div class="valid" valid="valid" title="valid: True, node: 1075, tag: div, level: 9" node_number="1075"> 21 January 2022 Applied Sciences Webinar | Sensing Based on Surface Plasmons</div> <div class="valid" valid="valid" title="valid: True, node: 1076, tag: div, level: 9" node_number="1076"> 16&#8211;18 February 2022 3rd MMCS: Shaping Medicinal Chemistry for the New Decade</div> <div class="valid" valid="valid" title="valid: True, node: 1077, tag: div, level: 9" node_number="1077"> More Conferences... </div> </div> </div> <div class="valid" valid="valid" title="valid: True, node: 1078, tag: div, level: 7" node_number="1078"> <div class="valid" valid="valid" title="valid: True, node: 1079, tag: div, level: 8" node_number="1079"> <h2 class="valid" valid="valid" title="valid: True, node: 1080, tag: h2, level: 9" node_number="1080">Special Issues</h2> </div> <div class="valid" valid="valid" title="valid: True, node: 1081, tag: div, level: 8" node_number="1081"> <div class="valid" valid="valid" title="valid: True, node: 1082, tag: div, level: 9" node_number="1082"> Edit a Special Issue </div> <div class="valid" valid="valid" title="valid: True, node: 1083, tag: div, level: 9" node_number="1083"><div class="valid" valid="valid" title="valid: True, node: 1084, tag: div, level: 10" node_number="1084"> Special Issue in Biomolecules</div> Prognostic and Predictive Biomarkers for Reactive Oxygen Species Related Diseases Guest Editor: Luciana BordinDeadline: 15 December 2021</div> <div class="valid" valid="valid" title="valid: True, node: 1085, tag: div, level: 9" node_number="1085"><div class="valid" valid="valid" title="valid: True, node: 1086, tag: div, level: 10" node_number="1086"> Special Issue in Biomolecules</div> Beyond Lipid Rafts and Caveolae: From Caveolae Compartmentalization of Signal Transduction to Medicine Guest Editors: Shengwen Calvin Li, Massimo Sargiacomo, Jacques Couet, Eric K&#252;blerDeadline: 31 December 2021</div> <div class="valid" valid="valid" title="valid: True, node: 1087, tag: div, level: 9" node_number="1087"><div class="valid" valid="valid" title="valid: True, node: 1088, tag: div, level: 10" node_number="1088"> Special Issue in Biomolecules</div> 3D Printing of Bioactive Structures for Engineering Artificial Tissues Guest Editor: Mehdi MehraliDeadline: 1 January 2022</div> <div class="valid" valid="valid" title="valid: True, node: 1089, tag: div, level: 9" node_number="1089"><div class="valid" valid="valid" title="valid: True, node: 1090, tag: div, level: 10" node_number="1090"> Special Issue in Biomolecules</div> New Developments in Histamine Research Guest Editors: Emanuela Masini, Laura LucariniDeadline: 15 January 2022</div> <div class="valid" valid="valid" title="valid: True, node: 1091, tag: div, level: 9" node_number="1091"> More Special Issues </div> </div> </div> <div class="valid" valid="valid" title="valid: True, node: 1092, tag: div, level: 7" node_number="1092"> <div class="valid" valid="valid" title="valid: True, node: 1093, tag: div, level: 8" node_number="1093"> <h2 class="valid" valid="valid" title="valid: True, node: 1094, tag: h2, level: 9" node_number="1094">Topical Collections</h2> </div> <div class="valid" valid="valid" title="valid: True, node: 1095, tag: div, level: 8" node_number="1095"> <div class="valid" valid="valid" title="valid: True, node: 1096, tag: div, level: 9" node_number="1096"><div class="valid" valid="valid" title="valid: True, node: 1097, tag: div, level: 10" node_number="1097"> Topical Collection in Biomolecules</div> Feature Papers in Molecular Genetics Collection Editor: J&#252;rg B&#228;hler</div> <div class="valid" valid="valid" title="valid: True, node: 1098, tag: div, level: 9" node_number="1098"><div class="valid" valid="valid" title="valid: True, node: 1099, tag: div, level: 10" node_number="1099"> Topical Collection in Biomolecules</div> Feature Papers in Bioinformatics and Systems Biology Section Collection Editor: Lukasz Kurgan</div> <div class="valid" valid="valid" title="valid: True, node: 1100, tag: div, level: 9" node_number="1100"><div class="valid" valid="valid" title="valid: True, node: 1101, tag: div, level: 10" node_number="1101"> Topical Collection in Biomolecules</div> Feature Papers in Enzymology Collection Editor: Umesh Desai</div> <div class="valid" valid="valid" title="valid: True, node: 1102, tag: div, level: 9" node_number="1102"><div class="valid" valid="valid" title="valid: True, node: 1103, tag: div, level: 10" node_number="1103"> Topical Collection in Biomolecules</div> Feature Papers in Biological Factors Collection Editor: Tracey Martin</div> <div class="valid" valid="valid" title="valid: True, node: 1104, tag: div, level: 9" node_number="1104"> More Topical Collections </div> </div> </div> <div class="valid" valid="valid" title="valid: True, node: 1105, tag: div, level: 7" node_number="1105"> <div class="valid" valid="valid" title="valid: True, node: 1106, tag: div, level: 8" node_number="1106"> <h2 class="valid" valid="valid" title="valid: True, node: 1107, tag: h2, level: 9" node_number="1107">Jobs in Research</h2> </div> <div class="valid" valid="valid" title="valid: True, node: 1108, tag: div, level: 8" node_number="1108"> <div class="valid" valid="valid" title="valid: True, node: 1109, tag: div, level: 9" node_number="1109"> Post New Job Opening </div> </div> </div> </div> </div> </div> </section> <div class="valid" valid="valid" title="valid: True, node: 1110, tag: div, level: 3" node_number="1110"> <div class="valid" valid="valid" title="valid: True, node: 1111, tag: div, level: 4" node_number="1111"> Biomolecules, EISSN 2218-273X, Published by MDPI <span class="valid" valid="valid" title="valid: True, node: 1112, tag: span, level: 5" node_number="1112"> Disclaimer <div class="valid" valid="valid" title="valid: True, node: 1113, tag: div, level: 6" node_number="1113"> The statements, opinions and data contained in the journal Biomolecules are solely those of the individual authors and contributors and not of the publisher and the editor(s). MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations. </div> </span> <div class="valid" valid="valid" title="valid: True, node: 1114, tag: div, level: 5" node_number="1114"> RSS Content Alert </div> </div> <div class="valid" valid="valid" title="valid: True, node: 1115, tag: div, level: 4" node_number="1115"> <div class="valid" valid="valid" title="valid: True, node: 1116, tag: div, level: 5" node_number="1116"> <h3 class="valid" valid="valid" title="valid: True, node: 1117, tag: h3, level: 6" node_number="1117"> Further Information </h3> Article Processing Charges <a class="valid" valid="valid" title="valid: True, node: 1118, tag: a, level: 6" node_number="1118"> Pay an Invoice </a> <a class="valid" valid="valid" title="valid: True, node: 1119, tag: a, level: 6" node_number="1119"> Open Access Policy </a> <a class="valid" valid="valid" title="valid: True, node: 1120, tag: a, level: 6" node_number="1120"> Contact MDPI </a> <a class="valid" valid="valid" title="valid: True, node: 1121, tag: a, level: 6" node_number="1121"> Jobs at MDPI </a> </div> <div class="valid" valid="valid" title="valid: True, node: 1122, tag: div, level: 5" node_number="1122"> <h3 class="valid" valid="valid" title="valid: True, node: 1123, tag: h3, level: 6" node_number="1123"> Guidelines </h3> <a class="valid" valid="valid" title="valid: True, node: 1124, tag: a, level: 6" node_number="1124"> For Authors </a> <a class="valid" valid="valid" title="valid: True, node: 1125, tag: a, level: 6" node_number="1125"> For Reviewers </a> <a class="valid" valid="valid" title="valid: True, node: 1126, tag: a, level: 6" node_number="1126"> For Editors </a> <a class="valid" valid="valid" title="valid: True, node: 1127, tag: a, level: 6" node_number="1127"> For Librarians </a> <a class="valid" valid="valid" title="valid: True, node: 1128, tag: a, level: 6" node_number="1128"> For Publishers </a> <a class="valid" valid="valid" title="valid: True, node: 1129, tag: a, level: 6" node_number="1129"> For Societies </a> </div> <div class="valid" valid="valid" title="valid: True, node: 1130, tag: div, level: 5" node_number="1130"> <h3 class="valid" valid="valid" title="valid: True, node: 1131, tag: h3, level: 6" node_number="1131"> MDPI Initiatives </h3> <a class="valid" valid="valid" title="valid: True, node: 1132, tag: a, level: 6" node_number="1132"> Sciforum </a> <a class="valid" valid="valid" title="valid: True, node: 1133, tag: a, level: 6" node_number="1133"> MDPI Books </a> <a class="valid" valid="valid" title="valid: True, node: 1134, tag: a, level: 6" node_number="1134"> Preprints </a> <a class="valid" valid="valid" title="valid: True, node: 1135, tag: a, level: 6" node_number="1135"> Scilit </a> <a class="valid" valid="valid" title="valid: True, node: 1136, tag: a, level: 6" node_number="1136"> SciProfiles </a> <a class="valid" valid="valid" title="valid: True, node: 1137, tag: a, level: 6" node_number="1137"> Encyclopedia </a> <a class="valid" valid="valid" title="valid: True, node: 1138, tag: a, level: 6" node_number="1138"> JAMS </a> <a class="valid" valid="valid" title="valid: True, node: 1139, tag: a, level: 6" node_number="1139"> Proceedings Series </a> </div> <div class="valid" valid="valid" title="valid: True, node: 1140, tag: div, level: 5" node_number="1140"> <h3 class="valid" valid="valid" title="valid: True, node: 1141, tag: h3, level: 6" node_number="1141"> Follow MDPI </h3> <a class="valid" valid="valid" title="valid: True, node: 1142, tag: a, level: 6" node_number="1142"> LinkedIn </a> <a class="valid" valid="valid" title="valid: True, node: 1143, tag: a, level: 6" node_number="1143"> Facebook </a> <a class="valid" valid="valid" title="valid: True, node: 1144, tag: a, level: 6" node_number="1144"> Twitter </a> </div> </div> <div class="valid" valid="valid" title="valid: True, node: 1145, tag: div, level: 4" node_number="1145"> <div class="valid" valid="valid" title="valid: True, node: 1146, tag: div, level: 5" node_number="1146"> <div class="valid" valid="valid" title="valid: True, node: 1147, tag: div, level: 6" node_number="1147"> &#169; 1996-2021 MDPI (Basel, Switzerland) unless otherwise stated </div> <div class="valid" valid="valid" title="valid: True, node: 1148, tag: div, level: 6" node_number="1148"> <a class="valid" valid="valid" title="valid: True, node: 1149, tag: a, level: 7" node_number="1149"> Disclaimer </a> <div class="valid" valid="valid" title="valid: True, node: 1150, tag: div, level: 7" node_number="1150"> The statements, opinions and data contained in the journals are solely those of the individual authors and contributors and not of the publisher and the editor(s). MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations. </div> <a class="valid" valid="valid" title="valid: True, node: 1151, tag: a, level: 7" node_number="1151"> Terms and Conditions </a> <a class="valid" valid="valid" title="valid: True, node: 1152, tag: a, level: 7" node_number="1152"> Privacy Policy </a> </div> </div> </div> </div> <div class="valid" valid="valid" title="valid: True, node: 1153, tag: div, level: 3" node_number="1153"> <div class="valid" valid="valid" title="valid: True, node: 1154, tag: div, level: 4" node_number="1154"> We use cookies on our website to ensure you get the best experience. Read more about our cookies <a class="valid" valid="valid" title="valid: True, node: 1155, tag: a, level: 5" node_number="1155">here</a>. </div> <div class="valid" valid="valid" title="valid: True, node: 1156, tag: div, level: 4" node_number="1156"> <a class="valid" valid="valid" title="valid: True, node: 1157, tag: a, level: 5" node_number="1157">Accept</a> </div> </div> <div class="valid" valid="valid" title="valid: True, node: 1158, tag: div, level: 3" node_number="1158"> <div class="valid" valid="valid" title="valid: True, node: 1159, tag: div, level: 4" node_number="1159"> We have just recently launched a new version of our website. Help us to further improve by taking part in this short 5 minute survey here. here. </div> <div class="valid" valid="valid" title="valid: True, node: 1160, tag: div, level: 4" node_number="1160"> <a class="valid" valid="valid" title="valid: True, node: 1161, tag: a, level: 5" node_number="1161">Never show this again</a> </div> </div> </div> <div class="valid" valid="valid" title="valid: True, node: 1162, tag: div, level: 2" node_number="1162"> <div class="valid" valid="valid" title="valid: True, node: 1163, tag: div, level: 3" node_number="1163"> <div class="valid" valid="valid" title="valid: True, node: 1164, tag: div, level: 4" node_number="1164"> <h2 class="valid" valid="valid" title="valid: True, node: 1165, tag: h2, level: 5" node_number="1165">Share Link</h2> </div> <div class="valid" valid="valid" title="valid: True, node: 1166, tag: div, level: 4" node_number="1166"> <a class="valid" valid="valid" title="valid: True, node: 1167, tag: a, level: 5" node_number="1167">Copy</a> </div> </div> <a class="valid" valid="valid" title="valid: True, node: 1168, tag: a, level: 3" node_number="1168"> <i class="valid" valid="valid" title="valid: True, node: 1169, tag: i, level: 4" node_number="1169">clear</i> </a> </div> <div class="valid" valid="valid" title="valid: True, node: 1170, tag: div, level: 2" node_number="1170"> <div class="valid" valid="valid" title="valid: True, node: 1171, tag: div, level: 3" node_number="1171"> <div class="valid" valid="valid" title="valid: True, node: 1172, tag: div, level: 4" node_number="1172"> <h2 class="valid" valid="valid" title="valid: True, node: 1173, tag: h2, level: 5" node_number="1173">Share</h2> </div> </div> <a class="valid" valid="valid" title="valid: True, node: 1174, tag: a, level: 3" node_number="1174"> <i class="valid" valid="valid" title="valid: True, node: 1175, tag: i, level: 4" node_number="1175">clear</i> </a> </div> <a class="valid" valid="valid" title="valid: True, node: 1176, tag: a, level: 2" node_number="1176">Back to TopTop</a> </body>
        <style tyle='text/css'>
body{
    position: relative;
    padding-left: 30px;
    top: 60px;
}
* {
    border: 1px solid #eee;
    padding: 5px 12px;
    margin: 3px 0;
    box-sizing: content-box;
    background-color: #fff;
    cursor: no-drop;
}
main:hover > *, section:hover > *, header:hover > *, nav:hover > *, a:hover > *, div:hover > *, p:hover > *, ul:hover > *, h1:hover > *, h2:hover > *, h3:hover > *, li:hover > *, span:hover > *{
    border: 2px solid green;
    background-color: #fffeee;
    padding: 5px 23px !important;
    margin: 1px 0;
    color: green;
}
main:hover, section:hover, header:hover, nav:hover, a:hover, div:hover, p:hover, ul:hover, h1:hover, h2:hover, h3:hover, li:hover, span:hover{
    border: 1px solid #fff;
    background-color: #eee;
}
a, span {
    display: block;
}
.selected {
    border: 2px solid orchid !important;
    opacity: 0.8;
    color: orchid !important;
}
.selected * {
    padding: 2px !important;
    color: orchid !important;
}
.valid {
  cursor: pointer;
}
.btn{
  cursor: pointer;
  font-weight: bolder;
  padding: 8px;
}
</style> 
        <script>function OpenOriginalLink($event){
    $event.stopPropagation();
    console.log(url);
}

function removeItem($event){
    $event.stopPropagation();
    console.log('Remove item: ', url)
    localStorage.removeItem(url)
}

function exportData($event){
    $event.stopPropagation();

    result = []
    for(let i=0; i<localStorage.length; i++) {
        let key = localStorage.key(i);
        result.push(localStorage.getItem(key))
    }
    const _url = URL.createObjectURL(new Blob([result.join("\n")], {type: 'text/plain'}))
    $event.target.href = _url;
    localStorage.clear()
}

var removeItemBtn = document.createElement("BUTTON");   // Create a <button> element
removeItemBtn.innerHTML = "Remove Item";
removeItemBtn.classList.add('btn');
removeItemBtn.style.position = "fixed";
removeItemBtn.style.left = '5px';
removeItemBtn.style.top = 0;
removeItemBtn.style.border = "1px solid";
removeItemBtn.style.boxShadow = "3px 3px #888";
removeItemBtn.onclick = removeItem;
document.body.appendChild(removeItemBtn);

var goToOriginLink = document.createElement("A");   // Create a <button> element
goToOriginLink.innerHTML = "GoToOrigin";
goToOriginLink.classList.add('btn');
goToOriginLink.style.position = "fixed"
goToOriginLink.style.left = '115px'
goToOriginLink.style.top = 0;
goToOriginLink.onclick = OpenOriginalLink;
goToOriginLink.setAttribute('href', decodeURIComponent(url));
goToOriginLink.target = '_blank';
document.body.appendChild(goToOriginLink);

var current = new Date
var exportDataLink = document.createElement("A");   // Create a <button> element
exportDataLink.innerHTML = "Export data";
exportDataLink.classList.add('btn');
exportDataLink.download = current.toISOString() + '.exported.txt';
exportDataLink.style.position = "fixed";
exportDataLink.style.right = '5px';
exportDataLink.style.top = 0;
exportDataLink.style.border = "1px solid #888";
exportDataLink.style.boxShadow = "3px 3px #888";
exportDataLink.onclick = exportData;
document.body.appendChild(exportDataLink);

data = {
    'title': null ,
    'article': null
}

var body = document.getElementsByTagName("body")[0];

body.onclick = function($e){
    var num = $e.target.getAttribute('node_number')
    var valid = $e.target.getAttribute('valid')

    if(!valid){
        console.log("Element is invalid")
        return
    }

    if(data.length > 2){
        data = data.splice(0, 2)
    }

    console.log("node:", $e.target)

    if(!data.title && !data.article){
        data.title = num;
        console.log("data:", data)
        $e.target.classList.add('selected')
    }else if (data.title && !data.article){
        data.article = num;
        console.log("data:", data)
        $e.target.classList.add('selected')
    }else{
        selected = Array.from(document.getElementsByClassName("selected"))
        selected.forEach(function(el){
            el.classList.remove('selected')
        })

        data.title = num;
        data.article = null;
        $e.target.classList.add('selected')

    }

    if(data.title && data.article){
        var obj = {
            url: url,
            text: body_html,
            title: data.title,
            article: data.article,
        }

        var datasetItem = JSON.stringify(obj)
        localStorage.setItem(url, datasetItem)
    }
}
</script> 
      </html>